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Current treatment after the loss of tissues or organs is mostly limited to the use of tissue 
autografts (e.g. skin) and organ allografts (e.g. kidney). However, the availability of grafts is 
restricted due to donor shortage as well as donor site morbidity. Recent advances in tissue 
engineering and regenerative medicine offer promising strategies for the generation of biological 
substitutes, which could help to overcome the mentioned problems. The core elements of tissue 
engineering are multipotent stem cells that have been discovered within the adult body and 
modern biocompatible materials, optionally combined with growth factors. While first cell-based 
treatments for the regeneration of avascular tissues (e.g. cartilage) are starting to enter the 
clinics, the engineering of vascularized tissues or even full organs remains a key challenge, as fast 
oxygen and nutrient supply of an implant is essential for its long-term survival and successful 
healing. 
In this study we investigated the angiogenic potential of human dental pulp stem cells (hDPSCs) 
cultured on 3D silk scaffolds, since the dental pulp presents an easily accessible source of 
autologous multipotent mesenchymal stem cells, which have been previously shown to possess 
pro-angiogenic properties, and silk is a biomaterial that is approved for clinical use. We 
hypothesized that hDPSCs are able to attract the host’s vasculature and can contribute to the 
neovascularization of the silk implant while recreating their stem cell niche within the biomaterial 
without any additional supplements. 
HDPSC-seeded silk scaffolds attracted more vessels than empty scaffolds within the same 
incubation period in both chicken and mouse host organisms, resulting in better and faster 
integration of the implants into the surrounding tissue. Human cells were found to participate in 
functional blood vessels, expressing vWF, and being involved in the production of collagen type IV 
and laminin, the two main components of the vascular basement membrane. Increased collagen 
types I and III content, which plays an important role in wound healing processes, was present in 
cell seeded samples potentially improving the quality of the extracellular matrix that was 
produced within the scaffold. Furthermore, some cells of human origin within the scaffolds still 
expressed markers typical for undifferentiated mesenchymal cells, suggesting the presence of 
potential stem cell niches. 
Taken together, the results suggest that the presence of hDPSCs supports and improves the 
vascular and tissue integration of the 3D silk scaffold within the host tissue, which is an essential 
factor for the development of future cell-based treatment strategies of tissue loss caused by 




Die heutigen Behandlungsmethoden, die nach dem Verlust von Gewebe oder eines Organs zur 
Verfügung stehen, beschränken sich grösstenteils auf die Transplantation von patienteneigenem 
Gewebe (z.B. Haut) und die Transplantation von Spenderorganen (z.B. Niere). Diese stehen jedoch 
nicht in ausreichender Menge zur Verfügung und verursachen zusätzlich Wunden an der 
Entnahmestelle, die zu Komplikationen führen können. Jüngste Fortschritte im Bereich des Tissue 
Engineering und der Regenerativen Medizin bieten vielversprechende Strategien für die 
Herstellung von biologischem Gewebeersatz, die helfen könnten die genannten Probleme zu 
lösen. Kernbestandteile des Tissue Engineering sind multipotente Stammzellen, die auch bei 
Erwachsenen entdeckt wurden, als auch moderne biokompatible Materialien, die optional mit 
Wachstumsfaktoren kombiniert werden können. Während erste zell-basierte 
Behandlungsmethoden für die Regeneration von gefässfreien Geweben (z.B. Knorpel) bereits in 
der Praxis angewandt werden, bleibt das Herstellen von durchbluteten Geweben oder gar ganzen 
Organen weiterhin eine wesentliche Herausforderung, da eine schnelle Sauerstoff- und 
Nährstoffversorgung eines Implantats für dessen langfristiges Überleben sowie für eine 
erfolgreiche Heilung unerlässlich ist. 
In dieser Studie haben wir das angiogene Potential von humanen dentalen Pulpa-Stammzellen 
(hDPSZ), die auf einem 3D Seiden-Biomaterial kultiviert wurden, untersucht. Die Zahnpulpa ist 
eine leicht zugängliche Quelle zur Isolation von autologen multipotenten mesenchymalen 
Stammzellen, von denen man bereits weiss, dass sie ein pro-angiogenes Potential besitzen; Seide 
wiederum ist ein bereits klinisch zugelassenes Biomaterial. Wir haben die Hypothese aufgestellt, 
dass hDPSZ in der Lage sind Gefässe des Wirtsorganismus zum Einwachsen in das 3D Seiden-
Biomaterial anzuregen und direkt zur Bildung neuer Gefässe beitragen zu können, während sie 
ihre eigene Stammzellnische innerhalb des Biomaterials ohne den Einsatz von Zusatzstoffen 
nachbilden. 
Wir konnten zeigen, dass hDPSZ-besiedelte 3D Seiden-Biomaterialzylinder zu einer stärkeren 
Gefässbildung innerhalb des Biomaterials als zell-freie Konstrukte führten, sowohl nach 
Implantation auf der Chorioallantois-membran eines Hühnereis als auch subkutan in der Maus. 
Dies resultierte in einer besseren und schnelleren Integration des Implantats in das umliegende 
Gewebe. Humane Zellen waren an der Bildung von funktionsfähigen Blutgefässen beteiligt, 
exprimierten vWF und produzierten Kollagen Typ IV sowie Laminin, zwei der Hauptkomponenten 
der vaskulären Basalmembran. Ein erhöhter Kollagengehalt (Typ I und III), der bei der 
Wundheilung eine wichtige Rolle spielt, war in den zell-besiedelten Proben vorhanden und kann 
potentiell zur Qualitätsverbesserung der Zellmatrix, die innerhalb des Konstrukts produziert wird, 
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beitragen. Des Weiteren haben einige der Zellen humanen Ursprungs immer noch Marker 
exprimiert, die für undifferenzierte mesenchymale Stammzellen charakteristisch sind und daher 
suggerieren, dass potentielle Stammzellnischen vorhanden sind. 
Zusammenfassend lässt sich sagen, dass die Anwesenheit von hDPSZ die vaskuläre als auch die 
Gewebsintegration eines 3D Seiden-Biomaterials innerhalb eines Wirtsorganismus unterstützen 
und verbessern kann. Dieses Wissen stellt einen essentiellen Faktor für die Entwicklung von 






3.1 Regenerative medicine and tissue engineering 
The idea of generating artificial tissues, organs or entire organisms dates back to ancient times. A 
first reference of organ regeneration can be found as early as in Greek mythology. As an eternal 
punishment by Zeus, Prometheus is chained to a rock and is attacked by an eagle every night who 
pecks away his daily regrowing liver (Chen and Chen, 1994). The famous painting ‘Healing of 
Justinian’ by Fra Angeliac, showing the transplantation of a homograft limb onto an injured 
soldier, represents another historical example of the early vision of regenerative medicine. This 
fundamental desire of people to generate, heal, and regenerate body parts fueled the emergence 
of all the related disciplines in engineering, medicine, and life sciences, whose principles are 
combined in regenerative medicine and tissue engineering. Consequently, the term regenerative 
medicine is used to define a field in health sciences that aims to replace or regenerate human 
cells, tissues, or organs to restore or establish normal function (Mason and Dunnill, 2008). Tissue 
engineering in turn is considered a subfield of regenerative medicine, focusing strictly on the ex 
vivo engineering of tissues by seeding cells on or into supporting biomaterials, optionally including 
soluble molecules to encourage cell proliferation and differentiation, as well as tissue growth 
(Katari et al., 2015) before being used as a graft. In contrast, regenerative medicine includes also 
in vivo regeneration by cell recruitment, gene manipulation, or combinations of these two 
elements (Orlando et al., 2011). 
One of the first tissue engineering experiments was performed in 1988 (Vacanti et al., 1988). 
Mouse and rat hepatocytes, pancreatic islet cells, and cells from the small intestine were seeded 
onto biodegradable synthetic scaffolds, showing cell viability in culture, partial proliferation, as 
well as engraftment and vascularization of hepatocyte-seeded scaffolds in vivo. This and similar 
experiments (Cao et al., 1997) laid the foundation for the first tissue engineered product, i.e. 
artificial skin containing living keratinocytes and fibroblasts known as ApligrafTM (Alvarez et al., 
1998), approved by the FDA in 1998. Bioengineered vessels (Shin’oka et al., 2001), bladder and 
urethra tissue (Atala et al., 2006; Raya-Rivera et al., 2011), as well as autologous nasal cartilage 
tissues for facial reconstruction (Fulco et al., 2014) represent further milestones in tissue 
engineering. Recently, the first stem cell-based product has been approved by the European 
Commission, namely Holoclar® (EMEA/H/C/002450), which uses autologous stem cells in order to 
enable patients with severe corneal injury to regain sight (Pellegrini and De Luca, 2014). An 
exemplary product falling under the definition of regenerative medicine is the INFUSE® bone graft 
(Medtronic), an absorbable collagen sponge carrying recombinant human bone morphogenetic 
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protein 2 (BMP2) that induces stem cell differentiation into osteoblasts, which results in 
accelerated bone healing. The FDA approved it to be administered in lumbar spinal fusion 
procedures, in bone fractures, and in dental restoration (McKay et al., 2007; Mundy, 1999). 
The development of successful stem cell-based therapies is paving the way for personalized 
medicine, where each patient’s genetic makeup is taken into consideration for a more precise, 
predictable, and powerful health care. Autologous stem cell-based products (e.g. Holoclar®) allow 
for therapies without the risk of immune rejections or toxicity caused by the transplant and will 
play an important role in future treatment of congenital and acquired diseases, as well as in the 
regeneration of injury- or disease-induced tissue loss. 
Early tissue engineering approaches were using differentiated cell types isolated from the same 
tissues that needed to be repaired. However, since the first isolation of human embryonic stem 
cells in 1998 (Thomson et al., 1998), extensive work in regenerative medicine has focused on the 
application of these cells and other undifferentiated cells of adult origin in stem cell-based 
therapies aiming to regenerate lost or diseased tissues (Berthiaume et al., 2011). 
 
3.2 Stem cells 
The presence of stem cells in living organisms is essential in many ways. During embryogenesis 
they are the body’s raw materials that give rise to all the cells, organs, and tissues in the fetus’s 
body, whereas later in the adult body, stem cells are responsible for tissue maintenance and 
regeneration (Pessina and Gribaldo, 2006). Common properties of all stem cells are their unique 
ability to self-renew by going through numerous cell division cycles while remaining 
undifferentiated, as well as their potential to differentiate into specialized cell types under the 
influence of intrinsic and extrinsic signals (Morrison et al., 1997; Watt and Hogan, 2000; 
Weissman, 2000). Based on their plasticity, stem cells are classified as totipotent if they can give 
rise to an entire organism (i.e. cells of the zygote/morula during the first four days after 
fertilization) (Seydoux and Braun, 2006), as pluripotent if they can differentiate into cells of the 
three germ layers (e.g. embryonic stem cells isolated from the inner cell mass of the blastocyst 
forming on day five after fertilization) (Thomson et al., 1998), and as multipotent if they can 
produce differentiated cells from a closely related lineage system (e.g. mesenchymal stem cells 
isolated from bone marrow) (Weissman et al., 2001). Oligo- and unipotent stem cells possess 
limited differentiation capacities and can produce only a few cell types or only one cell type, 
respectively, but still have self-renewal capacity, which distinguishes them from non-stem cells 
(Wagers and Weissman, 2004). 
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3.2.1 Embryonic stem cells 
Cultures of pluripotent stem cells from mouse embryos were first established in 1981 (Evans and 
Kaufman, 1981) laying the basis for regenerative medicine, tissue repair, modern stem cell 
research and gene therapy applications. Moreover, the development of genetically modified mice 
from embryonic stem cells became an important tool for studying genes involved in many human 
diseases (the Nobel Prize in Physiology or Medicine 2007 was jointly awarded to Mario R. 
Capecchi, Sir Martin J. Evans, and Oliver Smithies). The technologies developed for the isolation, 
culture, and maintenance of mouse embryonic stem cell lines ultimately led to the isolation of 
pluripotent embryonic stem cells from the inner cell mass of human blastocysts (Thomson et al., 
1998). Due to their unique ability to differentiate into any cell of the three germ layers 
(endoderm, mesoderm, and ectoderm) as well as their indefinite proliferation capacity, these 
pluripotent stem cells could potentially be used for the generation of cells and tissues for cell-
based therapies to treat diseases such as macular degeneration, spinal cord injury, stroke, burns, 
heart disease, and diabetes (Chang et al., 2013; Hamrahi et al., 2012; Lambert et al., 2015; Priest 
et al., 2015; S. D. Schwartz et al., 2015; Szot et al., 2014). However, the prospect of using 
embryonic stem cells also induced an ethical and moral debate, as potential life has to be 
destroyed first before embryonic stem cells can be used for research or for the treatment of 
diseases (Wobus and Boheler, 2005). Additional therapeutic problems related to embryonic stem 
cells are genetic and epigenetic concerns, the development of tumors as a result of uncontrolled 
differentiation, and the graft-versus-host reaction when allogeneic stem cells are transplanted, 
which all have to be solved in order to apply these cells in clinics (Wobus and Boheler, 2005). 
Despite these issues, findings from embryonic stem cell research are essential for the progress 
and development of therapeutic applications of adult stem cells, just as the isolation of human 
embryonic stem cells would not have been possible without the initial isolation of embryonic 






Figure 3.1. Stem cells classified by their potency. The totipotent zygote divides to form the inner cell mass 
(ICM) containing pluripotent embryonic stem cells, and the trophoblast of the blastocyst. During 
embryogenesis the stem cells of the ICM continue to differentiate into more specific cell types and give rise 
to multipotent and unipotent adult stem cells, which remain within tissues and organs for tissue 




3.2.2 Adult stem cells and their niches 
Tissue homeostasis throughout life includes the regular elimination and replacement of 
differentiated cells preserving the form and function of developed tissues and organs by cell 
turnover (Pellettieri and Alvarado, 2007; Watt and Driskell, 2010), but also the repair of tissues 
after injury or disease (Caplan, 1991; Pittenger, 1999). Even organs that were previously 
considered non-renewing, like brain and heart, were found to exhibit cell turnover (Kajstura et al., 
1998; Lois and Alvarez-Buylla, 1993). These processes require the presence of adult stem cells, 
which have been discovered in various tissues including lung, intestine, pancreas, liver, mammary 
glands, umbilical cord blood, bone marrow, heart, muscle, adipose tissue, tooth, brain, skin, and 
eye (Bianco et al., 2001; Burke et al., 2007; Gilbert et al., 2010; Gronthos et al., 2000; Haegebarth 
and Clevers, 2009; Lau et al., 2012; O. K. Lee et al., 2004; Merkle et al., 2007; Messina et al., 2004; 
Nadri et al., 2008; Welm et al., 2003; Zuk et al., 2002). Collected evidence suggests that most, if 
not all tissues may contain stem cells with the potential to repair damaged tissue (Raff, 2003). In 
this context, organs with a higher cell turnover, like skin, the hematopoietic system, and the lining 
of the intestine are assumed to have a higher regenerative capacity than tissues with slower 
self-renewal rates, like heart tissue or the spinal cord (Pellettieri and Alvarado, 2007; Poss, 2010).  
Initially, adult stem cells were believed to be exclusively multi- or unipotent stem cells that give 
rise to mature cell types of their tissue of origin without crossing germ layer boundaries 
(Hombach-Klonisch et al., 2008; Wagers and Weissman, 2004). However, various cell 
differentiation studies using adult stem cell populations have provided evidence for so-called 
transdifferentiation, i.e. “the conversion of a cell of one tissue lineage into a cell of an entirely 
distinct lineage, with concomitant loss of the tissue-specific markers and function of the original 
cell type, and acquisition of markers and function of the transdifferentiated cell type” (Wagers 
and Weissman, 2004). Especially mesenchymal and hematopoietic bone marrow stem cells were 
reported to transdifferentiate into hepatocytes (R. E. Schwartz et al., 2002), endothelial and 
myocardial cells (Jackson et al., 2001), neuronal and glial cells (Sanchez-Ramos et al., 2000), and 
epithelial cells of the liver, gastrointestinal tract, lung, and skin (Krause et al., 2001). Although the 
concept of adult stem cell plasticity is still controversial (Chagastelles and Nardi, 2011), it is 
accepted that some types of adult stem cells (e.g. mesenchymal stem cells) do have an extended 
plasticity and may therefore be good candidates for cell-based therapies (Meirelles and Beyer 
Nardi, 2009). Compared to embryonic stem cells, adult stem cells could be used for autologous 
transplantations, limiting the risk of immunological rejection and avoiding many ethical issues of 
religious, historical, cultural, and medical origin (Brignier and Gewirtz, 2010). Furthermore, their 
lower differentiation potential reduces the risk of tumor formation (Smith, 2001). 
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Adult stem cells reside in so-called stem cell niches within the individual tissues and organs 
(Mitsiadis et al., 2007; Watt and Hogan, 2000), which are considered to be an anatomical 
structure harboring stem cells but even more a microenvironment regulating stem cell behavior, 
i.e. proliferation, differentiation, survival, and localization. The concept of a stem cell niche was 
first introduced by Schofield in 1978 (Schofield, 1978), who hypothesized the existence of a 
microenvironment required for the maintenance of stem cells. Within this highly regulated 
microenvironment, the residing stem cells interact with stromal support cells and tissue-specific 
cells by direct cell-cell contact through cadherins and integrins, as well as through secreted 
soluble factors, such as chemokines, growth factors, and hormones (Fig. 3.2). A three-dimensional 
(3D) scaffolding is provided by extracellular matrix (ECM) proteins, which play a key role in 
creating cell-guiding gradients of soluble growth factors and whose stiffness and elasticity, as well 
as its topography and shear forces provide mechanical cues that directly affect stem cell fate, a 
process known as mechanotransduction (Ingber, 1997). Blood vessels allow the transport of 
systemic signals and the recruitment of inflammatory and other circulatory cells into the niche 
(Jones and Wagers, 2008). Cells of the innate and adaptive immune system dynamically regulate 
the niche during inflammation or tissue damage (Lane et al., 2014) and even distant physiological 
cues, e.g. after injury, can reach the niche through neural inputs (Scadden, 2006). Another 
important feature of the stem cell niche is the presence of low oxygen tensions (i.e. hypoxia), 
which has been found to be essential for the maintenance of stem cells’ multipotency as well as 
self-renewal capacities. Additionally, cell proliferation, differentiation, and quiescence are directly 
influenced by cellular metabolism (Lane et al., 2014). Stem cell fate is also regulated by extrinsic 
cues (e.g. through signaling pathways) and intrinsic genetic signals, as well as by the interaction of 
both intrinsic and extrinsic factors. Positive and negative feedback mechanisms regulate stem cell 
self-renewal and differentiation through autocrine, paracrine, and endocrine signaling, thus 
keeping the ratio of self-renewing and differentiating stem cells in balance. 
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Figure 3.2. Composition of the stem cell niche. Cellular components, secreted factors, immunological 
control, ECM, physical parameters, and metabolic control regulate stem cell behavior and provide an 
anatomical structure that protects and maintains stem cells as well as their multipotency and self-renewal 
(Lane et al., 2014). 
 
3.2.3 Mesenchymal stem cells 
Multipotent mesenchymal stem cells (MSCs) are adult stem cells that were initially isolated from 
the bone marrow of mice by Friedenstein and co-workers in 1966, who described them as clonal, 
plastic adherent cells capable of forming colonies and differentiating into osteoblasts 
(Friedenstein et al., 1966). For many years, bone marrow stem cells (BMSCs) were considered the 
golden standard for mesenchymal stem cell research due to their high expansion potential and 
reproducible isolation procedures. Apart from differentiating into osteoblasts, MSCs were also 
found to give rise to other lineages of the connective tissue, such as the adipogenic, the 
chondrogenic, and the myogenic lineage (Pittenger, 1999). Furthermore, reports about the 
transdifferentiation potential of MSCs (Heo et al., 2013; Liang et al., 2015; Pokrywczynska et al., 
2015; Xin et al., 2015) increased the interest of using MSCs for the development of stem cell-
based regenerative therapies. Knowledge gained in numerous studies has led to the development 
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of many potential stem cell-based therapies being tested in clinical trials and the approval of a 
first MSC-based product, Prochymal® (Osiris Therapeutics, Inc., Columbia MD, USA), for the 
treatment of acute graft-vs-host disease in Canada and New Zealand (Vaes et al., 2012). 
Since the cell populations isolated from bone marrow are not homogenous and a unique 
combination of surface markers for the isolation of a pure MSC population is still missing, minimal 
criteria for defining MSCs have been determined by the International Society for Cellular Therapy 
(Dominici et al., 2006). According to these criteria, MSCs have to be plastic adherent under 
normal culture conditions, they should express CD73, CD90, CD105 and lack CD11b, CD14, CD19, 
CD34, CD45, or CD79α, and HLA-DR surface molecules. Finally, MSCs must differentiate in vitro 
into osteoblasts, adipocytes, and chondrocytes. 
 
3.2.4 Induced pluripotent stem cells 
Stem cell-based regenerative medicine has been revolutionized by reprogramming mature cells 
into so-called induced pluripotent stem cells (iPS cells), a technology, pioneered by Shinya 
Yamanaka and colleagues (the Nobel Prize in Physiology or Medicine 2012 was jointly awarded to 
Shinya Yamanaka and Sir John Gurdon). Initially, mouse embryonic and adult fibroblast were used 
for the induction of the first pluripotent stem cells from differentiated cells (Takahashi and 
Yamanaka, 2006), followed soon by the first human iPS cells generated from human adult 
fibroblasts (Takahashi et al., 2007). The iPS technology holds great promise as the generated cells 
can give rise to any cell type, similar to embryonic stem cells, while being ethically unproblematic. 
As any adult cell can be used for the generation of iPS cells independent of their differentiation 
status, patient-matched pluripotent stem cell lines could be used for personalized regenerative 
cell therapies one day (Robinton and Daley, 2012). However, their pluripotency is considered not 
only a benefit, but also a risk for teratoma formation, which cannot be fully controlled with 
currently available reprogramming methods. Although the initial protocol for generating iPS cells, 
which was based on retroviral gene delivery, has been improved over the years, technical 








3.3 Dental mesenchymal stem cells 
3.3.1 The origin of dental stem cells - the tooth 
Teeth are specialized organs of the orofacial complex located in the oral cavity (Fig. 3.3). In each 
tooth four different tissues can be distinguished, which are the mineralized enamel, cementum, 
and dentin, as well as the soft dental pulp. These tissues start forming between the 10th and the 
12th week of fetal development as a result of sequential and reciprocal interactions between the 
ectoderm-derived oral epithelium and the neural crest-derived ectomesenchyme (Mitsiadis and 
Graf, 2009). Enamel develops from ectoderm, while all the other structures of the tooth are of 
ectomesenchymal origin (Jiménez-Rojo et al., 2012).  
 
Figure 3.3. Schematic representation of the anatomy of a human tooth. The periodontal ligament attaches 
the tooth to the surrounding gingiva and alveolar bone. Nerve fibers and blood vessels enter the tooth 
through the apexes of the roots. Modified figure (Mitsiadis et al., 2012). 
In fully developed teeth the tooth crown is covered by enamel, which is the hardest and most 
mineralized tissue of the human body and does not contain any cells. A thin layer of cementum is 
lining the outer layer of the roots of a tooth and is part of the periodontium that is responsible for 
proper tooth attachment to the alveolar bone of the jaw. Dentin can be found in both crown and 
roots, just below the enamel and cementum layers, respectively. Located in the center of the 
tooth, the dental pulp is a soft connective tissue constituting the vital part of the tooth. 
Vascularization and innervation of the pulp are essential as they ensure nutrition and sensation, 
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respectively (Nanci, 2012). Structurally, four areas can be distinguished (Nanci, 2012). The 
innermost pulpal core, which contains the majority of the vascular supply and nerves, is 
surrounded by a cell-rich zone, including mainly fibroblasts and undifferentiated mesenchymal 
stem cells. The third layer is known as the cell-free zone of Weil, which harbors capillaries and 
small nerve fibers. Odontoblasts, the dentin producing cells, form the outer layer of the dental 
pulp and send cellular projections into channels called dentinal tubules of the mineralized dentin. 
The pulp as a whole is connected with the surrounding tissues exclusively through the apexes of 
the roots, which makes it difficult to treat pulpitis, a common tooth disease, without degenerating 
the tooth. 
Apart from their main function in mastication and speech, healthy teeth also play an important 
role in keeping our facial profile and a pleasant appearance. Additionally, postnatal or adult 
human teeth were found to harbor multipotent dental mesenchymal stem cell populations that 
can be isolated from the different tissue structures and are believed to be a promising cell source 
for applications in stem cell- based regenerative therapies (Tatullo et al., 2015). 
 
3.3.2 Dental pulp stem cells 
In 2000, Gronthos and colleagues were the first to isolate adult human dental stem cells, termed 
dental pulp stem cells (DPSCs), from the only vital part of the mineralized tooth, the dental pulp 
(Gronthos et al., 2000) (Fig. 3.4). Assumptions about the presence of stem cells in the dental pulp 
were based on the observation of reparative dentin formation after tooth injury. Further studies 
led to the conclusion that odontoblast apoptosis occurring after tooth injury activates DPSCs, 
which start proliferating, migrating, and differentiating into odontoblasts producing a thin layer of 
reparative dentin to close the pulp chamber (Mitsiadis et al., 2011). A precise characterization of 
this newly discovered stem cell population in vitro confirmed their self-renewal capability and 
multi-lineage differentiation capacity (Gronthos et al., 2002). Due to the lack of specific dental 
stem cell markers, identification relies on morphology, selective adherence, and their 
differentiation potential (Mitsiadis et al., 2011). DPSCs show phenotypic characteristics similar to 
BMSCs and were found to express more than 4000 known human genes on a comparable level as 
BMSCs (S. Shi et al., 2001). Additionally, a donor-matched comparison of DPSCs and BMSCs 
isolated from a single adult Sprague-Dawley rat revealed faster population doubling time and a 
higher percentage of stem/progenitor cells in DPSC populations (Alge et al., 2010). Furthermore, 
these cells can be induced in vitro to differentiate into osteo-/dentinogenic, adipogenic, 
chondrogenic, myogenic, and neurogenic lineages (About, Bottero, et al., 2000; d’Aquino et al., 
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2007; Gronthos et al., 2002; Huang et al., 2006; Laino et al., 2005; Woloszyk et al., 2014; W. Zhang 
et al., 2006). In vivo they were shown to form a dentin-pulp-like complex, odontoblast-like cells, 
and mineralized bone-like tissue (Huang et al., 2009). Therefore, these cells are considered to be a 
promising cell source especially for vascularized dental pulp (Hilkens et al., 2014; Huang et al., 
2010; Iohara et al., 2009) and bone tissue engineering (d’Aquino et al., 2007, 2009; Graziano et 
al., 2008; Woloszyk et al., 2014).  
 
3.3.3 Stem cells from human exfoliated deciduous teeth 
Similar to permanent teeth, the dental pulps of exfoliated human deciduous teeth also contain a 
population of multipotent stem cells, known as stem cells from human exfoliated deciduous teeth 
(SHEDs) (Miura et al., 2003) (Fig. 3.4). Apart from their self-renewal capacity with a higher 
proliferation rate than DPSCs, they were shown to differentiate towards the neurogenic, 
adipogenic, and osteogenic lineage in vitro. Unlike DPSCs, SHEDs failed to reconstitute a 
dentin-pulp-like complex in vivo but were found to induce new bone formation by recruiting 
murine host osteogenic cells (Miura et al., 2003). More recent studies have used SHEDs for the 
successful repair of critical-size calvarial defects with substantial bone formation in mice (Seo et 
al., 2008), as well as in a rat model of Parkinson’s disease, where SHEDs differentiated into 
dopaminergic neuronal-like cells, mitigating the symptoms of the disease (Wang et al., 2010). 
When transplanted into completely transected adult rat spinal cords, SHEDs promoted locomotor 
recovery by differentiating into mature oligodendrocytes and by inhibiting multiple axon growth 
inhibitors as well as the spinal cord injury-induced apoptosis of neurons, astrocytes, and 
oligodendrocytes (Sakai et al., 2012). In regenerative dentistry-based studies, SHED-seeded 
biodegradable PLLA-scaffolds inserted into human tooth slices were transplanted into 
immunodeficient mice, which resulted in the formation of a dental pulp-like tissue (Cordeiro et 
al., 2008). 
 
3.3.4 Periodontal ligament stem cells 
The periodontal ligament is composed of fibrous connective tissue fibers, with neural and vascular 
components, that spans between the tooth root cementum and the alveolar bone (Fig. 3.4). Its 
primary function lies in the dynamic but strong attachment of the tooth to the surrounding 
alveolar bone, while contributing to tooth homeostasis, nutrition, and repair of damaged tissues 
at the same time (Shimono et al., 2003). Periodontal ligament stem cells (PDLSCs) can be isolated 
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from the root surface of extracted teeth and have been shown to differentiate into adipogenic 
and osteogenic lineages in vitro (Seo et al., 2004). One potential application of PDLSCs could be 
the regeneration of the periodontal ligament itself in patients suffering from periodontitis (Y. Liu 
et al., 2008; Menicanin et al., 2014).  
 
3.3.5 Stem cells from the apical papilla 
During the development of permanent teeth, the growing roots are apically covered by a 
smooth-surfaced soft tissue, the so-called apical papillae (Fig. 3.4). Stem cells from the apical 
papilla (SCAPs) are considered to have a higher regeneration potential than DPSCs due to their 
higher proliferation rate and telomerase activity, as well as their enhanced migration capacity, 
which might be related to the developing stage of their tissue of origin (Sonoyama et al., 2006, 
2008). This cell population can give rise to osteo-/odontogenic as well as adipogenic lineages 
upon induction in vitro and the cells stain positive for several neural markers without neurogenic 
stimulation (Abe et al., 2007). Due to their origin from the neural crest, their expression of 
numerous neurogenic markers, and SCAP-mediated neurite outgrowth and axonal targeting, 
SCAPs have been recently applied in a rat hemisection model and were found to improve gait in 
spinally injured rats, while reducing glial reactivity at the same time (De Berdt et al., 2015).  
 
3.3.6 Dental follicle stem cells 
Apart from the apical papillae, dental mesenchymal stem cells can also be isolated from another 
developing dental tissue, known as the dental follicle (Fig. 3.4). This ectomesenchymal tissue 
surrounds the developing tooth germ prior to eruption and gives rise to the periodontal ligament, 
alveolar bone, and cementum of the functional tooth (Morsczeck et al., 2005). In co-cultures with 
DPSCs, dental follicle stem cells (DFSCs) were observed to increase their migration activity and 
velocity, while surrounding the present DPSCs, which resembles in vivo developmental processes 
(Schiraldi et al., 2012). Under specific culture conditions, DFSCs can differentiate towards several 
mesenchymal-derived cell types, such as osteoblasts, chondrocytes, and adipocytes in vitro 
(Kémoun et al., 2007). Therefore, their potential to contribute to bone regeneration was recently 
investigated in a rat cranial critical-size defect, where bone regeneration was only observed in 
defects treated with DFSCs-seeded polycaprolactone scaffolds but not in empty scaffolds (Rezai-




Figure 3.4. Sources of adult dental mesenchymal stem cells in the oral cavity. DFSCs, dental follicle stem 
cells; DPSCs, dental pulp stem cells; PDLSCs, periodontal ligament stem cells; SCAP, stem cells from the 
apical papilla; SHED, stem cells from human exfoliated deciduous teeth. Modified figure (Egusa et al., 2012). 
 
3.3.7 Dental stem cell banking 
For potential future applications in autologous cell-based treatments, multipotent adult stem cells 
can be stored in so-called cell banks. Structurally intact living cells and tissues can be preserved by 
using very low temperatures, usually -196°C when stored in liquid nitrogen. For a flexible use of 
autologous multipotent stem cells in regenerative medicine and tissue engineering, the 
optimization of cryopreservation methods is crucial. Even though dental stem cells can be isolated 
from any intact tooth and its surrounding tissues at any point of life, studies have shown that the 
regenerative capacity of stem cells is diminishing with age (Oh et al., 2014). Therefore, the 
cryopreservation of stem cells isolated from either deciduous teeth or developing tissues like the 
dental follicle or dental pulp of unerupted molars is potentially better than the ones from older 
fully developed teeth. Apart from deciduous teeth, the most suitable type of teeth for potential 
cryopreservation of adult stem cells are wisdom teeth, as their extraction is one of the most 
common dental surgical procedures, with 60-85% of the population having one or more wisdom 
teeth removed (American Association of Oral and Maxillofacial Surgeons). Unlike stem cells 
derived from bone marrow, dental stem cells can be isolated non-invasively from ‘medical waste’ 
without causing extra pain or morbidity and without the need for general anesthesia. Companies 
offering the isolation, testing, and preservation of dental pulp stem cells from deciduous and 
extracted teeth are already on the market (e.g. StemSave, Inc, New York, NY, USA). Although it is 
common practice to isolate the cells before freezing, several studies have shown that the 
21 
 
cryopreservation of either the whole tooth or the dental pulp tissue followed by cell isolation 
after freezing might yield even better results (H. S. Lee et al., 2015; Woods et al., 2009). 
 
3.4 Vascularization 
Blood vessel formation is essential in both physiological and pathological processes. 
Haematopoietic cells circulating within the vasculature supply the surrounding tissues with 
oxygen and nutrients, transport hormones, remove waste products and CO2, and protect the body 
from infections (Carmeliet and Jain, 2011). Vascular structures are formed in two ways, through 
vasculogenesis and through angiogenesis, both being conserved in embryonic and adult blood 
vessel formation. In embryonic vasculogenesis, the vascular system starts developing from small 
blood islands of mesoderm-derived angioblasts around day 18 (Larsen, 1998). These endothelial 
progenitor cells differentiate into endothelial cells and create vesicular structures, which fuse to 
form the primary vascular blood plexus (Risau, 1997) (Fig. 3.5 A). Although it was generally 
accepted for many years that vasculogenesis takes place only during embryonic development, 
several studies in the 1990s have presented evidence for a similar process taking place, 
postnatally. In 1994, it was reported for the first time that a vascular graft implanted in both the 
arterial and venous systems of a dog showed a so-called fallout endothelialization, i.e. scattered 
islands of confluent endothelium developed from cells deposited from the circulation on the 
inside of the implant, in addition to the expected ingrowth of neighboring vessels (Q. Shi et al., 
1994). After the identification of an antigenic profile on peripheral blood mononuclear cells 
similar to the one typically found on embryonic angioblasts (Asahara, 1997), the assumption that 
these circulating cells are adult endothelial progenitor cells contributing to adult/postnatal 
vasculogenesis gained further support (Asahara and Kawamoto, 2004; Kässmeyer et al., 2009) 
(Fig. 3.5 B). 
Once a primary capillary network is established, new capillaries are formed from these pre-
existing structures during both embryonic development as well as adult life through angiogenesis. 
The extension of the vasculature includes vessel enlargement, sprouting, bridging, and 
intussusception (division of individual capillaries into two separate vessels), which results in a 
hierarchically branched vascular system (Adams and Alitalo, 2007) (Fig. 3.5 C). Vessel branching 
requires tip cell formation, the degradation of the surrounding ECM by specific proteases, and 
proliferation of the cells behind the tip cell, which invades the avascular tissue (Carmeliet and 
Jain, 2011). Maturation of newly formed blood vessels requires the recruitment of mural cells 
(pericytes and vascular smooth muscle cells; vSMCs) as well as the production of extracellular 
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matrix proteins, mainly collagen type IV and laminin that assemble into the so-called basal lamina 
(Gaengel et al., 2009). Pericytes form a single, often discontinuous, cell layer on the outer wall of 
blood vessels providing structural support and interacting with the underlying endothelial cells 
(Armulik et al., 2005). While pericytes are typically found around blood capillaries, pre-capillary 
arterioles, and post-capillary venules (Allt and Lawrenson, 2001), vSMCs are rather associated 
with larger vessels, i.e. arteries and veins, where they form multiple continuous layers (Fig. 3.5 D). 
However, it is believed that a continuum of phenotypes ranging from the typical pericyte to the 
classical vSMC exists. vSMCs play a key role in the local control of blood flow by contraction and 
relaxation, and together with pericytes they are responsible for the synthesis and the 
maintenance of the extracellular components of the vascular wall that build up the basal lamina 
(Armulik et al., 2005).  
Figure 3.5. Development of the vascular system. De novo formation of vessels in (A) embryonic 
vasculogenesis and (B) adult vasculogenesis. (C) Extension of the primary capillary plexus by angiogenesis. 
(D) Vessel maturation and stabilization by recruitment of mural cells (pericytes and smooth muscle cells) 
and formation of a basal lamina resulting in a mature vascular network of arteries, capillaries, and veins. 
EPCs, endothelial progenitor cells; ECs, endothelial cells. Modified figure (Korpisalo and Ylä-Herttuala, 2010; 
Pardali et al., 2010). 
 
The main constituents of the vascular basal lamina include collagen type IV and laminin, which 
form independent networks that are linked by nidogens and the heparin sulfate proteoglycan 
perlecan, resulting in a dense highly cross-linked sheet of 50-100 nm in thickness. Apart from 
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providing mechanical support and dividing tissues into compartments, the vascular basal lamina 
also regulates cell behavior by modulating cell attachment, spreading, migration, matrix synthesis, 
and tube formation (Kalluri, 2003). The inner wall of all blood vessels is lined by endothelial cells, 
which form a selectively permeable barrier allowing the transport of molecules between blood 
and tissues. Additionally, they regulate blood coagulation and fibrinolysis, as well as the vascular 
tone, and participate in inflammatory reactions (Michiels, 2003). 
 
3.4.1 Vascularization strategies for tissue engineering 
Successful engineering of functional tissue substitutes and transplantable organs depends on 
rapid blood vessel formation towards the transplanted tissue as sufficient oxygen and nutrient 
supply is essential for the long-term survival of the implant. Except for very few tissues such as 
skin, cartilage, or cornea, most tissues of the body are vascularized by a dense network of 
capillaries with a maximum distance of 200 nm, correlating with the diffusion limit of oxygen 
(Carmeliet and Jain, 2000; Novosel et al., 2011). Since spontaneous vascular ingrowth into the 
implant from the host tissue is limited to several tenths of micrometers per day, the improvement 
and acceleration of implant vascularization remains a key challenge in tissue engineering 
(Rouwkema et al., 2008). 
In the last two decades, various vascularization strategies for tissue engineering have been 
proposed, tested, and refined. Based on the tissue engineering triad (Murphy et al., 2013), they 
include approaches focusing on the scaffold design, (progenitor) cell-based techniques, and the 
delivery of angiogenic (growth) factors, either alone or in combination. Vascularization is either 
initiated in vitro by engineering pre-vascularized constructs before implantation, or starts in vivo 
directly at the defect site or alternatively at a vascularization site for in vivo pre-vascularization 




Figure 3.6. Vascularization strategies for tissue engineering. Scaffolds, (progenitor) cells, and growth factors 
can be used either alone or in combination. Potential implants can be pre-vascularized in vitro or in vivo 
before being implanted at the defect site or can be implanted directly without pre-vascularization 
(Rouwkema et al., 2008). 
 
3.4.1.1 Scaffolds for the engineering of vascularized tissues 
Scaffolds are 3D frame structures used in tissue engineering, serving as templates for tissue 
regeneration, which guide the growth of new tissue (O’Brien, 2011). The ideal scaffold for an 
engineered tissue would be the ECM of the tissue it is meant to replace. While it remains difficult 
to produce the ECM of native tissues, the development and use of new scaffolds has produced 
many promising alternatives, with the aim to resemble the original as closely as possible. These 
include decellularized ECM, stacks of cell sheets with their own secreted ECM, as well as a wide 
range of porous scaffolds and self-assembling hydrogels, consisting of either one or combinations 
of more than one material (Chan and Leong, 2008). Required scaffold properties include 
biocompatibility, degradability without toxic by-products, adequate mechanical properties, and 
tissue-specific scaffold architecture (O’Brien, 2011). These properties are mainly determined by 
the choice of material(s) and the fabrication process.  
For successful vascularization of scaffold-based implants, porosity is “a critical determinant of 
blood-vessel ingrowth” (Rouwkema et al., 2008). Scaffolds with pores larger than 250 μm were 
shown to accelerate vessel ingrowth significantly when compared to scaffolds with smaller pores 
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(Laschke and Menger, 2012). Besides porosity, also the pore interconnectivity plays an important 
role to allow for proper cell migration and vascularization (Rouwkema et al., 2008). Common 
fabrication techniques used for the production of porous scaffolds are electrospinning, solvent 
casting/particle leaching, thermally-induced phase separation, melt molding, gas foaming, 
emulsion freeze-drying, 3D printing, selective laser sintering, and stereolithography  (Janik and 
Marzec, 2015; Loh and Choong, 2013). Three groups of biomaterials used for the fabrication of 
scaffolds can be distinguished: ceramics, synthetic polymers, and natural polymers (O’Brien, 
2011). Ceramic scaffolds (e.g. hydroxyapatite, tri-calcium phosphate, bioglass) are characterized 
by a high mechanical stiffness and are mainly applied in dental and orthopaedic surgery to treat 
bone defects. Popular synthetic polymers are polystyrene, poly-l-lactic acid (PLLA), polyglycolic 
acid (PGA), and poly-lactic-co-glycolic acid (PLGA). Their architectural and degradation properties 
can be easily modified and their 3D structure is highly reproducible; however, their reduced 
bioactivity might result in immune rejection. Naturally-derived biopolymer scaffolds include 
proteins, such as silk, collagen, and gelatin, as well as polysaccharides like hyaluronan, cellulose, 
and amylose as their raw materials. These materials are bioactive and biodegradable, but the 
production of homogenous and reproducible structures is often difficult, and mechanical stability 
is limited (Novosel et al., 2011; O’Brien, 2011). 
3.4.1.2 Cell-based strategies for the engineering of vascularized tissues 
The use of cell-based techniques to generate vascularized tissues has several advantages. 
Relevant cells can be isolated from various tissues for autologous cell therapy, including 
endothelial precursor cells from circulating blood (Asahara et al., 2011), endothelial cells from 
human umbilical vein (Novosel et al., 2011) or from the microvasculature of adipose tissue and 
skin (Hewett, 2009), as well as multipotent adult stem cells, which decreases the risk for immune 
rejection and increases the biocompatibility of the implant. Furthermore, the use of cell-based 
grafts can stimulate the endogenous release of angiogenic growth factors induced by the 
experienced hypoxia at the implant site, triggering the ingrowth of new blood vessels from the 
surrounding tissue (Laschke et al., 2006). Additionally, cells can be transfected to overexpress 
angiogenic factors resulting in the release of cytokines that can regulate endothelial cell 
migration, proliferation, and maturation into tubular vessels in a controlled way (Lovett et al., 
2009). To achieve vascularization, the cells can be grown in vitro as spheroid co-cultures or as 
simple mix co-cultures of endothelial (precursor) cells with tissue-specific cells, which can produce 
capillary-like sprouts, especially in the presence of angiogenic factors, such as vascular endothelial 
growth factor (VEGF) or basic fibroblast growth factor (bFGF) (Lovett et al., 2009). However, 
rather than being applied alone, cells are mainly used to functionalize scaffolds by seeding them 
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with endothelial cells only or as co-cultures with pericytes, vSMCs, fibroblasts, mesenchymal stem 
cells, osteoblasts, or other specialized cells. Cell-seeded scaffolds can be implanted directly or 
further processed for in vitro pre-vascularization before implantation (Costa-Almeida et al., 2014). 
3.4.1.3 Growth factors 
The application of growth factors is another possibility to functionalize a previously produced 
scaffold by loading or chemically coupling angiogenic factors, such as VEGF, bFGF, and 
platelet-derived growth factor (PDGF) (Lovett et al., 2009). These can attract endothelial 
(precursor) cells from existing vasculature of the host tissue or can induce the secretion of several 
factors by activating signaling pathways, thereby accelerating the onset of angiogenesis towards 
the inside of the graft and the maturation of newly formed vessels (Rouwkema et al., 2008). 
Recombinant proteins can be delivered either through passive diffusion or are released locally in 
response to cellular demand when degraded by matrix metalloproteinases secreted by ingrowing 
endothelial cells (Ehrbar et al., 2004). However, the use of growth factors for the vascularization 
of engineered tissues also requires a strict coordination of the correct signaling factors, dosing, 
and exposure time points (Phelps and García, 2010). 
The presented strategies can be combined in various ways to bring together the advantages of 
scaffolds, cells, and growth factors to encourage the formation of vessel networks inside the graft. 
However, not only vessel formation, but also the maturation and functionality of the engineered 
or ingrown vessels from the host are important. Finally, for clinical success, the manufacturing 
technology of scaffolds and growth factors should be commercializable and the procedures for 
generating personalized grafts clinically applicable.  
 
3.5 Chorioallantoic membrane assay 
The study of vascularization is based on so-called angiogenesis assays. One of the well-established 
assays is the chorioallantoic membrane (CAM) assay (Fig. 3.7). During the development of the 
chicken three extraembryonic membranes are formed: the yolk sac membrane, the amnion, and 
the CAM. The CAM is highly vascularized and serves as a transient gas exchange surface during 
the incubation period, similar to the lung (Romanoff, 1960). Originally, the CAM assay was used in 
order to study the developmental potential of embryonic tissue grafts (Laschke et al., 2006). As 
chicken embryos become immunocompetent only by day 18 of their development (Janković et al., 
1975), various biological processes where vascularization plays a role can be studied, including 
insufficient vascularization (e.g. ischemic disorders) or excessive vessel formation (e.g. cancer), 
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with the goal to either enhance or decrease vessel growth, respectively (Ribatti, 2014). In tissue 
engineering, experimental models are required to study blood vessel ingrowth into engineered 
tissue implants. Compared to other in vivo angiogenesis assays (e.g. dorsal skinfold chamber, 
subcutaneous implantation in mice), the CAM assay is a simple, cost-effective, and highly 
reproducible method, which does not require an ethical approval when performing experiments 
in chicken embryos until embryonic day 14 (Swiss animal care guidelines, TSchV, Art. 112). 
Additionally, the chicken embryo serves as a natural bio-incubator, as grafted tissues and cells can 
be sustained without any additional media supply. Even though the incubation time on the CAM is 
limited to a period of about one week, it constitutes an excellent screening method, which allows 
the study of cell behavior, i.e. proliferation, migration, and differentiation, within 3D biomaterials 
during the early phase of vascularization. Apart from the effect of different cell populations, also 
the influence of growth factors, gene therapy, as well as the architecture and material properties 
of scaffolds on blood vessel ingrowth can be investigated. Various available in situ imaging and 
quantification methods including magnetic resonance imaging of the blood flow (Kivrak Pfiffner et 
al., 2015) enhance the scientific impact and the range of application of the CAM assay. Following 
the ‘3Rs’ principles of replacement, refinement, and reduction of animal use in research, the CAM 
assay provides a valuable intermediate platform for rapid assessments prior to pre-clinical studies 
in mammals (Nowak-Sliwinska et al., 2014). 
 
Figure 3.7. Chorioallantoic membrane assay. (A-D) Fertilized chicken egg cultured in a plastic dish on 
embryonic day 3 (ED 3) (A), ED 7 (B), ED 10 (C), and ED 14 (D). (E) Egg incubation after opening the shell. 
(F) Egg with a sample placed within a silicone ring after 1 week of incubation. (G, H) Vascularized scaffold 




4. Aims of the project 
The requirement for tissue and organ replacement is high and is expected to increase due to 
population ageing, especially in highly developed countries. Advances in tissue engineering and 
regenerative medicine can offer new therapies for the treatment of tissue or organ loss induced 
by injury or disease. Hence, the shortage of donor tissues and organs could be overcome by 
applying the principles of cell transplantation, bioengineering, and material science, and 
combining them to generate biological substitutes with the potential to regenerate and replace 
lost tissues and organs. The discovery of various multipotent stem cell populations in the adult 
body has provided ethically unproblematic cell sources that could potentially be used for 
autologous cell-based therapies with a reduced risk for immune rejection. The selected cell 
population should not only be easily accessible, but should also have a good proliferative 
potential to obtain high cell numbers in cell culture, as well as the required differentiation 
potential. Additionally, rapid vascularization and integration of a tissue engineered transplant into 
the surrounding host tissues is a prerequisite for its long-term survival. 
Teeth present an easily accessible cell source, as deciduous teeth or commonly extracted 
(wisdom) teeth could be banked for autologous or maybe even allogeneic therapeutic use in the 
future without any additional discomfort for the patient once tissue or organ replacement is 
necessary later in life. Multipotent mesenchymal stem cells isolated from the human dental pulp 
reside in perivascular stem cell niches and have been shown to express angiogenic factors, 
suggesting an angiogenic potential of human dental pulp stem cells (hDPSCs). 
In the present study we hypothesize that hDPSCs are able to attract the host’s vasculature and 
contribute to the vascularization of a three-dimensional (3D) silk scaffold while recreating their 
own stem cells niche within the biomaterial without any additional supplements. In this context, 
also the question if using a CD34+/CD90+ sorted hDPSC population is beneficial for the 
vascularization and integration efficiency of the implant when compared to unsorted hDPSCs 
should be answered. Therefore, freshly isolated hDPSCs will be characterized and sorted before 
seeding unsorted and sorted cells on 3D silk scaffolds placed on the chorioallantoic membrane of 
fertilized chicken eggs (i.e. in ovo culture). By analyzing the expression of endothelial stem cell 
markers, components of the extracellular matrix, as well as stem cell markers, the tissue 
structures inside the biomaterial will be characterized to test our hypothesis. Following this 
analysis, empty and cell-seeded silk scaffolds will be implanted subcutaneously in 
immunocompromised mice in order to assess the validity of the results obtained in ovo as well as 
to assess the long-term effect that unsorted and sorted hDPSC populations will have on the tissue 
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integration of 3D silk scaffolds. Finally, MicroFil® perfusion followed by a visualization and analysis 
by microcomputed tomography will be adapted and applied to in ovo cultured samples in order to 




5. Materials and Methods 
5.1 Production of silk fibroin scaffolds 
Silk fibroin scaffolds were produced using the salt leaching technique as previously described 
(Hofmann et al., 2007; Nazarov et al., 2004; Sofia et al., 2001). Silkworm cocoons (Trudel Inc., 
Zurich, Switzerland) were boiled twice for 1 h in 0.02 M sodium carbonate (Fluka AG, Buchs SG, 
Switzerland) and rinsed with ultrapure water (UPW) to extract sericin. After drying, the silk was 
dissolved in 9 M lithium bromide and dialyzed against UPW for 36 h using a Slide-A-Lyzer™ 
Dialysis Cassette (Fisher Scientific AG, Wohlen, Switzerland) followed by lyophilization (Alpha 1-2, 
Martin Christ GMBH, Osterode am Harz, Germany). A 17% (w/v) silk fibroin solution was prepared 
by dissolving lyophilized silk in 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP) (abcr GmbH & Co., 
Karlsruhe, Germany). This solution was added to Teflon containers filled with sodium chloride 
(200-300 mm in diameter) (Sigma-Aldrich Chemie GmbH, Buchs SG, Switzerland) at a ratio of 1:20 
(silk fibroin:NaCl). After complete evaporation of HFIP, conformational transition from α- to β-
sheet domains was induced by immersing the blocks in 90% methanol (Sigma-Aldrich Chemie 
GmbH, Buchs SG, Switzerland) for 30 min (Sofia et al., 2001). The scaffolds were dried for at least 
48 h before sodium chloride was leached out in five changes of UPW within 48 h resulting in 
scaffolds with more than 90% porosity (Nazarov et al., 2004). Wet silk fibroin scaffolds were cut 
into cylinders of 5 mm diameter and 3 mm height by using a mold, a razor blade, and a biopsy 
punch. These scaffolds were sterilized by autoclaving at 121°C and 1 bar for 20 min. 
 
5.2 Cell isolation, culture, and sorting 
The procedure for anonymized cell collection was approved by the Kantonale Ethikkommission of 
Zurich (reference number 2012-0588) and performed with patients’ written consent.  
Human dental pulps were obtained from healthy teeth of adult patients within 24 h after the 
extraction of impacted wisdom teeth. After the removal of the dental pulp from the tooth, human 
dental pulp stem cells (hDPSCs) were isolated as previously described (Gronthos et al., 2000; 
Tirino et al., 2012). Dental pulps were enzymatically digested in a solution of 3 mg/mL collagenase 
type I (Life Technologies Europe B.V., Zug ZG, Switzerland) and 4 mg/mL dispase (Sigma-Aldrich 
Chemie GmbH, Buchs SG, Switzerland) for 1 h at 37°C. For a single-cell suspension the solution 
was filtered through a 70 µm strainer (Falcon, Corning, Root Längenbold LU, Switzerland) and 
plated in a 35 mm Petri dish after washing away the enzyme solution. Sorted hDPSCs (s-hDPSCs) 
were obtained by isolating a CD34+/CD90+ subpopulation using antibodies (CD34: Miltenyi Biotec, 
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Bergisch Gladbach, Germany; CD90: BD Biosciences, Allschwil BL, Switzerland) and fluorescence-
activated cell sorting (FACS) (FACSAria™, Beckton, Dickinson and Company, Franklin Lakes, NJ, 
USA). Unsorted and sorted were expanded using DMEM/F12 (Sigma-Aldrich Chemie GmbH, Buchs 
SG, Switzerland), 10% fetal bovine serum (FBS) (Biochrom AG, Berlin, Germany), 
1% Penicillin/Streptamycin (P/S) (Sigma-Aldrich Chemie GmbH, Buchs SG, Switzerland), and 
0.5 µg/mL fungizone (Thermo Fisher Scientific AG, Reinach BL, Switzerland) with medium changes 
every 3-4 days and were passaged at 80-90% confluency. 
 
5.3 Cell characterization 
5.3.1 Flow cytometry 
For flow cytometric characterization unsorted hDPSCs (uns-hDPSCs) were stained with CD34 
antibodies conjugated to PE (Miltenyi Biotec, Bergisch Gladbach, Germany) and CD45 antibodies 
conjugated to APC-Cy7, as well as with CD90 antibodies conjugated to FITC and CD105 antibodies 
conjugated to PerCP-Cy5.5 (CD45, CD90, CD105: BD Biosciences, Allschwil BL, Switzerland) 
according to the manufacturers’ protocols. Cell debris and dead cells were excluded from the 
analysis based on scatter signals and 7-aminoactinomycin D staining (Thermo Fisher Scientific AG, 
Reinach BL, Switzerland). 
5.3.2 Immunocytochemistry 
For immunocytochemical characterization uns-hDPSCs and s-hDPSCs were grown on 8-well glass 
slides (Millipore, Merck & Cie, Schaffhausen SH, Switzerland) for 24 h and were stained with 
anti-Nestin (1:100; MA1-110, Thermo Fisher Scientific AG, Reinach BL, Switzerland) anti-Sox2 
(1:200; ab59776, Abcam plc, Cambridge, United Kingdom), and anti-Vimentin (1:300; M0725, 
Dako, Glostrup, Denmark) antibodies. The primary antibodies were detected using secondary 
antibodies conjugated to Alexa Fluor® 488 (Thermo Fisher Scientific AG, Reinach BL, Switzerland). 
Cell nuclei were stained with 4',6-diamidino-2-phenylindole (DAPI; Thermo Fisher Scientific AG, 
Reinach BL, Switzerland). Slides were mounted with Vectashield® (Reactolab, S.A., Servion VD, 
Switzerland). 
 
5.4 Cell proliferation assay 
Uns-hDPSCs isolated from wisdom teeth of three patients were seeded in 24-well-plates at a 
density of 2 x 104 cells/well in 400 μL of hDPSC growth medium, respectively. On day 1, day 3, and 
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day 7, the medium was changed before 40 μL of MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide) was added followed by an incubation at 37°C for 3 h. After the 
medium was removed, the formed formazan crystals were solubilized by adding 200 μL of acidic 
isopropanol per well and incubating for 15 min at RT in the dark. The solution was transferred to 
wells of a 96-well-plate and the absorbance of the converted dye was measured at 570 nm with 
background subtraction at 690 nm. 
 
5.5 Cell cytotoxicity assay 
Uns-hDPSCs were seeded in wells of a 96-well-plate at a density of 5 x 103 cells/well in 100 μL of 
growth medium (see section 5.2). On day 1, day 3, and day 7, supernatant was collected and used 
to determine lactate dehydrogenase (LDH) cytotoxicity according to the manufacturer’s 
instructions (Thermo Fisher Scientific AG, Reinach BL, Switzerland). Absorbance was measured at 
490 nm with background subtraction at 680 nm. 
 
5.6 Cryopreservation of cells 
At passage 2 (P2), the cells were detached from the culture flasks by tripsinization. In detail, the 
cell monolayer was washed with PBS twice before trypsin (Sigma-Aldrich Chemie GmbH, Buchs 
SG, Switzerland) was added for 3 min at 37°C for cell detachment and was stopped by the 
addition of growth medium. Next they were pelleted (5 min, 1,500 rpm, RT) and resolved in a 
concentration of 1 · 106 cells/400 μL growth medium. Labeled cryotubes were placed in a freezing 
container and filled with 100 μL of a 1:1 mix containing pure FBS and 50 μL of dimethyl sulfoxide 
(Sigma-Aldrich Chemie GmbH, Buchs SG, Switzerland). 400 μL of the cell suspension were added 
to each cryotube for a final volume of 500 μL. The freezing container was kept at -80°C for 
approximately 4 h before transferring the cryotubes into a liquid nitrogen storage tank. 
 
5.7 Differentiation assays 
5.7.1 Osteogenic differentiation 
Uns-hDPSCs and s-hDPSCs were seeded in 24-well-plates at a density of 2 x 104 cells/well in 
400 μL of growth medium (see section 5.2), respectively, and were incubated for 24 h. On the 
next day, the growth medium was replaced by DMEM high glucose containing 10% FBS and 
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1% P/S as well as a mix of ingredients for osteogenic differentiation, which were 0.1 mM 
L-ascorbic acid, 10 mM β-glycerophosphate, and 10 nM dexamethasone (all Sigma-Aldrich Chemie 
GmbH, Buchs SG, Switzerland). Controls were cultured with the same basic media without the 
addition of the osteogenic ingredients. Medium was changed every 3-4 days. After 21 days of 
culture, the cells were washed in PBS and fixed in 4% paraformaldehyde (PFA) for 30 min at RT. 
The PFA solution was washed away and Alizarin Red S staining solution (Sigma-Aldrich Chemie 
GmbH, Buchs SG, Switzerland) was added to the cells followed by an incubation in the dark for 45 
min at RT. The cells were washed four times with distilled water (dH2O) and pictures were taken 
immediately for documentation. Extracellular calcium deposits appeared bright orange-red. 
5.7.2 Chondrogenic differentiation 
0.5 x 106 of uns-hDPSCs and s-hDPSCs were pelleted in 15 mL Falcon tubes (Falcon, Corning, Root 
Längenbold LU, Switzerland) by centrifugation (5 min, 1500 rpm, RT). The supernatant (500 μL) 
was not removed and the cap was kept loose for gas exchange. After 48 h, the growth medium 
was replaced by chondrogenesis differentiation medium (StemPro® Chondrogenesis 
Differentiation Kit, Thermo Fisher Scientific AG, Reinach BL, Switzerland), which was changed 
every 2-3 days. Controls were grown in DMEM low glucose with GlutaMAXTM (Thermo Fisher 
Scientific AG, Reinach BL, Switzerland) containing 10% FBS and 1% P/S. After 21 days of culture, 
the cell pellets were washed in PBS and fixed in 4% PFA for 30 min at RT. They were washed in 
PBS and embedded in cryo embedding medium (Medite GmbH, Burgdorf, Germany) in order to 
cut 10 μm sections (Cryostat CM3050 S, Leica Biosystems AG, Muttenz BL, Switzerland) for Alcian 
Blue staining (Sigma-Aldrich Chemie GmbH, Buchs SG, Switzerland). Blue staining indicated the 
synthesis of proteoglycans by chondrocytes. 
5.7.3 Adipogenic differentiation 
Uns-hDPSCs and s-hDPSCs were seeded in 48-well-plates at a density of 2 x 104 cells/well in 
200 μL of DPSC growth medium. Before changing the regular growth medium to adipogenesis 
differentiation medium (StemPro® Adipogenesis Differentiation Kit, Thermo Fisher Scientific AG, 
Reinach BL, Switzerland), the cells were cultured for 3 more days until 75% confluency. The 
differentiation medium was changed every 3-4 days. After 21 days, the differentiation was 
stopped and Oil Red O staining was performed to confirm adipogenic differentiation. The cell 
monolayers were washed with PBS, fixed with PFA for 30 min at RT, and were washed with dH2O 
before adding 60% isopropanol for 5 min at RT. The isopropanol was replaced by freshly prepared 
Oil Red O staining solution followed by an incubation of 15 min at RT. After the staining, the cells 
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were first washed with dH2O until the water became clear, and were then covered with PBS for 
microscopic analysis and documentation. Lipid vesicles in mature adipocytes stained bright red. 
 
5.8 Cell seeding 
The cells were seeded on sterile silk fibroin scaffolds at a density of 1 x 106 cells per scaffold in a 
volume of 60 μL of growth medium (see section 5.2). For cell attachment, the seeded scaffolds 
were placed in a humidified incubator for 1 h at 37°C. Non-attached cells were washed away from 
the scaffolds, which were incubated for additional 24 h at 37°C before being placed on the 
chorioallantoic membrane (CAM) of fertilized chicken eggs (see 5.9) or subcutaneously in 7 week-
old BALB/c Nude Mice (see 5.10). Scaffolds for the in vivo experiment contained cells labeled with 
1,1'-Dioctadecyl-3,3,3',3'-Tetramethylindocarbocyanine Perchlorate (DiI) according to the 
manufacturer’s protocol (Thermo Fisher Scientific AG, Reinach BL, Switzerland). 
 
5.9 Chorioallantoic membrane assay 
No approval is necessary when performing experiments in chicken embryos until embryonic day 
14 (ED 14) according to Swiss animal care guidelines (TSchV, Art. 112). Fertilized Lohman white 
LSL chicken eggs (Animalco AG, Staufen AG, Switzerland) were pre-incubated for 3 days at 38°C at 
a rotation speed of 360°/4 h (Bruja 3000, Brutmaschinen-Janeschitz GmbH, Hammelburg, 
Germany). On ED 3, the eggs were processed for in ovo (Fig. 5.1) cultivation. Before opening the 
eggs, the egg shell was wiped with 70% ethanol. In ovo cultivation required the opening of the 
shell using ScotchTM tape and scissors after removing 4 mL of albumen through a small hole in the 
shell to lower the developing embryo. The egg was stabilized in a 60 mm Petri dish lid and the 
opening was covered with a second 60 mm Petri dish lid, which was fixed to the bottom lid with 
tape. The eggs were incubated at 37°C. On ED 7, empty and cell-seeded scaffolds were placed on 
the CAM (1-2/egg) in the middle of previously placed silicone rings (taken from sterile cryovials) to 
ensure a flat surface and were incubated for 7 days until ED 14. 
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Figure 5.1. Scheme of the experimental setup. The scaffold is placed in the middle of a silicone ring on top 
of the CAM of a fertilized egg grown inside the egg shell (in ovo) for histological and molecular analysis or 
for MicroFil® perfusion followed by microCT scanning. CAM, chorioallantoic membrane. 
 
5.10 In vivo assay 
All animal experiments were carried out in accordance with the Swiss Animal Welfare Law and in 
compliance with the regulations of the Cantonal Veterinary office of Zurich and with the 
permission of the Animal Ethics Committee (license number: 11/2014). 12 nude mice (BALB/c 
Nude Mice - CAnN. Cg-Foxn1nu/Crl, Charles River, Cologne, Germany) were used at 7 weeks of 
age. Buprenorphine (0.1 mg/kg bodyweight) was injected subcutaneously one hour before the 
surgery. For surgery, the mice were anesthetized using isoflurane (3-5% for induction and 1-3% 
for maintenance). The mice were placed on a warming pad in a prone position and four 
subcutaneous pouches were prepared to hold the scaffolds on the back of the mice. 
Subsequently, the wounds were closed with an absorbable polyglycolic acid suture (Resorba 
Wundversorgung GmbH + Co. KG, Nürnberg, Germany). After cleaning the surgical site, the mice 
were kept on a warming pad under observation until they regained consciousness. For pain 
management, Buprenorphine (0.1 mg/kg bodyweight) was injected subcutaneously 8 h after the 
surgery. Moreover, Buprenorphine (1 mg/kg bodyweight) was added to the drinking water and 
the level was marked to make sure that the mice consume the water containing the analgesic. 








5.11.1 MicroFil® perfusion and microCT imaging 
On ED 14, the chicken embryos were perfused with a mix of the MicroFil® components (Flow 
Tech, Inc., Carver MA, USA). The silicone rubber injection compound (yellow) was diluted 10-fold 
in MV-Diluent and 10% (by weight) of MV-Curing Agent was added right before use. Working time 
of the MicroFil® was at least 20 min and started with the addition of the MV-Curing agent. The 
MicroFil® mix was filled into a 5 mL syringe (B. Braun Melsungen AG, Melsungen, Germany) to 
which a three-way valve (Discofix® C; B. Braun Melsungen AG, Melsungen, Germany) with a 10 cm 
tube was attached for more flexibility between the 30G ½” needle (Beckton, Dickinson and 
Company, Franklin Lakes, NJ, USA) and the syringe. Using a stereoscope, a branch of the vitelline 
vasculature matching the diameter of the needle was fixed with blunt end tweezers and the 
needle was carefully inserted into the vessel. A small drop of superglue was applied where the 
needle entered the vasculature. The MicroFil® mix was carefully injected into the vasculature until 
the pressure increased. If the filling of the vasculature was not sufficient after the first injection, 
MicroFil® was injected a second time into a non-perfused vessel. Next, the tube was removed 
from the needle, which remained in the CAM. A fresh needle was attached to the tube before 
continuing with the injection. The perfused chicken embryo was placed overnight at 4°C for 
complete curing of the MicroFil®. On the next day, the perfused scaffold samples were cut out 
from the CAM using scissors, washed in PBS, fixed in 4% PFA, washed in PBS, and placed in 70% 
ethanol until imaging. MicroCT scanning (μCT 40; Scanco Medical AG, Brüttisellen ZH, Switzerland) 
was performed at an isotropic resolution of 20 μm, an energy level of 70 kVp, an intensity of 
114 μA, and 300 ms integration time. 
5.11.2 Histology and histomorphometrical analysis 
Samples for histological stainings were washed in PBS and fixed in 4% PFA ON at 4°C right after 
extraction. The constructs were embedded in paraffin and sectioned at 5 µm thickness. Before 
staining, the sections were deparaffinized and rehydrated. 
5.11.2.1 Hematoxylin and Eosin staining 
Hematoxylin is a basic dye used to stain acidic structures like DNA and RNA, which appear in a 
blue-purple color. Eosin is an acidic dye staining basic structures like proteins in varying degrees of 
pink. Therefore, Hematoxylin and Eosin (H&E) staining was used to visualize cell nuclei (blue-
purple) and the cytoplasm as well as the extracellular matrix (pink). Deparaffinized and 
rehydrated slides were immersed in hematoxylin for 1 min 30 sec, rinsed in four changes of tap 
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water, washed in dH2O for 3 min, placed in Eosin for 1 min, before they were dehydrated and 
mounted using Eukitt® (Sigma-Aldrich Chemie GmbH, Buchs SG, Switzerland). 
5.11.2.2 Manual blood vessel analysis 
The number of vessels and the percent vessel per scaffold area were determined by counting the 
number of vessels in longitudinal sections taken from the center of the scaffold. Each vessel was 
marked in black and ImageJ v1.48s (National Institutes of Health, USA) was used to analyze the 
number of marked vessels and their total area. Three sections of three in ovo cultured samples 
and three sections of two in vivo cultured samples were used resulting in nine and six evaluated 
sections per group, respectively. 
5.11.2.3 Picrosirius Red staining 
Picrosirius Red is used to detect collagen, which is stained in a red color. Dewaxed and rehydrated 
sections were immersed in hematoxylin to stain nuclei. Next, the slides were washed in four 
changes of tap water, rinsed in dH2O, stained in Sirius Red solution for 1 h at RT, washed twice in 
acidified water, dehydrated, cleared in xylene, and mounted using Eukitt®. 
5.11.2.4 Quantitative assessment of the collagen content 
Picrosirius Red-stained sections were used for estimating the collagen (type I and III) content 
within the scaffold area, isolated from microscopical pictures recorded with a slide scanner (Axio 
Scan.Z1, Carl Zeiss AG, Feldbach ZH, Switzerland). The pictures were processed in imageJ and 
thresholded in order to determine the percentage of red-stained areas within the scaffold.  
5.11.2.5 Von Kossa staining 
Deparaffinized and rehydrated samples were incubated in 1% silver nitrate solution for 20 min 
under ultraviolet light. After washing in dH2O, the unreacted silver was removed by incubating the 
sections with 5% sodium thiosulfate for 5 min. Eosin was used for counterstaining before 




Immunohistochemistry was performed on deparaffinized and rehydrated sections. Endogenous 
peroxidases were quenched by incubating the sections in 3% H2O2 in ice-cold methanol for 
45 min. If necessary, antigens were retrieved by applying either sodium citrate buffer, pH 6.0 and 
heat or trypsin solution, pH 7.8 at 37°C (for details see Table 5.1). To reduce non-specific staining, 
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the sections were incubated in 20% normal goat serum/PBS for 20 min at RT. Vectastain ABC and 
Vectastain ABC-AP kits (Reactolab, S.A., Servion VD, Switzerland) were used for the staining 
procedure. The primary antibody was applied ON at 4°C or for 1 h at RT. For the development of 
the staining either 3-amino-9-ethylcarbazole (AEC; Reactolab, S.A., Servion VD, Switzerland), or 
3,3′-diaminobenzidine (DAB; Sigma-Aldrich Chemie GmbH, Buchs SG, Switzerland), or 
5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium chloride (BCIP/NBT; Reactolab, S.A., 
Servion VD, Switzerland) were chosen as chromogenic substrates. Omission of the primary 
antibody served as a negative control. Stained sections were mounted in Eukitt®. Pictures were 
taken using the Leica DM6000 FS microscope, the Leica DFC350FX camera, and the Leica 












NuMA GTX113510 GeneTex trypsin 1:500 ON AEC 
Collagen IV ab6586 abcam trypsin 1:750 ON BCIP/NBT 
Laminin ab11575 abcam trypsin 1:200 ON BCIP/NBT 
vWF ab6994 abcam trypsin 1:300 ON BCIP/NBT 
Table 5.1. Antibodies used for immunohistochemistry. AEC, 3-amino-9-ethylcarbazole; BCIP, 5-bromo-4-
chloro-3-indolyl phosphate; conc., concentration; NBT, nitro blue tetrazolium chloride; NuMA, nuclear 
mitotic apparatus protein 1; ON, overnight; vWF, von Willebrand Factor. 
 
5.11.4 Immunofluorescence 
Immunofluorescent stainings were performed on deparaffinized and rehydrated slides. If 
necessary, antigens were retrieved by applying either sodium citrate buffer, pH 6.0 and heat or 
trypsin solution, pH 7.8 at 37°C (for details see Table 5.2). To reduce non-specific staining, the 
sections were blocked in 20% normal goat serum/PBS for 20 min at RT. The sections were 
incubated with the primary antibody ON at 4°C followed by incubation in the secondary antibody 
(1:250; Thermo Fisher Scientific AG, Reinach BL, Switzerland) for 1 h at RT, and DAPI staining to 













Nestin MA1-110 ThermoFS citrate buffer 1:100 ON Alexa Fluor® 488 
NuMA GTX113510 GeneTex citrate buffer 1:400 ON Alexa Fluor® 568 
Sox2 ab59776 abcam citrate buffer 1:200 ON Alexa Fluor® 488 
Vimentin M 0725 Dako citrate buffer 1:300 ON Alexa Fluor® 488 
Table 5.2. Antibodies used for immunofluorescence. conc., concentration; NuMA, nuclear mitotic apparatus 
protein 1; ON, overnight; Sox2, SRY (sex determining region Y)-box 2; ThermoFS, Thermo Fisher Scientific. 
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5.11.5 RNA isolation and quantitative real-time polymerase chain reaction 
RNA was extracted from in ovo and in vivo cultivated samples using the RNeasy Plus Universal 
Mini Kit (Qiagen AG, Hombrechtikon ZH, Switzerland) and quantified using the UVS-99 micro-
volume UV/Vis spectrophotometer (ACTGene Inc., Piscataway NJ, USA). If necessary, samples 
were purified by ethanol precipitation. The iScript cDNA Synthesis Kit (Bio-Rad Laboratories AG, 
Cressier FR, Switzerland) was used to reverse-transcribe 1 µg of extracted RNA into cDNA. The 
primers were designed to be specific for human sequences without targets in the chicken or 
mouse genome. Specificity of the primers was checked with the Primer-Basic Local Alignment Tool 
(Primer-BLAST; http://www.ncbi.nlm.nih.gov/tools/primer-blast/). Quantitative real-time 
polymerase chain reaction (qRT-PCR) (Eco Real-Time PCR System, Illumina Inc., San Diego CA, 
USA) was performed using the Power SYBR Green Master Mix (Life Technologies Europe B.V., Zug 
ZG, Switzerland), 2 µM of primers (Table 5.3), and a 1:10 dilution of the cDNA in a total volume of 
10 μL. Target gene expression was normalized to the expression of the control gene (beta-Actin). 
The 2-ΔΔCT method (Livak and Schmittgen, 2001) was used to calculate relative changes in gene 
expression. 
Gene Accession no. Forward primer 5’-3’ Reverse primer 5’-3’ 
beta-Actin NM_001101.3 AAA CTG GAA CGG TGA AGG TG AGA GAA GTG GGG TGGCTT TT 
Nanog NM_024865.3 TTT GTG GGC CTG AAG AAA ACT AGG GCT GTC CTG AAT AAG CAG 
Nestin NM_006617.1 CCT GCA AAA GGA GAA TCA AG GTT CTC AAT GTC TCT TGG TC 
TGFb1 NM_000660.5 GCC ACA GAT CCC CTA TTC AA GTC TCC CGG CAA AAG GTA G 
VEGFA NM_001287044.1 CCA GGC CCT CGT CAT TG AAG GAG GAG GGC AGA ATC AT 
RUNX2 NM_001015051.3 AGC AAA GCC GCT TCC TCT CT CGG AGG GCA CTG GTC CAT AC 
Table 5.3. Human-specific primer sequences used for gene expression analyses. RUNX2, runt-related 
transcription factor 2; TGFb1, transforming growth factor beta 1; VEGFA, vascular endothelial growth 
factor A. 
 
5.12 Statistical analysis 
For a comparison of the groups a one-way analysis of variance (ANOVA) was performed using 
GraphPad Prism v6.05 (GraphPad Software, Inc., La Jolla, CA, USA). A Bonferroni’s multiple 
comparison test was conducted to determine significant differences between the groups. Data 
were considered significant at p < 0.05 (*) and highly significant at p < 0.01 (**).  
40 
 
Figure 6.1. Two colony forming units of primary hDPSCs 
three days after cell isolation from the dental pulp. 
6. Results 
6.1 In vitro characterization of hDPSCs 
Cultures of human dental pulp stem cells (hDPSCs) were established by enzymatically digesting 
dental pulps previously removed from extracted impacted molars of adult patients within 
24 hours. The cells were expanded until passage 3 (P3) before being cryopreserved for further 
characterization and experimental use. 
6.1.1 Cell morphology and proliferation of freshly isolated hDPSCs 
In monolayer cultures of freshly isolated hDPSCs grown on plastic Petri dishes, first colony forming 
units were observed three days after plating (Fig. 6.1). Adherent cells showed a typical fibroblast-
like morphology similar to bone marrow 
stem cells (BMSCs). Dead cells, non-adhering 
cells, and cells that cannot survive in a 
growth medium consisting of Dulbecco's 
Modified Eagle Medium/Nutrient Mixture 
F-12 (DMEM/F12) supplemented with 10% 
serum and 1% L-glutamine were washed 
away when the growth medium was 
changed. A frequent problem when culturing 
cells of oral origin is mycoplasma 
contamination, as these bacteria are 
commonly found in the human oral cavity. Therefore, the medium of the primary cell cultures was 
regularly tested for the presence of mycoplasma using specific primers recognizing DNA 
fragments from the most common types of mycoplasma. Affected cultures were discarded. 
To keep the cells at an optimal density for continued growth and to stimulate further 
proliferation, the cells were passaged at a confluency of 80-90%. Cell numbers and time until 
reaching the right cell density for passaging were recorded for all the isolated hDPSC populations 
(Fig. 6.2). Initially, an average of 2 x 105 cells after an average time of almost ten days were 
counted when passaging the freshly isolated cells for the first time. At passage 2, the average cell 
number increased to 3 x 106 in approximately six days. In the final passage 3, the cells reached an 
average number of 19 x 106 in four to five days, and were frozen in portions of 1 x 106 cells for 
cryopreservation. Their exponential growth behavior resulted in a 97-fold increase in cell number 
from passage 1 to 3 within 21 days on average.  
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Figure 6.2. Proliferation behavior of freshly isolated hDPSCs. (A) Average cell number recorded at each 
passage. (B) Average time period between passages. Data is shown as mean ± SD, n = 17. 
   
6.1.2 Cell proliferation and cytotoxicity of hDPSCs 
Cells of three different patients were used to compare their proliferation rates and possible 
cytotoxicity during cell culture by using the MTT and the LDH assay, respectively (Fig. 6.3).  
Figure 6.3. Cell proliferation and cytotoxicity of hDPSCs. (A) Cell proliferation measurement based on the 
MTT assay, where cell metabolic activity is assessed. (B) Cell cytotoxicity assay based on the concentration 
of lactate dehydrogenase (LDH), which is released by stressed and dead cells into the medium. Data is 




No statistically significant differences were observed between the cell proliferation and LDH 
activity of the hDPSCs from three different donors. On average, cell numbers showed a 4.5-fold 
and 15.7-fold increase on day 3 and day 7, respectively, when compared to day 1 (Fig. 6.3 A). At 
the same time the average LDH activity, indicating possible cytotoxicity, did not increase but 
remained stable during seven days of culture in all the tested cells (Fig. 6.3 B). These results 
suggest similar behavior of hDPSCs isolated from different patients.  
6.1.3 Expression of cell surface markers 
Unsorted hDPSCs (uns-hDPSCs) were analyzed for their expression of typical cell surface markers 
identifying mesenchymal stem cells. Samples of uns-hDPSCs isolated from three different patients 
were used and showed similar cell surface marker profiles. An exemplary profile is presented in 
Figure 6.4.  
Figure 6.4. Cytofluorimetric analysis of CD90, CD105, CD34, and CD45 expression on unsorted hDPSCs. 
Histograms represent the fluorescence intensity on the x-axis and the number of cells on the y-axis. 
Unstained control cells and cells marked with antibodies are shown in light grey and dark grey color, 
respectively. 
All tested samples were positive for the mesenchymal stem cell markers CD90 and CD105, while 
being negative for the hematopoietic stem cell marker CD45. A small percentage of cells was also 
positive for CD34, which has been shown to be expressed on a small proportion of various cell 
populations, distinguishing a subset of cells with enhanced progenitor activity (Sidney et al., 




Figure 6.5. Fluorescence-activated cell sorting (FACS) plots for the sorting of hDPSCs. FITC-A, fluorescein 
isothiocyanate area; FSC-A, forward scatter area; PE-A, phycoerythrin area; SSCA, side scatter area. 
 
6.1.4 Immunocytochemical analysis of unsorted hDPSCs and sorted hDPSCs 
To further characterize the cells, their expression of Nestin, Sox2, and Vimentin were examined by 
immunocytochemical analysis (Fig. 6.6). Uns-hDPSCs were compared with CD34+/CD90+ sorted 
hDPSCs (s-hDPSCs) in order to elucidate if using sorted stem cell populations is advantageous for 
the vascularization efficiency of a 3D biomaterial when used as an implant. 
Nestin is known as a marker for multi-lineage progenitor cells but is also expressed by nerve cells, 
which require Nestin for proper self-renewal. Both uns-hDPSCs and s-hDPSCs were positive for 
Nestin (Fig. 6.6 A, B). Sox2 is commonly expressed by embryonic stem cells and is used as a 
marker for the identification of undifferentiated pluripotent cells. The expression of this 
pluripotency marker in the tested cell groups (Fig. 6.6 C, D) suggests the existence of a primitive 
stem cell population in our cultures and indicates that the chosen culture conditions support 
self-renewing cells. Vimentin is the major intermediate filament protein of mesenchymal cells. 




Figure 6.6. Immunocytochemistry showing Nestin, Sox2, and Vimentin expression. (A, B) Expression of 
Nestin. (C, D) Expression of Sox2. (E, F) Expression of Vimentin. (G, H) Negative controls. Cell nuclei are 
stained with DAPI. Scale bar = 50 μm. 
 
6.1.5 In vitro differentiation potential of unsorted hDPSCs and sorted hDPSCs 
One of the minimal criteria for the definition of multipotent mesenchymal stem cells is their 
ability to differentiate into several mesenchymal cell lineages, like osteoblasts, chondrocytes, and 
adipocytes. Therefore, the trilineage differentiation potential of monolayer cultures of the 
isolated uns-hDPSCs and s-hDPSCs was tested by culturing them in osteogenic, chondrogenic, and 
adipogenic differentiation media.  
6.1.5.1 Osteogenic differentiation 
Alizarin Red staining of hDPSCs cultured for 14 days in osteogenic media, containing ascorbic acid, 
β-glycerophosphate, and dexamethasone, was used to identify calcium deposits in the 
extracellular matrix (ECM) of successfully differentiated cells. Bright orange-red staining of 
calcified nodules was observed in both uns-hDPSCs (Fig. 6.7 A) and s-hDPSCs cultures (Fig. 6.7 B) 
grown in osteogenic medium, whereas control cultures (Fig. 6.7 C, D) remained unstained after 
washing away the Alizarin Red staining solution. S-hDPSCs showed bigger and a higher number of 
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calcified nodules than uns-hDPSCs. These results confirm the osteogenic differentiation potential 
of hDPSCs in vitro. 
6.1.5.2 Chondrogenic differentiation 
For chondrogenic differentiation, a commercially available Chondrogenesis Differentiation Kit was 
used. Instead of being cultured as monolayers, the cells were pelleted in conical Falcon tubes, 
where they formed visible cell aggregates within 24 hours of culture. After 21 days, the cell pellets 
were analyzed for the presence of acidic polysaccharides, stained in blue, which are building 
blocks of proteoglycans (mainly aggrecan) and are highly abundant in mature cartilage. Nuclei and 
the cytoplasm were counterstained with nuclear fast red, resulting in a red-pink background in 
non-differentiated areas. Both uns-hDPSCs (Fig. 6.7 E) and s-hDPSCs (Fig. 6.7 F) were successfully 
differentiated towards the chondrogenic lineage when cultured in chondrogenic medium as seen 
by an intense blue color within the cell pellets, however, weaker in cultures of s-hDPSCs than in 
uns-hDPSCs. Negative controls did not show any signs of chondrogenic differentiation 
(Fig. 6.7 G, H). 
6.1.5.3 Adipogenic differentiation 
Adipogenic differentiation was induced by using a commercially available Adipogenic 
Differentiation Kit. The cells were incubated for 21 days followed by an Oil Red O staining, which 
stains intracellular lipid vesicles in bright red, which are only present in successfully differentiated 
cells. Both uns-hDPSCs and s-hDPSCs showed only tiny spots of red staining (Fig. 6.7 I, J), but real 
lipid vesicles were not observed, which suggests that the differentiation might not be complete. 
S-hDPSCs showed a similar result even when cultured in control medium (Fig. 6.7 L), which might 






Figure 6.7. Trilineage differentiation potential of uns-hDPSCs and s-hDPSCs. (A, B) Alizarin Red S staining of 
cells cultured in osteogenic medium and (C, D) in control medium for 14 days in vitro. Extracellular calcium 
deposits are stained in bright orange-red, indicating successful osteogenic differentiation. 
Scale bar = 200 μm. (E-H) Chondrogenic differentiation assay of uns-hDPSCs and s-hDPSCs. Alcian Blue 
staining on sections of cell pellets cultured (E, F) in chondrogenic medium and (G, H) in control medium for 
21 days in vitro. Acidic polysaccharides are stained in blue, indicating successful chondrogenic 
differentiation. Scale bar = 100 μm. (I-L) Adipogenic differentiation assay of uns-hDPSCs and s-hDPSCs. Oil 
Red O staining of cells cultured (I, J) in adipogenic medium and (K, L) in control medium for 21 days in vitro. 
Successful adipogenic differentiation is recognized by intracellular lipid vesicles stained in bright red, which 
was not complete in any of the samples. Scale bar = 100 μm. 
 
6.1.6 Cell survival of unsorted hDPSCs and sorted hDPSCs on 3D silk scaffolds in vitro 
The 3D silk scaffold used in this study is made of silk fibroin extracted from the cocoons of the 
silkworm Bombyx mori. Before having been used as a 3D biomaterial in tissue engineering 
(Altman et al., 2003), the material has been used in clinics for decades as a suture material, where 
it has proven its biocompatibility after the removal of sericin, a glue-like protein known to induce 
inflammatory responses. The crude material (Fig. 6.8 A left) was soaked in PBS before being cut 
into the final size of 3 mm height and 5 mm diameter (Fig. 6.8 A right) used for the following 
studies. Its properties are summarized in Figure 6.8 B and the 2D structure of an empty scaffold 




Figure 6.8. Silk scaffold biomaterial and its properties. (A) Left: crude material after production. Right: 
Medium-soaked scaffold after being cut into the final size of 3 mm height and 5 mm diameter. 
(B) Properties. (C) Hematoxylin and Eosin (H&E) staining of a section of the silk scaffold. 
Cell growth within the 3D silk scaffolds was first observed in an in vitro setup before using the 
cell-seeded constructs for the planned studies. Using common cell proliferation assays like the 
MTT or the PicoGreen assay proved to be difficult due to the 3D architecture of the samples. 
Therefore, cell survival was assessed qualitatively from H&E-stained sections of silk scaffolds 
seeded with either uns-hDPSC or s-hDPSCs for one and seven days. One day after seeding single 
cell suspensions onto the silk scaffolds, the cells appeared in sphere-like aggregates attached to 
the fibers of the scaffold in both groups (Fig. 6.9 A, B). Within seven days of culture these 
aggregated cells proliferated and spread between the scaffold fibers, while producing their own 
ECM (Fig. 6.9 C, D). These results indicate that the environment provided by the silk scaffold is not 
limiting cell proliferation and allows for normal cell functioning. 
Figure 6.9. In vitro growth of cells seeded in 3D silk scaffolds. H&E-stained sections show typical cell 
arrangements as observed after one (A, B) and seven (C, D) days of culture. sc, silk scaffold fibers. 
Scale bar = 50 μm. 
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6.2 Histological and molecular analysis of 3D silk scaffolds cultured in ovo 
Empty and cell-seeded scaffolds cultured in ovo were analyzed after 1 week to assess the quality 
of the tissues grown within the scaffold pores as well as the quantity of blood vessels, to 
characterize the extracellular matrix and the origin of the vessel structures, and to find out if and 
to what extent the implanted cells express markers of undifferentiated mesenchymal cells. Finally, 
the expression of selected genes in the human cells was investigated. 
6.2.1 Tissue morphology and histomorphometrical blood vessel analysis 
In order to qualitatively analyze the effect of cell-seeding of a 3D silk scaffold on vascularization 
and tissue integration, H&E-stained cross-sections of empty, uns-hDPSC-seeded, and 
s-hDPSC-seeded scaffolds were compared after their removal from the chorioallantoic membrane 
(CAM) of the fertilized eggs (Fig. 6.10 A). After 1 week of incubation a clear difference in the level 
of tissue growth within the scaffold was observed especially between the empty and the cell-
seeded scaffolds (Fig. 6.10 B-D). The empty scaffold showed only minimal ingrowth of the CAM 
tissue at the interface between the scaffold and the CAM (Fig. 6.10 B) with the majority of the 
scaffold pores remaining empty. In contrast, most pores of cell-seeded scaffolds were filled with 
ingrowing tissue of chicken origin at the interface and with hDPSCs in the center and at the top of 
the scaffold (Fig. 6.10 C, D). The seeded cells were spread between the scaffold fibers (Fig. 6.10 
c’’, d’’) and seemed to proliferate more efficiently and more homogenously within the scaffold 
than in scaffolds cultured in vitro.  
Capillaries within the scaffold pores were found in all three groups (Fig. 6.10 b’-d’). The 
distribution of the vasculature along the horizontal axis of the scaffold was nearly homogeneous, 
whereas the vessel density decreased along the vertical axis from the bottom to the top of the 
scaffold. Blood vessels were only found in tissue- and/or cell-filled scaffold pores. Therefore, the 
empty scaffold was vascularized to a lower extent than the cell-seeded scaffolds. To quantify the 
degree of vascularization a histomorphometrical blood vessel analysis was performed. The 
percent area that the vessels occupy in the analyzed scaffold sections (Fig. 6.11 A) as well as the 
number of vessels per scaffold section (Fig. 6.11 B) were assessed. The number of vessels was 
normalized to a full scaffold section with an area of 15 mm2 (3 mm height x 5 mm width) for all 
the evaluated samples. Lowest values for both vessel area and vessel number were obtained for 
the empty scaffolds, while the seeding of scaffolds with cells led to an increase of the vessel area 
within the scaffold by 1.6-fold and 1.5-fold for uns-hDPSCs and s-hDPSCs, respectively. Also the 
number of counted vessels was higher by 1.7-fold and 1.4-fold in uns-hDPSCs and s-hDPSCs, 
respectively, when compared to the empty scaffold. Scaffolds seeded with s-hDPSCs were slightly 
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less vascularized than scaffolds seeded with uns-hDPSCs. Interestingly, both graphs showed an 
almost proportional behavior among the groups, indicating that the counted blood vessels on 
average were of similar size in all the three groups. Even though no statistically significant 
differences in the histomorphometrical measurements among the groups were observed, 
cell-seeded scaffolds resulted in better tissue distribution within the scaffold pores and a higher 
number of vessels found within the scaffold. 
 
Figure 6.10. H&E staining of longitudinal sections after in ovo culture for 1 week. (A) Sample processing 
after the removal from the CAM of the fertilized egg. (B) Empty silk scaffold. (C) Silk scaffold seeded with 
uns-hDPSCs. (D) Silk scaffold seeded with s-hDPSCs. (B-D) Exemplary scaffold section overview. Red dotted 
lines indicate the outline of the scaffold. Scale bar = 500 μm. (b’-d’) Magnifications showing single capillaries 
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in the area marked with an orange box in the corresponding overview picture. Scale bar = 10 µm. (b’’-d’’) 
Magnifications showing the empty pore and seeded cells spread between the scaffold fibers, respectively. 
Scale bar = 25 µm. sc, silk scaffold fibers. 
 
 
Figure 6.11. Histomorphometrical analysis of cell-seeded samples grown in ovo for 1 week. (A) Percent 
vessel area per scaffold section. (B) Number of vessels per scaffold section. Data is shown as mean ± SD, 
n = 3 (per n three complete sections were analyzed). No statistically significant differences between the 
groups were found. 
 
6.2.2 Characterization of the extracellular matrix 
To further analyze the tissue present within the scaffold, Picrosirius Red-stained sections 
identifying the collagen types I and III content of a matrix was assessed quantitatively in in ovo 
cultured samples. Together with collagen type II, collagen type I and III are the main collagens of 
connective tissue and constitute up to 90% of the collagens in the body and plays an important 
role during wound healing (Martin, 1997). In samples cultured for 1 week in ovo the presence of a 
collagenous matrix was lowest in empty scaffolds where only the collagen content within the 
CAM was measured as the rest of the scaffold remained empty (Fig. 6.12 A, a’, D). In samples 
containing hDPSCs an increase of collagen of approximately 160% and 170% in scaffolds seeded 
with uns-hDPSCs (Fig. 6.12 B, D) or s-hDPSCs (Fig. 6.12 C, D), respectively, was observed. A closer 
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look at the ECM of the cells spread within the scaffold fibers revealed small islands of an increased 
collagen content as identified by a darker red staining (Fig. 6.12 b’, c’). 
 
Figure 6.12. Collagen types I and III content in samples cultured in ovo for 1 week. In Picrosirius Red-stained 
sections collagen fibers appear red. The intensity of the color is proportional to the content of collagen. 
(A-C) Samples removed after 1 week of in ovo culture. Scale bar = 500 μm. (a’-c’) Magnified areas of 
samples shown in A-C marked by a green box. Scale bar = 25 μm. (D) Quantification of the collagen content 
within the scaffold area. Data is shown as mean ± SD, n = 3 (per n three complete sections were analyzed). 
No statistically significant differences between the groups were found. sc, silk scaffold fibers. 
 
6.2.3 Identification and characterization of vessel structures 
The basement membrane is the ECM separating the endothelium from the underlying connective 
tissue. In vessels it appears as a sheet-like layer of laminin and collagen-rich (esp. collagen type IV) 
fibers formed by pericytes and endothelial cells, which can be identified using antibodies directed 
against epitopes of the corresponding proteins. Combined with a human-specific marker for the 
nuclear mitotic apparatus protein (NuMA), cells of human origin can be distinguished from cells of 
chicken origin. To answer the question if the human cells used to seed the 3D silk scaffolds do not 
only attract vessels growing in from the host tissue but if they are able to also contribute to newly 
developing vessels within the scaffolds, double-stainings using either anti-NuMA with anti-laminin 
or anti-NuMA with anti-collagen type IV antibodies were performed. Vessels were identified by a 
positive staining of either laminin (Fig. 6.13 A, a’, B, b’) or collagen type IV (Fig. 6.13 C, c’, D, d’) 
(stained in purple) and by blood cells of chicken origin present within the endothelial lumen. 
Human cell nuclei were visible in an orange-red color (Fig. 6.13) and were located very close and 
partially even as part of the endothelium, suggesting a potential pericyte or endothelial cell 
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function for the hDPSCs. Both components of the vascular basement membrane were identified in 
all cell-seeded samples. The anti-laminin antibody was not human-specific, staining both chicken 
and human laminin. Therefore, the distinction between human- and chicken-derived laminin was 
not possible. However, the anti-collagen type IV antibody did not show any staining in cell-free 
silk scaffolds, thus identifying human collagen type IV only.  
 
Figure 6.13. Immunohistochemistry showing laminin and collagen type IV expression in the basement 
membrane of capillaries within the scaffold material after in ovo implantation for 1 week. (A, B) NuMA 
(orange-red) and laminin (purple) staining of samples containing uns-hDPSCs (A) or s-hDPSCs (B). 
(C, D) NuMA and collagen type IV (purple) staining of samples containing uns-hDPSCs (C) or s-hDPSCs (D). 
(a’ d’) Magnifications of the area marked with a green dotted line in the corresponding overview picture. 
White arrows indicate cells of human origin involved in the vessel structures. Scale bar (all 
pictures) = 25 μm. sc, silk scaffold fibers. 
 
6.2.4 Identification of stem cells of mesenchymal origin 
When using undifferentiated stem cells for tissue engineering, a part of the cells should 
differentiate in order to recreate the tissue according to signals coming from the immediate 
environment, but part of the cells should also remain in an undifferentiated state in order to keep 
up tissue homeostasis. To assess if the cells seeded into the silk scaffold are able to remain 
undifferentiated, the sections were stained using anti-Nestin, anti-Sox2, and anti-Vimentin 
antibodies, which have been detected before in monolayer cultures of both uns-hDPSCs and 
s-hDPSCs (Fig. 6.6). Human origin of the cells was assessed with the anti-NuMA-antibody. Nestin 
was expressed in both cell populations, similar to the results previously observed in monolayer 
cultures (Fig. 6.14 A, B). However, the Sox2 stainings showed an unexpected staining pattern, 
where mostly the cytoplasm was stained, while only few cells were Sox2-positive in the nucleus of 
both uns-hDPSCs and s-hDPSCs (Fig. 6.14 C, D). Nestin- and Sox2-positive cells were mostly 
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localized where the human cells had not been in touch with chicken-derived tissue. Vimentin was 
used to identify cells of mesenchymal origin and follow their integration within the ingrowing 
tissue of the host (Fig. 6.14 E, F). The staining showed that the human cells were localized not only 
at the edges of the scaffold but also in the center and mixed with cells of chicken origin, which 
were identified by negative NuMA staining. 
 
Figure 6.14. Immunofluorescence of stem cell markers and a mesenchymal cell marker of samples cultured 
in ovo. (A, B) NuMA (red) and Nestin (green) staining of samples containing uns-hDPSCs (A) or s-hDPSCs (B). 
(C, D) NuMA (red) and Sox2 (green) staining of samples containing uns-hDPSCs (C) or s-hDPSCs (D). 
(E, F) NuMA (red) and Vimentin (green) staining of samples containing uns-hDPSCs (E) or s-hDPSCs (F). 
Arrows indicate cells of human origin expressing Nestin, Sox2, or Vimentin. Small pictures on the left side of 






6.2.5 Gene expression analysis 
The expression of human Nanog and Nestin (stem cell markers), transforming growth factor 
beta 1 (TGFb1) and vascular endothelial growth factor A (VEGFA) (angiogenic cytokines), as well as 
runt-related transcription factor 2 (RUNX2) (key transcription factor of osteoblast differentiation) 
was analyzed in samples after 1 week of in ovo culture (Fig. 6.15). While the expression of Nestin, 
TGFb1, and VEGFA was 2-fold lower in s-hDPSCs than in uns-hDPSCs, Nanog- and 
RUNX2-expression were upregulated in s-hDPSCs when compared to uns-hDPSCs by a factor of 
1.85 and 1.6, respectively. However, the observed differences between the two groups were not 
statistically significant, suggesting similar gene regulation in both cell populations. In comparison 
to monolayer cultures of uns-hDPSCs, all genes showed increased expression after in ovo 
incubation.  
 
Figure 6.15. Gene expression analysis of cell-seeded samples grown in ovo for 1 week. Gene expression 
relative to uns-hDPSCs cultured as a monolayer. RUNX2, runt-related transcription factor 2; TGFb1, 
transforming growth factor beta 1; VEGFA, vascular endothelial growth factor A. Data is shown as mean ± 
SD, monolayer samples: n = 3, in ovo samples: n = 6. Asterisks indicate significant (*, p ˂ 0.05) or highly 







6.3 Histological and molecular analysis of 3D silk scaffolds cultured in vivo 
For a direct comparison of the results obtained from samples cultured in ovo with a more 
common angiogenesis assay, empty and cell-seeded samples that were prepared and analyzed in 
exactly the same way as for the in ovo study, were implanted subcutaneously in mice for a time 
period of 1 week. Furthermore, samples were cultured also for 4 weeks and 47 days in order to 
assess the long-term effect on tissue integration of uns-hDPSC- and s-hDPSC-seeded silk scaffolds 
within a typical time frame of wound healing.  
6.3.1 Tissue morphology and histomorphometrical blood vessel analysis 
After the removal of the implants from the subcutaneous pockets of immunocompromised mice, 
H&E-stained cross-sections of empty, uns-hDPSC-seeded, and s-hDPSC-seeded scaffolds were 
analyzed with a focus on tissue growth and vascularization (Fig. 6.16 A). Empty and cell-seeded 
samples removed after 1 week of in vivo culture demonstrated clear differences in the cell/tissue 
content within the scaffold pores (Fig. 6.16 B, E, H). While the seeded human cells were 
proliferating and spreading within the scaffold pores (Fig. 6.16 e’’, h’’), the pores in the empty 
scaffold were filled with acellular fibers appearing blue in the H&E staining (Fig. 6.16 b’’). 
Additionally, s-hDPSCs seemed to proliferate a bit less than the uns-hDPSCs resulting in a higher 
percentage of scaffold pores that appeared empty (Fig. 6.16 H). Compared to in ovo cultured 
samples more pores containing dead cells were found after 1 week of implantation in vivo, which 
might be induced by the closed environment provided by the subcutaneous pocket. Similar to 
observations from the in ovo samples minimal ingrowth of host tissue was visible at the interface 
along the edges of the scaffold. Blood vessels were found exclusively at the border of the scaffold 
in all samples analyzed after 1 week of incubation (Fig. 6.16 b’, e’, h’). The vessel area in 
uns-hDPSC- and s-hDPSC-seeded scaffolds was 31 and 22 times higher, respectively, when 
compared to the empty scaffold (Fig. 6.17 A). The number of vessels showed an increase of 
40- and 25-fold for uns-hDPSCs and s-hDPSCs, respectively (Fig. 6.17 B). In contrast to in ovo 
cultured samples the percent vessel area of scaffolds implanted in vivo for 1 week were lower by 
98%, 57%, and 67% for empty, uns-hDPSC- and s-hDPSC-seeded scaffolds, respectively.  
The next samples were analyzed after 4 weeks of implantation, as this is a time where the 
proliferative phase of wound healing is finishing. Even though differences between the empty 
scaffolds and the cell-seeded scaffolds were not as obvious as they have been after 1 week, still 
the empty scaffolds were showing more empty areas within the scaffold than the cell-seeded 
groups (Fig. 6.16 C, F, I). The tissue structure within the pores was less dense and less organized 
(Fig. 6.16. c’’). Based on the H&E-stained sections samples seeded with s-hDPSCs were showing a 
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pore filling of almost 100% and a homogenously dense network of ECM throughout the whole 
scaffold (Fig. 6.16 i’’). Also in uns-hDPSC-seeded scaffolds most pores were filled and even though 
the ECM was homogenously distributed, it appeared slightly less compact than the one seen in 
the other cell-seeded group (Fig. 6.16 f’’). Blood vessels were present in all areas of the scaffold, 
including the center (Fig. 6.16 c’, f’, i’). The average percent vessel area for all the three groups 
was around 1%, while on average around 280 vessels were counted per scaffold section, with the 
lowest value found in empty scaffolds and the highest in samples containing uns-hDPSCs. 
The third and final time point for sample analysis was chosen at 47 days, as we wanted to 
compare the degree of potential matrix mineralization with experiments we had previously 
performed for the same silk fibroin scaffolds seeded with hDPSCs, which were cultured statically 
and in bioreactors for 47 days in vitro (Woloszyk et al., 2014). Histologically, similar tissue 
structures and degrees of pore filling were found as in the samples analyzed after 4 weeks. The 
center of the empty scaffolds was clearly free of vessels and tissue (empty area in Fig. 6.16 D, d’’), 
while most of the pores in cell-seeded scaffolds (Fig. 6.16 G, J) contained a homogenous ECM, 
again being more compact in s-hDPSC-seeded scaffolds than in the case of uns-hDPSCs (Fig. 6.16 
g’’, j’’). The histomorphometric analysis of blood vessels seen in all the samples (Fig. 6.16 d’, g’, j’) 
showed an increase of the total percent vessel area from 1 week to 47 days by 1.6-, 6.3-, and 
4-fold for the empty, uns-hDPSC-, and s-hDPSC-seeded scaffolds, respectively (Fig. 6.16 A). Also 
the number of blood vessels rose by 129-fold (empty scaffold), by 5.7-fold (uns-hDPSCs), and by 
4.1-fold (s-hDPSCs) (Fig. 6.16 B). The values obtained in cell-seeded scaffolds for vessel area and 
vessel number behaved proportionally, which demonstrates that the average size of blood vessels 
in those two groups were the same. The disproportionate increase observed in empty scaffolds 
appeared so much higher due to a very low number of blood vessels found in empty scaffolds 
after 1 week. Compared to the vessel area and number determined in samples incubated for 
4 weeks, both values increased in samples collected after 47 days on average by 150%. 
Furthermore, in cell-seeded scaffolds analyzed after both 4 weeks and 47 days, almost no cell 
death within the scaffold pores was observed, indicating that the cells that survived the first week 
after implantation were sufficient for the development of vascularized tissue within the scaffolds. 
 









Figure 6.16 B-J (see previous page). H&E staining of longitudinal cross-sections cultured in vivo. (B-D) Empty 
silk scaffold incubated for 1 week, 4 weeks, and 47 days. (E-G) Silk scaffold seeded with uns-hDPSCs 
incubated for 1 week, 4 weeks, and 47 days. (H-J) Silk scaffold seeded with s-hDPSCs incubated for 1 week, 
4 weeks, and 47 days. (B-J) Exemplary scaffold section overview. Red dotted lines indicate the outline of the 
scaffold. Scale bar = 500 μm. (b’-j’) Magnifications showing single capillaries in the area marked with an 
orange box in the corresponding overview picture. Scale bar = 20 µm. (b’’-j’’) Magnifications showing the 
seeded cells spread between the scaffold fibers. Scale bar = 40 µm. sc, silk scaffold fibers. 
 
 
Figure 6.17. Histomorphometric analysis of cell-seeded samples grown in vivo for 1 week and for 47 days. 
(A) Percent vessel area per scaffold section (15 mm
2
). (B) Number of vessels per scaffold section. Crosses 
indicate the values of two different samples (resulting from 3 analyzed sections per sample), black lines 
indicate the mean value. 
 
6.3.2 Characterization of the extracellular matrix 
Similar to the in ovo cultured samples also the samples implanted in vivo were stained with 
Picrosirius Red stain in order to measure the content of collagen types I and III of the matrix 
grown within the 3D silk scaffolds. In samples analyzed after 1 week of culture, the highest 
content of collagen was found in sections of scaffolds seeded with s-hDPSCs (Fig. 6.18 C, D). The 
measured collagen content in uns-hDPSC-seeded scaffolds was only slightly lower (Fig. 6.18 B, D), 
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while the empty scaffold showed a reduced collagen content of approximately 30% compared to 
the cell-seeded scaffolds (Fig. 6.18 A, D). Small islands of more intensely colored collagen fibers 
were observed being stretched between the scaffold fibers (Fig. 6.18 a’, b’, c’), similarly to the in 
ovo results. After 47 days of incubation, the staining seen in sections of all the three groups was 
significantly stronger (Fig. 6.18 E-G). As shown in the magnified areas (Fig. 6.18 e’, f’, g’) also the 
matrix was much denser, especially in the scaffolds seeded with uns-hDPSCs (Fig. 6.18 f’), 
resulting in a percent difference of 20% and 12% when compared to empty and s-hDPSC-seeded 
scaffolds (Fig. 6.18 D), respectively. The collagen content was determined to be 1.9, 1.7, and 1.5 
times higher for empty, uns-hDPSC-, and s-hDPSC-seeded scaffolds than in the corresponding 
1 week-samples.  
 
Figure 6.18. Collagen type I and III content in samples cultured in vivo for 1 week and 47 days. In Picrosirius 
Red-stained sections collagen type I and III fibers appear red. The intensity of the color is proportional to 
the content of collagen. (A-C) Samples removed after 1 week of culture. (D) Quantification of the collagen 
content within the scaffold area. Crosses indicate the values of two different samples (resulting from 3 
analyzed sections per sample), black lines indicate the mean value. (E-G) Samples removed after 47 days of 
culture. (a’-c’, e’-g’) Magnified areas of samples shown in A-C and E-G marked by a green box. 







6.3.3 Identification and characterization of vessel structures 
In order to investigate if the results observed in ovo are reproducible in vivo, the vessel structures 
growing within the scaffolds were characterized. We analyzed samples collected after 4 weeks, as 
the samples removed after only 1 week did not contain a sufficient number of vessels. The same 
antibodies were used as previously for the in ovo incubated samples to visualize cells of human 
origin (NuMA), the two main constituents of the vascular basement membrane (laminin and 
collagen type IV) and additionally the endothelial cell marker von Willebrand Factor (vWF), a 
glycoprotein that plays a major role in blood coagulation. Even though neither laminin (Fig. 6.19 
A, a’, B, b’) nor collagen type IV (Fig. 6.19 C, c’, D, d’) were human-specific, the observed 
NuMA-positive human cell nuclei embedded in the vessels walls (white arrows in Fig. 6.19 a’-d’) 
proved the ability of both uns-hDPSCs and s-hDPSCs to directly contribute to newly forming 
vessels within the scaffold. This finding was further supported by a positive vWF-staining of 
human-derived cells, which were observed in the vessel wall of tiny capillaries in both cell-seeded 
groups, indicating the differentiation into endothelial cells (white arrows in Fig. 6.19 e’, f’).  
Figure 6.19. Immunohistochemistry showing laminin, collagen type IV, and vWF expression in the basement 
membrane of capillaries within the scaffold material after in vivo implantation for 4 weeks. (A, B) NuMA 
(orange-red) and laminin (purple) staining of samples containing uns-hDPSCs (A) or s-hDPSCs (B). 
(C, D) NuMA and collagen type IV (purple) staining of samples containing uns-hDPSCs (C) or s-hDPSCs (D). 
(E, F) NuMA and vWF (purple) staining of samples containing uns-hDPSCs (E) or s-hDPSCs (F). (a’-f’) 
Magnifications of the area marked with a green dotted line in the corresponding overview picture. White 




6.3.4 Identification of stem cells of mesenchymal origin 
The goal was to confirm the presence of undifferentiated cells of mesenchymal origin expressing 
Nestin, Sox2, and Vimentin as previously observed in ovo. Instead of using the NuMA-antibody, 
the human origin of the seeded cells was tracked by staining the cells with Dil stain 
(1,1'-Dioctadecyl-3,3,3',3'-Tetramethylindocarbocyanine Perchlorate) prior to seeding them on 
the 3D silk scaffolds. After the experiment, the stain was detected in the red fluorescence channel 
(ex:  549 nm, em: 565 nm). The stainings were performed on samples collected after an in vivo 
incubation time of 4 weeks. In both uns-hDPSC- and s-hDPSC-seeded scaffolds, Nestin- and 
Vimentin-postive cells of human origin were observed (Fig. 6.20 A, B, E, F). Nestin-postive cells 
were mostly localized close to scaffold fibers and did not occur in a very high number, while 
Vimentin-positive cells were detected all over the scaffold pores throughout all the scaffold. 
Similar to the Sox2-staining performed in in ovo cultured samples, also in the in vivo samples Sox2 
expression was not exclusively limited to the cell nucleus (Fig. 6.20. C, D) and only a few cells were 
found to show some Sox2-positive signal coming from the nucleus.  
     The corresponding figure legend can be found on the next page. 
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Figure 6.20. Immunofluorescence of stem cell markers and a mesenchymal cell marker of samples cultured 
in vivo. (A, B) DiI (red) and Sox2 (green) staining of samples containing uns-hDPSCs (A) or s-hDPSCs (B). 
(C, D) DiI (red) and Nestin (green) staining of samples containing uns-hDPSCs (C) or s-hDPSCs (D). (E, F) DiI 
(red) and Vimentin (green) staining of samples containing uns-hDPSCs (E) or s-hDPSCs (F). Arrows indicate 
cells of human origin expressing Sox2, Nestin, or Vimentin. Small pictures on the left side of each picture 
show the three individual channels. Scale bar = 25 μm. sc, silk scaffold fibers. 
 
6.3.5 Preliminary gene expression analysis 
Gene expression analysis was performed for samples obtained after 4 weeks of incubation. As 
only one sample per group was available for analysis only preliminary results can be presented 
(Fig. 6.21). The same set of genes was analyzed as previously in in ovo cultured samples. 
 
Figure 6.21. Preliminary gene expression analysis of cell-seeded samples grown in vivo for 4 weeks. Gene 
expression relative to uns-hDPSCs cultured as a monolayer. RUNX2, runt-related transcription factor 2; 
TGFb1, transforming growth factor beta 1; VEGFA, vascular endothelial growth factor A. Data is shown as 
mean for monolayer samples (n = 3) and measurement from one single sample per group for in vivo 
samples (n = 1). 
Nanog-expression was higher in both in vivo groups than in monolayer cultures but lower than in 
both in ovo groups, suggesting a lower differentiation potential and self-renewal ability, even 
stronger in the s-hDPSCs than in uns-hDPSCs. However, Nestin-expression was found to be much 
higher in both in vivo groups than in the in ovo groups, which in contrast to the lower Nanog-
expression indicates an increase in pluripotency and self-renewal ability. TGFb1 was expressed 
higher in the in vivo groups than in both in ovo groups, while VEGFA-expression was lower, 
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especially in s-hDPSC-seeded scaffolds after in vivo incubation. This might indicate a TGFb1-
induced inhibition of VEGF. Furthermore, an increase in RUNX2-expression was observed when 
compared to in ovo samples, stronger in uns-hDPSCs than in s-hDPSCs. 
 
6.3.6 Mineralization 
To test if the formation of ectopic bone does occur in samples implanted in a non-mineralized 
environment, we prolonged the in vivo experiment to a period of 47 days as we had previously 
shown that silk scaffolds containing hDPSCs can produce mineralized matrix when cultured 
statically in non-osteogenic medium in vitro (Woloszyk et al., 2014). Therefore, a microCT scan of 
the samples removed after 47 days was performed prior to histological analysis. Except for one 
sample that showed a minimal bone volume of 0.19 mm3 (Fig. 6.22), which accounts for as little as 
0.3% of the total volume of the scaffold (58.9 mm3), no mineralized nodules were found in any of 
the other samples. Histological analysis of the mineral-containing sample showed that the 
nodules were located at the edges of the scaffold and therefore were most probably of 
mouse-origin and less likely a product of the seeded human cells.  
Figure 6.22. MicroCT analysis of samples cultured in vivo for 47 days. (A) Side view of the mineralized 
nodules found in one of the scaffolds seeded with uns-hDPSCs. Scale bar = 1 mm. (B) Top view of the same 
sample. The red dashed line indicates the outline of the scaffold. Scale bar = 1 mm. (C) Von Kossa staining 
showing the mineralized nodules in brown-black color within the sample. Purple dashed line indicated the 
border between the host tissue on the right and the implant on the left. Scale bar = 50 μm. (c’) The 
magnification of the area marked with a green dotted line in the corresponding overview picture shown in 
C. Scale bar = 50 μm. sc = silk scaffold fibers. 
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6.4 Visualization of the vascular network within hDPSC-seeded 3D silk 
scaffolds cultured in ovo 
We have used the CAM assay in ovo setup (Fig. 5.1) to study the vascularization of a 
3D biomaterial when placed in a vascularized host environment. The perfusion of the vascular 
system was performed without pre-perfusion with PBS, instead the blood was directly replaced by 
the injected MicroFil® (Fig. 6.23 A). The perfusion efficiency with MicroFil® initially diluted 
according to the manufacturer’s recommendation (i.e. 1:1) was improved by using a 10-fold 
dilution of the silicone rubber injection compound in MV-diluent, which required an increased 
amount of MV-Curing Agent of 10% instead of 5% (by weight). If perfusion with the yellow 
MicroFil® was not complete after the first injection (Fig. 6.23 B), as seen by the presence of 
blood-filled vessels (red), a second injection site was chosen to increase the number of perfused 
vessels (Fig. 6.23 C). The microCT scan showed the MicroFil® perfused 3D vasculature growing into 
the scaffold (red area in Fig. 6.23 E) from the bottom and from the sides within 1 week of in ovo 
culture. While the macroscopical image of the same sample within the CAM (Fig. 6.23 D) provides 
only the information about the vascularization visible on the surface of the CAM, the microCT 
image visualizes the whole 3D vascular network. Interestingly, there seems to be one large vessel 
encircling the scaffold, from which new capillaries are sprouting into the scaffold (white arrows in 
Fig. 6.23 E). The generated microCT data could be further used for complete morphometric 
characterization of the vascular network, including the vessel number, vessel diameter, vessel 




Figure 6.23. MicroFil® perfusion and microCT scan of a 3D silk scaffold incubated in ovo for 1 week. 
(A) Setup for the perfusion of the chorioallantoic membrane vasculature. The scaffold is placed in the 
middle of a silicone ring for in ovo culture. For proper perfusion a 30G ½” needle is fixed with a drop of 
superglue before MicroFil® (yellow) injection. (B) Perfused (yellow) and non-perfused (red) vessels after one 
injection showing incomplete perfusion. (C) Exemplary sample after two injections of MicroFil®. 
(D) Macroscopic view of an in ovo-cultured scaffold (green dashed line) immediately after perfusion with 
yellow MicroFil®. The silicone ring is seen in white, vasculature in yellow. (E) Microcomputed tomography 
image of the vascular cast within the scaffold marked in red. Vasculature outside the scaffold area is 
marked in brown. New capillaries are sprouting into the scaffold from one large vessel that encircles the 




Successful engineering of vascularized tissues and organs remains one of the key challenges in 
regenerative medicine (Dew et al., 2015; Mitsiadis et al., 2012; Novosel et al., 2011) even though 
many promising approaches have been developed and applied with the aim to improve and 
accelerate the vascularization of potential tissue engineered implants (Dew et al., 2015). 
Throughout the years, various combinations of biomaterials, cells, and growth factors have been 
investigated using established as well as newly developed angiogenesis assays in order to gain 
new insights into the processes involved in neovascularization (Laschke and Menger, 2015). 
Especially the use of multipotent stem cells, which can be differentiated into the desired 
tissue-specific cells (incl. endothelial cells), optionally with the help of transcription and growth 
factors, has become a core element in tissue engineering (Almubarak et al., 2016; Jin et al., 2016).  
As stem cell populations are known to possess a natural differentiation potential influenced by 
their immediate environment, in the present study we hypothesized that human dental pulp stem 
cells (hDPSCs) are able to improve the vascularization of a three-dimensional (3D) silk biomaterial 
by attracting the host’s vasculature and can contribute to the vascularization while recreating 
their stem cell niche within the biomaterial without any additional supplements.  
 
7.1 Tissue integration and vascularization of 3D silk scaffolds 
In order to study the effect that hDPSCs have on the tissue integration and vascularization of 3D 
silk scaffolds, we compared cell-seeded scaffolds with empty scaffolds after an implantation 
period of 1 week in ovo. Clear differences between empty and cell-seeded scaffolds were 
observed, regarding the degree of pore filling, amount of blood vessels within the scaffold, and 
the collagen content of the extracellular matrix (ECM). All the listed parameters showed higher 
values in cell-seeded than in empty scaffolds, proving that the presence of cells accelerated and 
improved the tissue and vascular integration of the 3D silk scaffold when used as an implant for 
potential tissue regeneration. This finding corresponds with previous reports, where cell-seeded 
synthetic or natural porous biomaterials as well as other types of silk fibroin scaffolds have been 
combined with undifferentiated or differentiated cells in order to functionalize the implants and 
induce a better integration in the host organism. For example, co-cultures of osteoblast and 
endothelial cells have been used to enhance the neovascularization as well as the cellular 
ingrowth of the host tissue of a synthetic polyester-urethane scaffold (DegraPol®) cultured in ovo 
(Buschmann et al., 2011). In another study, porous collagen scaffolds seeded with either amniotic 
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fluid- or dental pulp-derived stem cells improved the healing outcome when implanted into a 
critical-sized bone defect in rat calvariae when compared to empty collagen scaffolds (Maraldi et 
al., 2011). Even when silk fibroin micronets were pre-cultured with already differentiated 
non-endothelial cells, in this case osteoblasts, host endothelial cells were found to migrate, 
proliferate, and vascularize the cell-seeded biomaterial significantly better than cell-free control 
scaffolds (Ghanaati et al., 2011). Cells present in a manufactured biomaterial might help to 
‘vitalize’ the scaffold structures. By secreting hypoxia-induced growth factors and cytokines, the 
implanted cells can trigger angiogenesis in the host’s vasculature, facilitating the ingrowth of the 
host’s tissue.  
Apart from attracting vessels and enhancing tissue ingrowth from the host, the seeded cells 
should also proliferate, differentiate, as well as synthesize and secrete their own ECM (Geckil et 
al., 2011; O’Brien, 2011), creating the tissue from inside the scaffold as seen in our cell-seeded 
samples. This process requires a scaffold that provides the cells with the right biophysical cues 
(Gasiorowski et al., 2013), while allowing for good diffusion so that the cells can be properly 
supplied until functional vascularization can take over. In samples cultured in vivo, we had 
observed how some of the cells did not survive the first week of incubation, resulting in areas of 
cell death. However, in samples recovered after 4 weeks and 47 days, the appearance of the cells 
as well as the surrounding matrix was completely normal throughout the entire scaffold. This 
finding indicates that cells surviving within the scaffold during the initial days after transplantation 
were able to proliferate sufficiently to repopulate the entire silk scaffold, most probably 
supported by the advanced degree of scaffold vascularization. A previous study has shown how a 
higher scaffold macroporosity (i.e. 25% instead of 15%) can accelerate blood vessel development 
and therefore improve cell survival within the scaffold (Walthers et al., 2014).  
The produced ECM within our samples was identified to contain collagen types I and III in both the 
in ovo and the in vivo setup after 1 week, with a strong increase observed in vivo after 47 days. In 
wound healing, fibroblasts initially produce collagen type III, which is gradually replaced by the 
stronger collagen type I, a process that can be detected by an increase in the ratio of 
collagen type I/collagen type III during scar maturation (Cheng et al., 2011). However, also 
mesenchymal stem cells have been shown to synthesize collagen types I and III (Ku et al., 2006; L. 
Zhang et al., 2008). In our previous in vitro study hDPSCs cultured on 3D silk scaffolds under static 
and dynamic conditions in either normal or osteogenic medium for 47 days have been observed 
to produce collagen types I and III, which was strongest in samples cultured in osteogenic medium 
(Woloszyk et al., 2014). Naturally, collagen type I fibrils also serve as a template for the nucleation 
and growth of apatite during the mineralization process of bone and tooth structures (Silver and 
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Landis, 2011) and therefore the presence of collagen type I is required before mineralization can 
be initiated. As collagen type I is the most abundant protein (up to 90%) in all types of connective 
tissues (Hall, 1981), the presence of collagen type I does not necessarily imply mineralization or 
bone formation. In the present study, spontaneous minimal mineralization was found in only one 
single sample. All the other scanned samples remained unmineralized within 47 days of in vivo 
implantation, even though collagen type I was present and RUNX2 gene expression was detected 
in both uns-hDPSCs and s-hDPSCs. This finding could be explained by the fact that the cells seeded 
into the 3D silk scaffolds were not supplemented with any osteogenic or other differentiation-
inducing factors at any time of the experiment. Furthermore, the subcutaneous implantation site 
is not mineralized either, which is why the implants did not receive any osteoinductive signals 
from the immediate surrounding host tissue. Other studies, where hDPSCs alone or seeded into 
scaffolds had been used for bone tissue engineering approaches, always included a pre-incubation 
of the cells in osteoinductive medium. D’Aquino et al. used an increased amount of fetal bovine 
serum (FBS) (20% instead of 10%) for osteogenic differentiation and cultured hDPSCs for 60 days 
in vitro to obtain 3D woven bone tissue chips. These were implanted subcutaneously into 
immunosuppressed rats and were shown to yield vascularized bone after 45 days of 
transplantation (d’Aquino et al., 2007). Similarly, hDPSCs and human amniotic fluid stem cells 
seeded on silk fibroin scaffolds, which were implanted into critical-sized cranial defects in 
immunocompromised rats for 4 weeks, had been pre-incubated in osteogenic medium and 
improved the healing outcome by producing mineralized tissue (Riccio et al., 2012). When no pre-
differentiation of hDPSCs took place, no distinct hard tissue formation was found under in vivo 
conditions in any of the tested scaffold materials (Niu et al., 2014; Zhang et al., 2011). Even in a 
first clinical trial, which has been performed several years ago, autologous hDPSCs isolated from a 
maxillary molar had been pre-cultured in medium containing 20% FBS that had shown 
osteoinductive properties in earlier studies for at least 21 days. Subsequently, these cells were 
seeded on commercially available collagen scaffolds (i.e. Gingistat®), which were used to 
reconstruct alveolar bone after the extraction of mandibular teeth in the same patient (d’Aquino 
et al., 2009). The control site (opposite mandibular wisdom tooth) was filled with a cell-free 
collagen-sponge. A follow-up study after three years proved increased bone formation. However, 
the bone was more compact than normal spongy alveolar bone when cells had been transplanted 
together with the collagen scaffold than at the control site (Giuliani et al., 2013).  
Taken together, the presented findings combined with what is known in the literature suggest 
that cell seeding is beneficial for the tissue and vascular integration of biomaterials implanted in a 
host organism with the goal to improve the healing of a tissue defect. Furthermore, spontaneous 
differentiation of mesenchymal stem cells of dental or other origin into bone tissue is limited, 
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especially when the site of transplantation is not mineralized. Therefore, in the case of bone 
tissue engineering, osteogenic differentiation would have to be induced in vitro before 
implantation takes place. 
 
7.2 Human cell contribution to vascular structures within the 3D silk scaffold 
According to our hypothesis the seeded hDPSCs should not only attract tissue and vessel ingrowth 
into the scaffold, but also contribute directly to the vascular structures by environment-induced 
differentiation into endothelial cells or pericytes. In fact, our results support this hypothesis, as 
hDPSCs have been observed to be embedded in the vascular basement membrane of in ovo 
cultured samples after only 1 week of incubation, where they were involved in the production of 
basement membrane components of functional blood-perfused vessels. The integration of human 
cells into the vessel wall was confirmed and even more evident in samples cultured in vivo for 4 
weeks. These findings are in agreement with those of d’Aquino et al., where human cell-derived 
vessel structures within hDPSC-produced scaffold-free bone chips were observed in 
immunocompromised rats after 45 days (d’Aquino et al., 2007). HDPSC-derived vascularized bone 
tissue has also been generated when hDPSCs-seeded collagen scaffolds were implanted in 
critical-sized bone defects in rats for 8 weeks, where the human origin of endothelial cells within 
the newly formed bone tissue was proved using an anti-human mitochondrial protein (Maraldi et 
al., 2011). A more recent study used a combination of hDPSCs with 45S5 Bioglass scaffolds to 
grow vascularized tissue in a diffusion chamber that was implanted intraperitoneally in 
immunocompromised mice for 8 weeks (El-Gendy et al., 2015). In contrast to the previously 
mentioned two studies, the latter one was the first showing hDPSC-derived capillaries without 
pre-incubating the cells in differentiation medium prior to implantation, supporting our own 
findings. 
The angiogenic growth factors vascular endothelial growth factor A (VEGFA) and transforming 
growth factor beta 1 (TGFb1) genes were found to be expressed by human cells within our 
cell-seeded construct after implantation. VEGF is the key mediator of angiogenesis (Ferrara, 1996) 
and is expressed by hDPSCs without the need of induction (Bronckaers et al., 2013). Furthermore, 
Bento et al. showed that the VEGF/MEK1/ERK signaling pathway is a key regulator of the 
endothelial differentiation of dental pulp stem cells (Bento et al., 2013; Virtej et al., 2013). TGFb1 
is known to induce angiogenesis through an indirect mechanism, by recruiting inflammatory cells 
that secrete VEGF and/or other angiogenesis inducers (Ferrari et al., 2012). Additionally, an earlier 
study had found evidence for a biphasic effect of TGFb1 on in vitro angiogenesis, as high 
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concentrations of TGFb1 inhibited VEGF-induced angiogenesis, while low concentrations 
stimulated angiogenesis (Derringer and Linden, 2004; Pepper et al., 1993). 
Collectively, the findings provide evidence that hDPSCs are able to contribute to vascular 
structures as endothelial cells and pericytes, resulting in functional blood-perfused mosaic 
structures of human- and host-derived cells. HDPSC-derived laminin and collagen type IV form the 
vascular basement membrane, which stabilizes neovasculature and is a sign of vascular 
maturation. In our study we were able to show that these processes start as early as 1 week after 
in ovo implantation of the cell-seeded silk scaffold. Interestingly, the ability of hDPSCs to 
contribute to vessel structures after either short (1 week) or long (8 weeks) periods of incubation 
seems to be material independent, as similar results have been generated in a variety of 
materials, including silk fibroin, collagen, and 45S5 Bioglass scaffolds or osteoinduced hDPSC-
derived bone chips. 
 
7.3 Presence of potential progenitor cell reservoirs within cell-seeded 3D silk 
scaffolds 
Most adult tissues have been shown to harbor progenitor cells, which are responsible for 
functional tissue homeostasis throughout life (Watt and Driskell, 2010). Therefore, tissue-
engineered constructs should not only support the healing of a defect temporarily, but should 
also be able to continue the natural occurring tissue homeostasis for physiological functionality. 
Here, stainings performed on in ovo and in vivo incubated samples indicated that part of the 
seeded cells kept their initial characteristics of (multi-lineage) progenitor cells of mesenchymal 
origin. Based on previous studies, Nestin-expression in adult tissues, including the dental pulp, has 
been described to be mostly restricted to areas of regeneration and to be upregulated after 
injury, contradicting the initial believe of Nestin being an exclusive marker for neural stem cells 
(About, Laurent-Maquin, et al., 2000; Lizier et al., 2012; Wiese et al., 2004). In our samples, also 
Nestin gene expression supported the positive Nestin-expression obtained by immunofluorescent 
stainings. Sox2-immunostainings showed a predominant cytoplasmic localization in samples 
retrieved after implantation in ovo and in vivo. In contrast, clear expression of Sox2 in the nuclei 
had been observed in both cell populations (uns-hDPSCs and s-hDPSCs) in vitro, indicating an 
initial multipotent and self-renewing phenotype (Fong et al., 2008). Sox2-expression at various 
passages of dental pulp cells has been previously investigated by Liu et al. (L. Liu et al., 2011). 
Nuclear localization of Sox2 was observed at early passages (P0-P2), while in later passages (up to 
P7) Sox2 was translocated to the cytoplasm, ‘implying the potential loss of pluripotency along 
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extended passaging’ (L. Liu et al., 2011). Therefore, the Sox2 staining pattern in our samples might 
be indicative for a gradual loss of their differentiation potential. The mesenchymal character of 
the implanted cells was tracked following Vimentin-expression, which was found to be positive in 
cells before as well as after in ovo and in vivo implantation. These results align with previously 
reported Vimentin-expression patterns of hDPSCs examined at early and late passages, where 
also Nestin-expression was observed to be stably expressed (Lizier et al., 2012). 
Considering our findings in the light of previous reports, we can conclude that potential 
progenitor cell reservoirs of mesenchymal origin are still present within the 3D silk scaffolds after 
in ovo and in vivo culture, even though these properties might be gradually decreasing in the 
course of differentiation.  
 
7.4 3D imaging of the developing vasculature within stem cell-seeded 
scaffolds cultured in ovo 
Studying the spatio-temporal aspects of the vascularization of tissue engineered constructs 
requires proper tools for the visualization of vessels within such implants, which is essential for 
predicting and understanding the outcome of new regenerative approaches before their 
application in clinics. In the present study, one of the aims was to combine existing tools, i.e. 
MicroFil® perfusion and microcomputed tomography (microCT) scanning and analysis with the 
chorioallantoic membrane (CAM) assay, to develop a time- and cost-efficient technique for testing 
and visualizing the potential effect that selected scaffolds, cells, and growth factors might have on 
the vascularization efficiency of an in vitro engineered implant.  
Casting techniques have been used extensively to study the vascular architecture in health and 
disease, ranging from whole organisms to specific organs and organ structures. Combining the use 
of a radiopaque perfusion substance (i.e. MicroFil®) with modern microCT imaging and analysis 
has improved our knowledge on tissue anatomy, physiology, and pathology. Additionally, the 
perfused specimen can be used for further histological analyses, thereby reducing the amount of 
required samples. Therefore, it has been applied in various fields, including embryonic vascular 
development (Anderson-Berry et al., 2005), cancer research (Xuan et al., 2007), cardiac disease 
models (Sangaralingham et al., 2012), and tissue engineering (Bolland et al., 2008; Stoppato et al., 
2013). For example, angiogenesis has been visualized by microCT in MicroFil®-perfused tissue 
engineered constructs implanted subcutaneously into immunosuppressed mice. Both natural and 
synthetic materials used showed an increase in the vessel number within the implants when 
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seeded with bone marrow stromal cells (BMSCs) (Bolland et al., 2008). More recently, the same 
technique was used to compare the vascularization in pure poly (D,L)-lactic acid (PDLLA) scaffolds 
with PDLLA combined with silk fibers. The latter was demonstrated to promote vascular ingrowth 
when implanted subcutaneously into rats (Stoppato et al., 2013). However, the mentioned studies 
were always using rodents as hosts of the implants, which require extensive animal care-taking, 
ethical approvals, as well as surgical skills and equipment. Moreover, usually a longer incubation 
period is necessary in order to analyze the angiogenic effect of engineered implants. In contrast, 
the CAM assay is a simple, cost-effective, and highly reproducible method, which does not require 
approval when performing experiments in chicken embryos until reaching the last third of their 
development before hatching (i.e. embryonic day 14) (Swiss animal care guidelines, TSchV, 
Art. 112). Even though the incubation time on the CAM is limited to a period of about 7 days, it 
constitutes an excellent screening method to study the early phase of the vascular integration of a 
3D biomaterial by the host. Following the ‘3Rs’ principles of replacement, refinement, and 
reduction of animal use in research, the CAM assay combined with MicroFil® perfusion and 
microCT analysis as described in this work could provide a valuable intermediate platform for 
initial assessments prior to pre-clinical studies in mammals. Even repeated monitoring could be 
possible, if an in vivo-applicable contrast agent (e.g. AuroVist 15 nm, ExiTron nano 12000) was 




The presented work is the first experimental study combining hDPSCs with 3D silk scaffolds in 
order to investigate the early phase of tissue integration and vascularization using the CAM assay. 
Apart from cell-mediated vessel attraction, our study focused on the potential of hDPSCs to 
contribute to ingrowing vessels from the host as well as to maintain a pool of stem cells within the 
biomaterial. Our findings showed a higher degree of scaffold integration and vascularization in the 
presence of cells, which further allowed for the creation of new mosaic vessels of host and human 
origin inside a biomaterial that is approved for clinical use. Additionally, evidence for remaining 
human multipotent stem cells of mesenchymal origin was provided. The long-term fate of the 
cell-scaffold-constructs was observed after subcutaneous implantation in mice. The lack of 
mineralization in the absence of osteogenic factors during the pre-culture of the cell-seeded 
scaffolds proves that this process can be controlled by adjusting pre-culture conditions. No 
obvious difference was observed between unsorted hDPSCs and CD34+/CD90+ sorted hDPSCs. 
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Further optimization of the 3D vessel imaging technique of in ovo cultivated samples would result 
in a valuable analytical tool with the power to reduce animal use in research.  
In conclusion, autologous multipotent stem cells isolated from human dental pulp are easily 
accessible and have the potential to support the tissue integration and vascularization of future 
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9. List of Abbreviations 
3D   three-dimensional 
AEC    3-amino-9-ethylcarbazole 
APC-Cy7  alophycocyanin: Cy-7 tandem conjugate 
BCIP    5-bromo-4-chloro-3-indolyl phosphate 
bFGF   basic fibroblast growth factor 
BMP2   bone morphogenetic protein 2 
BMSC(s)  bone marrow stem cell(s) 
CAM   chorioallantoic membrane 
CD   cluster of differentiation 
cDNA   complementary deoxyribonucleic acid 
CO2   carbon dioxide 
conc.    concentration 
DAPI   4',6-diamidino-2-phenylindole 
DFSC(s)   dental follicle stem cell(s) 
dH2O   distilled water 
DiI   1,1' dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate 
DMEM   Dulbecco's Modified Eagle's medium 
DMEM/F12  Dulbecco's Modified Eagle's medium/nutrient mixture F-12 
DNA   deoxyribonucleic acid 
DPSC(s)   dental pulp stem cell(s) 
ECM   extracellular matrix 
ECs   endothelial cells 
ED   embryonic day 
EPCs   endothelial progenitor cells 
FBS   fetal bovine serum 
FITC   fluorescein isothiocyanate conjugate 
hDPSC(s)  human dental pulp stem cell(s) 
H&E   Hematoxylin and Eosin 
HLA-DR   human leukocyte antigen - D related 
ICM   inner cell mass 
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iPS cells  induced pluripotent stem cells 
LDH   lactate dehydrogenase 
MSC(s)   mesenchymal stem cell(s) 
MTT   3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide 
n   sample number 
NBT    nitro blue tetrazolium chloride 
NuMA    nuclear mitotic apparatus protein 1 
ON   overnight 
P   cell passage 
PBS   phosphate buffered saline 
PE   phycoerythrin 
PerCP-Cy5.5  peridinin-chlorophyll-protein complex: CY5.5 conjugate 
PDLSC(s)  periodontal ligament stem cell(s) 
PFA   paraformaldehyde 
PGA   polyglycolic acid 
PLGA   poly-lactic-co-glycolic acid 
PLLA   poly-L-lactic acid 
P/S   penicillin/streptomycin 
qRT-PCR  quantitative real-time polymerase chain reaction 
RNA   ribonucleic acid 
RT   room temperature 
RUNX2    runt-related transcription factor 2 
s-hDPSC(s)  CD34+/CD90+ sorted human dental pulp stem cell(s) 
SCAP(s)   stem cell(s) from the apical papilla 
sc   silk scaffold fibers 
SCs   stem cells 
SD   standard deviation 
SHEDs   stem cell(s) from human exfoliated deciduous teeth 
Sox2   SRY (sex determining region Y)-box 2 
TGFb1    transforming growth factor beta 1 
uns-hDPSC(s)  unsorted human dental pulp stem cell(s) 
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VEGF   vascular endothelial growth factor 
VEGFA    vascular endothelial growth factor A 
vSMC(s)  vascular smooth muscle cell(s) 
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Fighting for Territories: Time-lapse Analysis of Dental Pulp and Dental Follicle Stem Cells in Co-
Culture Reveals Specific Migratory Capabilities (PAPER) 
 
Dental pulp stem cells (DPSCs) and dental follicle stem cells (DFSCs) are two dental mesenchymal 
stem cell populations that can be isolated from human teeth. Previous studies have shown that 
these two cell populations may have different functions when used for tissue repair in vivo. The 
presented project investigated the migratory and proliferative behavior of both cell populations in 
mono- and co-culture setups in vitro. Low and irregular migration profiles were observed when 
DPSCs and DFSCs were cultured alone. However, in co-cultures DFSCs but not DPSCs increased 
their migration activity and velocity and surrounded the DPSCs. This behavior resembles the in 
vivo embryonic developmental process of odontogenesis, where follicle cells encircle both the 
dental papilla and the enamel organ of the developing tooth germ. Together with a gene 
expression analysis of regulatory genes involved in dental cell migration and differentiation, the 
findings prove that stem cell populations isolated from distinct tissues behave differently 
according to their environment, retain their genetic memory, and compete with each other to 
acquire the appropriate territory. Therefore, these specific characteristics of stem cell populations 
have to be considered when selecting them for the future repair and regeneration of particular 
dental tissues in the clinic. 
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Abstract
Stem cell migration is a critical step during the repair of 
damaged tissues. In order to achieve appropriate cell-
based therapies for tooth and periodontal ligament repair 
it is necessary first to understand the dynamics of tissue-
specific stem cell populations such as dental pulp stem cells 
(DPSC) and dental follicle stem cells (DFSC). Using time-
lapse imaging, we analysed migratory and proliferative 
capabilities of these two human stem cell lines in vitro. 
When cultured alone, both DPSC and DFSC exhibited 
low and irregular migration profiles. In co-cultures, DFSC, 
but not DPSC, spectacularly increased their migration 
activity and velocity. DFSC rapidly surrounded the DPSC, 
thus resembling the in vivo developmental process, where 
follicle cells encircle both dental epithelium and pulp. 
Cell morphology was dependent on the culture conditions 
(mono-culture or co-culture) and changed over time. 
Regulatory genes involved in dental cell migration and 
differentiation such as TWIST1, MSX1, RUNX2, SFRP1 
and ADAM28, were also evaluated in co-cultures. MSX1 
up-regulation indicates that DPSC and DFSC retain their 
odontogenic potential. However, DPSC lose their capacity 
to differentiate into odontoblasts in the presence of DFSC, 
as suggested by RUNX2 up-regulation and TWIST1 down-
regulation. In contrast, the unchanged levels of SFRP1 
expression suggest that DFSC retain their potential to 
form periodontal tissues even in the presence of DPSC. 
These findings demonstrate that stem cells behave 
differently according to their environment, retain their 
genetic memory, and compete with each other to acquire 
the appropriate territory. Understanding the mechanisms 
involved in stem cell migration may lead to new therapeutic 
approaches for tooth repair.
Keywords: Tooth; odontoblast; dental follicle; periodontal 
ligament; dental pulp; dental stem cells; tooth repair; 
regeneration.
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Introduction
Cell migration is a widespread, highly dynamic and 
complex process that is crucial for the appropriate 
development of organs and tissues (Aman and Piotrowski, 
2010; Binamé et al., 2010). Aberrant cell migration often 
results in severe morphogenetic defects and/or diseases 
(Friedl and Gilmour, 2009). Reactivation of cell migration 
underlies tissue repair processes, as well as several 
pathological conditions, such as metastatic cancers, thus 
making the study of cell movement clinically relevant.
 In order to understand better the mechanisms involved 
in tissue repair and/or regeneration in vivo, in vitro assay 
systems have been developed that can bring considerable 
information about motility and directional migration of 
cells (Okumoto, 2010; Stephens and Allan, 2003; Wang 
et al., 2008). Cellular dynamics and functions (e.g. cell 
migration, proliferation, apoptosis) can be visualised 
and quantitatively analysed through computational live 
image processing (Huth et al., 2011; Wang et al., 2008), 
thus allowing us to obtain biochemical and biophysical 
information about different cell populations at precise 
temporo-spatial windows (Aman and Piotrowski, 2010).
 Tooth development results from sequential and 
reciprocal interactions between the oral epithelium and the 
cranial neural crest-derived mesenchyme (Bluteau et al., 
2008; Mitsiadis and Graf, 2009; Mitsiadis and Luder, 2011; 
Thesleff et al., 1989; Thesleff et al., 1991; Thesleff et al., 
1995). Epithelial cells give rise to the enamel producing 
ameloblasts, while mesenchymal cells are involved 
in the formation of the dental pulp and dental follicle. 
Odontoblasts originated by the dental pulp produce the 
dentin matrix, whereas dental follicle cells contribute to the 
formation of cementum, periodontal ligament, and alveolar 
bone (Diep et al., 2009). Periodontal ligament occupies 
the space between the tooth root and the alveolar bone 
and serves for tooth anchorage to the bone and masticatory 
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force distribution. Although it has been shown that dental 
follicle cells express a plethora of regulatory molecules 
(Liu and Wise, 2007; Morsczeck and Schmalz, 2010), 
the mechanisms controlling their in vivo behaviour (e.g., 
cell proliferation, migration, and differentiation) remains 
elusive. Dental follicle cells are in close contact with cells 
of the dental papilla and root dentin during odontogenesis 
(Mitsiadis and Luder, 2011; Thesleff et al., 1989), and it 
has been demonstrated that these interactions constitute 
an important step for dental follicle differentiation (Bai 
et al., 2010). Signalling molecules, derived from the 
dental papilla and root dentin, could be responsible for the 
proliferation and differentiation of dental follicle cells in 
vivo (Bai et al., 2010; Mitsiadis and Rahiotis, 2004).
 During tooth repair after injury or carious lesion, 
numerous genes that are expressed throughout embryonic 
tooth development are reactivated. For example, nestin 
and Notch molecules are re-expressed in the dental pulp 
during the reparative processes (Mitsiadis and Rahiotis, 
2004). Tooth repair also involves activation of various 
dental stem cell populations (Mitsiadis et al., 2011). During 
tissue repair and/or regeneration, stem cells self-replicate, 
generate daughter cells and finally re-populate the damaged 
tissue (Laird et al., 2008; Smith, 2001; Smith, 2005). 
This process requires the oriented or directed movement 
of stem cells toward this particular anatomic destination 
(Laird et al., 2008). In human teeth, stem cell populations 
have been isolated and characterised from dental pulp and 
dental follicle (Gronthos et al., 2000; Handa et al., 2002; 
Laino et al., 2005; Miura et al., 2003; Papaccio et al., 2006; 
Takeda et al., 2008). Dental pulp stem cells (DPSC) and 
dental follicle stem cells (DFSC) were sorted by FACS 
using cell-surface markers such as CD117, CD34 and flk-1 
for DPSC (d’Aquino et al., 2007; Graziano et al., 2008; 
Tirino et al., 2011) and SSEA4, OCT-4, TRA1-80 and 
TRA1-81 for DFSC (d’Aquino et al., 2011). These stem 
cell populations reside in various niches within the dental 
pulp and follicle (Lovschall et al., 2007; Mitsiadis et al., 
2011). DPSC are very flexible and can differentiate into 
chondrocytes, adipocytes, neurons, muscles, odontoblasts 
and bone cells. In vivo, DPSC can form a vascularised 
pulp-like tissue that is surrounded by odontoblast-like cells 
(Nakashima and Iohara, 2011). The first clinical trial was 
successfully performed a few years ago, where DPSC from 
patients were capable to fully repair their own alveolar 
bone defects (d’Aquino et al., 2009). Similarly to the 
DPSC, DFSC exhibit a great differentiation potential (e.g. 
adipocytes, myoblasts, neurons, glial cells, cementoblasts, 
periodontal ligament fibroblasts), with the exception of 
bone formation (d’Aquino et al., 2011; Morsczeck et al., 
2005; Yao et al., 2008). Indeed, DFSC are not capable of 
differentiating into osteoblasts unless a specific culture 
medium is used (Bai et al., 2010; d’Aquino et al., 2011; 
Yagyuu et al., 2010; Wu et al., 2008). Taken together these 
findings indicate that DPSC and DFSC may have different 
functions when used for tissue repair in vivo. Thus, it is 
desirable to understand their behaviour in vitro better, 
before any future clinical application.
 In this study we applied time-lapse cell imaging, in 
an attempt to understand complex biological phenomena 
related to dental injury and repair/regeneration. We 
have found that DPSC and DFSC in co-culture behave 
differently from in mono-culture and compete with each 
other to increase their vital territory. The fact that DFSC 
rapidly migrate and occupy most of the culture space by 
surrounding and restraining the DPSC suggests new criteria 
for the clinical use of the various stem cell populations 
during tooth repair.
Materials and Methods
Subjects, stem cell extraction, digestion, and culture
Dental pulps were extracted from intact teeth of 21 to 45 
year-old healthy individuals. Dental follicles were collected 
from wisdom tooth germs with not yet formed roots from 
18 to 40 year-old healthy individuals. Dental pulps as well 
as dental follicles were incubated in a digestive solution 
composed of 3 mg/mL type I collagenase and 4 mg/mL 
dispase in phosphate buffered saline (PBS) for 1 h at 
37 °C. After enzymatic digestion, the solution was filtered 
through 70 µm Falcon strainers (Becton & Dickinson, 
Milan, Italy) and then cells were immersed in DMEM 
culture medium supplemented with 10 % foetal bovine 
serum (FBS) (Lonza, Milan, Italy), 100 mM 2P-ascorbic 
acid, 2 mM L-glutamine, 100 U/mL penicillin, 100 µg/mL 
streptomycin (Invitrogen, San Giuliano Milanese, Milan, 
Italy) and cultured in 75 cm2 flasks with filtered valves 
(Papaccio et al., 2006). FGF2 (20 ng/mL) was added to 
the medium for the culture of the dental follicles. Cells 
were cultured at 37 °C in a 5 % CO
2 
incubator. The culture 
medium was renewed twice per week. Upon confluence, 
cells were used either for cell sorting or for time-lapse 
experiments (generally, at the first passage). Digested 
tissues were permitted to achieve near confluence (90 % 
of flask surface), which corresponds to 4x105 cells/25 cm2 
for both cell populations. However, the average doubling 
time for DPSC is about 3 d while for DFSC it is 1 d (for 
details see Tirino et al., 2011).
Colony efficiency assays and proliferation potential
To evaluate colony efficiency and proliferation potential, 
single cells obtained by limiting dilutions were plated. 
After three weeks of culture, cells were stained with 0.1 % 
(w/v) toluidine blue in 1 % paraformaldehyde (PFA) and 
the number of clones (>50 cells) was counted.
Fluorescence-activated cell sorting (FACS)
For the collection of DPSC, approximately 1x106 dental pulp 
cells per sample were detached from the flasks, washed and 
incubated with the CD117 and CD34 antibodies for 30 min 
at 4 °C. After incubation, CD34 and CD117 co-expressing 
cells were sorted using a FACS Aria II BD (BD Biosciences, 
Milan, Italy). The purity of these sorted cell populations 
was 90 %. The CD34+/CD117+cells were cultured in 
DMEM supplemented with 10 % FBS and then used for 
the time-lapse experiments.
 For the collection of DFSC, nearly 1x106 follicle cells 
per sample were detached from the flask using 0.02 % 
EDTA in PBS, pelleted (10 min at 1,000 rpm), washed in 
0.1 % bovine serum albumin (BSA) in PBS at 4 ºC, and 
then incubated with the SSEA4 antibody for 30 min at 4 °C. 
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After washing, the cells were analysed by flow cytometry 
and sorted by FACS. The purity of the sorted SSEA4+ 
population was 90 %. SSEA4+ cells were cultured in 
DMEM at 10 % FBS and used for time-lapse experiments.
Dye staining
Lipophilic cell tracking dyes such as PKH26 and PKH67 
(Sigma Aldrich, Milan, Italy), use membrane-labelling 
technology to stabilise the incorporation of a fluorescent 
dye into the lipid regions of the cell membrane. Lipophilic 
cell labelling is simple to use and allows the follow up of the 
tagged cells in vitro and/or in vivo. Therefore, it constitutes 
a powerful tool for studying the kinetics and behaviour of 
various cell populations in a heterogeneous environment. 
DPSC and DFSC were stained with the PKH26 and PKH67 
dyes, respectively, at a final concentration of  2x10-6 M 
and 3x105 cells/mL according to the manufacturer’s 
instructions. Diluent C is the labelling vehicle provided 
with the kit, an isosmotic aqueous solution designed to 
maintain cell viability and maximise dye solubility and 
staining efficiency (Lee-MacAry et al., 2001).
Time-lapse co-culture experiments
DPSC were cultured together with DFSC in a standard 24-
well culture plate with μ-dish (35 mm, high) culture-insert 
(Ibidi, Integrated BioDiagnostics, Munich, Germany). 
In order to identify the behaviour of these two specific 
dental stem cell populations in this co-culture system, 
a series of cell mixtures with different ratio of DPSC/
DFSC (i.e.1.7x102 cells/mm2/1.7x103 cells/mm2{1:10}, 
1.7x103 cells/mm2/1.7x102 cells/mm2 {10:1}, 2.8x102 
cells/mm2/2.8x102 cells/mm2{1:1}) were prepared (Fig. 
1). Briefly, adherent cells were removed from flasks after 
24 h of culture, using proteolytic enzymes (trypsin/EDTA; 
Invitrogen, Milan, Italy), immediately re-suspended and 
either plated as such or labelled prior to seeding. The 
labelling procedure consists in re-suspending centrifuged 
cells in 1 mL of staining solutions (i.e. PKH26 and PKH67) 
for 5 min, washing in culture medium for fluorescent dye 
excess removal, and finally seeding and incubating at 
37 °C. After 2 h of incubation, fluorescence microscopy 
images were taken to analyse the morphology of the cells. 
The cells were observed for 30 h on Oko-Full time-lapse 
Fig. 1. Cell movement and orientation of DPSC and DFSC cultured alone. (A) When cultured alone, DPSC exhibit 
a random and restricted motility through the x or y axes. Coloured lines (right image) are representative of extracted 
cell tracks for DPSC in overall time (30 h). (B) When cultured alone, DFSC show circular movements. Coloured 
lines (right image) represent extracted cell tracks for DFSC in overall time (30 h).
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in bright field and in fluorescence. In particular, the images 
in bright field were captured every 1 h (∆t), while those in 
fluorescence were captured every 4 h. This feature allowed 
us to reduce sample photo-bleaching and cell damage. It 
is possible to change the acquisition time of the images 
through a Ludl shutter controlled by the Oko-Vision 
software. The latter is an optical video-microscopy station, 
composed of a microscope (Zeiss Axiovert 200), with a 
10x objective in phase contrast, equipped with motorised 
“stage incubator” for automated sample positioning, a stage 
incubator where the temperature and the atmosphere were 
kept at 37 °C and 5 % CO
2
, respectively, and controlled 
humidity. The sequential images were captured by a 
CCD video camera (ORCA ER, Hamamatsu Photonics, 
Hamamatsu City, Japan). The monolayer was imaged 
using phase contrast, while the fluorescently labelled stem 
cells were imaged using Chroma Filters multi-channel 
(86013V2), for FITC (excitation BP 450-490 nm, emission 
LP 515 nm) and TRITC (excitation BP 550 nm, emission 
LP 580 nm).
Cell tracking software and analysis
The time-lapse video microscopy system represents a novel 
fully automated high-throughput approach for a precise 
and detailed cell tracking. In time-lapse video microscopy, 
manual cell tracking remains the most common method 
for analysing migratory behaviour of cell populations. 
Cell-Tracker, automatic tracking and analysis software was 
implemented using oko-vision (version 2009) and consists 
of a graphical, cross-platform open source application, 
adjustable to various types of microscopy images and 
video files. A modular architecture allows for the expansion 
of image processing and independent tracking. The 
Graphicator allows plotting of cell coordinates versus 
time, cell velocity and orientation. Cell-Tracker software 
allows easy following of cell movement in an interactive 
way. The cell trajectory is superimposed on the images, 
for visual validation of the analysis.
 Manual tracking was performed with a custom viewing 
program that enabled storage of x and y coordinates by 
clicking on cells in sequential images with a computer 
mouse. Manual cell tracking was performed for a total of 
4 cells for each field of view (object), for a total of four 
objects selected in each well. Generally, each condition was 
repeated at least three times. In addition, each experiment 
was performed for all cells located within the preselected 
regions of analysis, during the considered recording time 
(i.e. 30 h - 30 tracks).
 The speed and motility of DPSC and DFSC in separate 
wells were analysed using the above-mentioned software. 
The speed, area, deformation, trajectory and detailed 
tracking of the cells were computed and displayed for 
analysis. The interaction of the two dental stem cell 
populations was studied in different conditions in the same 
well. Tabulated data of tracking results were exported 
into Microsoft Excel for further numerical analysis 
and evaluated statistically using Student’s t-test. The 
conversion factor for measured pixels to microns (1.06 for 
10x objective) was determined using a stage micrometer.
 Cell-Tracker was plotted as cell coordinates (x and y) 
versus time. The cell velocity along x axis (vector) was 
calculated by the following equation:
   





final time and initial time, respectively.
 Analyses were performed considering the ratio DPSC/
DFSC (1.7x103 cells/mm2/1.7x102 cells/mm2 and 1.7x102 
cells/mm2/1.7x103 cells/mm2) per well and the major cell 
number (1.7x103 cells/mm2). Data represent the mean ± 
SD of three independent experiments.
Isolation of total RNA and quantitative real-time 
(qRT)-PCR
Total RNA was extracted by using 1 mL of TRIzol® 
(Invitrogen, Milan, Italy), according to the manufacturer’s 
instructions. The precipitate was then re-suspended in 
nuclease-free water. The concentration of the extracted 
RNA was determined using a Nanodrop spectrophotometer 
(Celbio, Milan, Italy), and qualitative analysis of the 
RNA was accomplished by 1 % agarose-gel (w/v) 
electrophoresis. For cDNA synthesis, performed with the 
Reverse Transcription System Kit (Promega, Milan, Italy), 
1 μg of DNase-digested total RNA was used (DNA-free kit; 
Ambion-Applied Biosystems, Monza, Italy). Quantitative 
RT-PCR was obtained by using the iQ™ SYBR® Green 
Supermix (Bio-Rad Laboratories, Milan, Italy) to analyse 
the expression of TWIST1, MSX1, RUNX2, ADAM28 and 
SFRP1. BLAST query permitted the specificity analysis of 
Table 1. Oligonucleotide primers for real time PCR.
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each qRT-PCR primer pair, and corresponding sequences 
were designed by Beacon Designer™ software. The primer 
sequences are shown in Table 1. All reactions were carried 
out in triplicate, and the expression of specific mRNA 
relative to the control was determined after normalisation 
with respect to GAPDH gene. The fold-change of test 
gene mRNA expression was calculated by considering 
the efficiency of each primer (between 80 and 110 %), 
and by using the comparative threshold method (ΔΔCt = 
difference of ΔCt between co-cultured cells and single cell 
populations used as controls). The results were expressed 
as normalised fold expression, calculated by the ratio of 
crossing points of amplification curves of several genes 
and internal standard, by using the Bio-Rad iQ™5 software 
(Bio-Rad Laboratories Srl).
Results
Colony efficiency assays and proliferation potential
To assess the proliferation and clonogenic potential 
of DPSC and DFSC, we performed a limiting dilution 
Fig. 2. Cell motility in co-culture of DPSC and DFSC. The graphs show the cell tracker analyses of DPSC and DFSC 
co-cultured at a ratio 1:1 along x (A) and y axis (B), at a ratio 10:1 along x (C) and y axis (D), and at ratio 1:10 along 
x (E) and y axis (F).
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Fig. 3. Time-lapse panel images. (A) DPSC and DFSC in co-culture at a ratio 1.7x102 cells/mm2/1.7x103 cells/mm2 
(1:10). Note that DFSC completely surround DPSC. (B) DPSC and DFSC in co-culture at a ratio 1.7x102 cells/
mm2/1.7x102 cells/mm2 (1:1). Note that DPSC do not move, building up a wall slide by slide. Merge micrographs 
(bright field, FITC and TRITC) captured at 4 h intervals.
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assay. After 3 weeks of culture, 92 % of the wells (442 of 
480), which were initially plated with one or two DPSC, 
contained colonies (formed of >50 cells), with a doubling 
time of ≈2.6 d. For DFSC, 93 % of the wells (445 of 480) 
contained colonies with a doubling time of ≈2.4 d.
Cytometry assay
To isolate DPSC, dental pulp cells were detected and sorted 
for co-expression of CD34 and CD117 markers at passage 
1 of culture. The positivity of these antigens was ~15 % of 
the total cell population. To isolate DFSC, dental follicle 
cells were detected and sorted for SSEA4 expression at 
passage 1 of culture. The percentage of SSEA4 positivity 
was ~80 %. DPSC and DFSC were sorted and then used 
for time-lapse and RT-PCR experiments.
Time-lapse observations
In order to observe the behaviour of DPSC and DFSC in 
vitro (i.e. cell movement, orientation, morphology and 
velocity), time-lapse video-microscopy analyses were 
performed on 6-8 tracks for each image (4 fields of view 
per well). These two stem cell populations were cultured 
either alone or together in various cell ratios. As a control, 
1x104 DPSC or DFSC per well (200 mm2) were used. In co-
cultures, DPSC and DFSC were seeded separately using a 
spacer (Culture-Insert). In a first set of experiments, the cell 
ratio was fixed at 1:1, 1:10 and 10:1 along x and y axes, and 
each stem cell population was stained with a different dye 
(green colour for DPSC, red colour for DFSC). Analyses 
of the DPSC and DFSC behaviour were performed on the 
side of the well containing the greater number of cells 
(1.7x103 cells/mm2).
Cell movement and orientation
When cultured alone, DPSC and DFSC moved trivially for 
short distances and often returned in their point of origin 
(Fig. 1A and B). More precisely, DPSC showed random 
and small motility through the x or y axes (Fig. 1A), while 
most of the DFSC displayed circular movements within 
a small perimeter (Fig. 1B). The behaviour of DPSC and 
DFSC changed significantly in the co-culture experiments, 
and this was dependent on both the number and ratio of 
cultured cells.
DPSC/DFSC 1:1 co-culture
A substantial and interesting change of cell movements was 
observed when the two stem cell populations were seeded 
at the same density. In this case, a better linear progression 
was detected for DFSC movements along both coordinates 
(x and y axis), as confirmed by curve analyses, although 
Fig. 4. Cell dimension analysis. (A) Major axis averaged sizes during time of DPSC and DFSC cultured alone, 
demonstrating that in both populations cells become elongated. (B) Major axis averaged dimensions during time 
of DPSC and DFSC co-cultured at a ratio 1:10 and 10:1. In both cases DFSC significantly (p < 0.05) increase their 
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DFSC moved oppositely to DPSC along the y axis. The 
track of DPSC along the x axis (Dx) was more linear than 
the track along the y axis (Dy) (Fig. 2A and B).
DPSC/DFSC 10:1 co-culture
When DPSC and DFSC were co-cultured at a 10:1 ratio, 
both cell populations exhibited a linear progression along 
the x axis (Dx), while cell movements were highly irregular 
along the y axis. More precisely, DPSC showed only short 
irregular movements, and remained practically in the same 
position. In contrast, DFSC covered a long distance, and 
although their initial movement was irregular it finally 
became linear and unidirectional (Fig. 2C and D).
DPSC/DFSC 1:10 co-culture
When DPSC and DFSC were co-cultured at the 1:10 
ratio, both cell types showed a linear progression of their 
movements along the x axis (Dx), while their movements 
were irregular along the y axis (Dy). However, DFSC 
moved more than DPSC along the y axis (Fig. 2E and F).
Fig. 5. Cell velocity analysis. DPSC and DFSC in co-culture at a ratio 1:10 (A), 10:1 (B), and 1:1 (C). DFSC result 
in 2-fold horizontal velocity in comparison with DPSC and even 3-fold along the vertical axis. Data represent the 
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Image analyses
The observation of the panels (Fig. 3) confirmed that there 
is an interaction between DFSC and DPSC in terms of 
motility. We observed that DFSC movement was mainly 
directed along the horizontal axis on the way to surround 
the DPSC, almost embracing or moving them out, 
occupying the whole territory in a short period of time (Fig. 
3A). In contrast, the movement of DPSC was comparable 
to a plug flow along the x axis, being much slower than that 
of DFSC. The images clearly showed that DPSC migration 
was less directional than the DFSC migration (Fig. 3B). 
At the initial stages of the co-culture (day 1), we have 
observed “pioneer” DFSC moving towards DPSC (Fig. 
3A). These “pioneer cells” quickly returned to the DFSC 
territory once they approached or contacted the DPSC. This 
step may represent a stimulatory signal to the whole DFSC 
population for starting their migration towards DPSC (see 
also supplementary movies 1, 2 and 3 on the kinetics of 
DFSC “red cells” and DPSC “green cells” – on the web 
page for this paper).
Cell morphology
Another important point that has been addressed in this 
study concerns the morphological modifications (i.e. 
shapes and dimensions) of DPSC and DFSC when cultured 
either alone or together. We have observed that, when 
cultured alone, both DPSC and DFSC (which are slightly 
longer than the DPSC at the starting point) changed 
their shapes during movement and became considerably 
flattened and elongated after 12 h (Fig. 4A). More precisely, 
cells increased their length by up to 1.7-fold (Table 2). In all 
co-culture variants, DFSC significantly (p < 0.05) increased 
their size (2-fold higher; Table 2), became elongated and 
acquired a spindle shape (Fig. 4B). The enveloping attitude 
of DFSC seemed to induce this restricted elongation of 
DPSC in co-culture: DPSC decreased in size (p < 0.05) 
and assumed a polygonal shape (Fig. 4B).
Cell velocity
Concerning cell velocity, in co-cultures of DPSC and 
DFSC at a ratio 1:10, DFSC were twice as fast as DPSC 
(p < 0.001) on the x axis. On the y axis, cell movement was 
slower when compared with the x axis but also, in this case, 
DFSC were faster than DPSC (Fig. 5A). In co-cultures 





(Fig. 5B), while at a ratio 1:1, DFSC were 
significantly faster than DPSC, in both x and y axes (Fig. 
5C). Specifically, DFSC v
x
 resulted in a 2-fold increase 
over DPSC horizontal velocity, and even 3-fold along the 
vertical axis (Fig. 5C). This confirms that DFSC are more 
active when compared with DPSC.
Real-time PCR observations
The expression of several genes that are regulators of 
cell proliferation, migration and differentiation during 
odontogenesis was evaluated by RT-PCR in our culture 
system (Table 1). We have used the comparative threshold 
method (ΔΔCt = difference of ΔCt between co-cultured 
cells and single cell populations used as controls) and 
the results were expressed as normalised fold expression, 
calculated by the ratio of crossing points of amplification 
curves of several genes and internal standard. TWIST1 
was markedly up-regulated in DPSC at 24 h, while it was 
down-regulated at 48 h (Fig. 6A). In contrast, MSX1 and 
RUNX2 expression showed a strong down-regulation at 
24 h that changed into a significant up-regulation at 48 h 
(Fig. 6A). The expression of SFRP1 was up-regulated at 
24 h and 48 h of culture (Fig. 6A). ADAM28 expression 
was drastically up-regulated in DPSC after 48 h of culture 
(Fig. 6A).
 Analysis of the same profiles of gene expression in 
co-cultures with prevalent DFSC has shown that the 
expression of TWIST1 was slightly decreased at 24 h and 
48 h of culture, whereas expression of MSX1 and ADAM28 
were significantly up-regulated after 48 h of culture (Fig. 
6B). RUNX2 expression was initially decreased (24 h) and 
thereafter increased (48 h). SFRP1 expression was slightly 
decreased after 48 h of culture.
Discussion
Cell-based dental tissue repair or regeneration is an 
attractive approach that complements traditional restorative 
and surgical techniques for replacement of injured 
or pathologically damaged tissues. Such therapeutic 
approaches often require large numbers of stem cells that 
after injection migrate towards the injury site following 
a gradient of directional stimuli. However, a frequent 
problem of these therapies is the integration of the injected 
stem cells with the injured or pathological site (Mitsiadis 
et al., 2012). A deeper appreciation of the mechanisms 
involved in stem cell behaviour will certainly facilitate 
cell-based treatments for tissue repair.
 In this study, we investigated the in vitro behaviour 
of two different dental stem cell populations, DPSC and 
DFSC, using time-lapse imaging. This technique offers 
an ideal platform for understanding stem cell kinetics in 
response to injuries and cell-based therapeutic interventions 
(Aman and Piotrowski, 2010; Wang et al., 2008). The 
ability of DPSC and DFSC to actively migrate, either 
randomly or directionally, and fill the empty space during 
dental tissue repair is an important biological parameter 
in pathological contexts (Huth et al., 2011). The vast 
majority of DPSC and DFSC did not show any peculiar or 
systematic migratory behaviour when cultured separately 
in vitro. Both DPSC and DFSC exhibit tumbling phases: 
DPSC showed a limited and random migratory activity, 
while DFSC followed a circular mode of movement to 
explore their local environment and often returned to their 
Major axis length T = 0 T = 12 h
DPSC 67.1 ± 4.1 151.5 ± 21.7
DFSC 73.6 ± 7.3 126.3 ± 4.4
DPSC/DFSC 10:1 67.1 ± 8.7 87.8 ± 8.2
DPSC/DFSC 1:10 73.7 ± 20.1 150.0 ± 23.1
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point of origin. It has been shown that the tumbling phase is 
cell-autonomous and independent of directional cues such 
as chemokine signalling (Reichman-Fried et al., 2004). 
DPSC and DFSC motion was tortuous, probably due to 
the frequent reversals in directions caused by successive 
protrusions with opposing orientations. Reduction of 
direction reversals makes cell movement less tortuous and 
cells adopt an oriented trajectory towards a chemical or 
electric signal (Aman and Piotrowski, 2010; Arocena et al., 
2010; Zhao et al., 2011a). Indeed, the co-culture of DPSC 
and DFSC stimulated their migration abilities, particularly 
when these two stem cell populations were seeded in equal 
cell numbers. DPSC showed limited proliferation and 
migration capabilities, and adopted a non-directed random 
“walk”. In contrast, DFSC exhibited quick spreading and 
directionally migrated towards DPSC. Pre-migratory 
DFSC started to extend protrusions for guidance and 
traction in a non-directed fashion. Early DFSC migration 
serves to populate the empty Petri-dish space, whereas late 
migration apparently relies on directional cues emanating 
from DPSC. It has been shown that the direction of late cell 
migration is established by gradients of repulsive and/or 
attractant molecules diffusing from the target tissue (Aman 
and Piotrowski, 2010; Kuriyama and Mayor, 2008). In 
addition to guidance cues, cell movement requires physical 
forces that are established through interactions of cells 
with their environment (Grashoff et al., 2010; Hoffman 
et al., 2011). In collectively migrating cells, only a few 
pioneer (or leading) cells perceive guidance cues (Aman 
and Piotrowski, 2010; Binamé et al., 2010; Friedl and 
Gilmour, 2009). Indeed, in our co-culture system DFSC 
started to migrate collectively after getting spatial and 
directional information from pioneer cells. Migration of 
pioneer DFSC initially occurred with no interactions with 
Fig. 6. Gene expression analysis. Images showing normalised fold expression for the genes TWIST 1, MSX 1, RUNX 
2, SFRP1 and ADAM 28 in co-cultures of DPSC and DFSC containing (A) a prevalent population of DPSC (DPSC/
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Fig. 7. Schematic representation showing DPSC and DFSC cultured alone or together in vitro. DPSC are isolated 
from the dental pulp (dp, green colour) and DFSC from the dental follicle (df, red colour), which surrounds both the 
enamel organ (eo) and dental pulp of the developing tooth. In vivo, the functions of these two stem cell populations 
are tissue specific, DPSC control repair/regeneration of the dentin-pulp complex, while DFSC operate for the 
homeostasis and repair of the periodontium. Genes are differentially expressed in dental pulp (e.g. MSX1, PAX9 
etc., in green) and dental follicle cells (DLX3, MSX2 etc., in red). Signalling pathways such as BMP/TGFβ and Wnt 
regulate the expression of these genes. It is not yet known if there are interactions between DPSC and DFSC in vivo 
after tooth eruption. However, these two stem cell populations interact in co-cultures: DFSC migrate fast (small 
arrows) towards DPSC (probably due to DPSC-derived attractant signals, green arrow) and finally embrace them. 
In contrast, DPSC stay on place (possibly because of DFSC-derived repulsive signals, red symbol). This movement 
recapitulates the kinetics of the dental follicle and dental papilla cells during odontogenesis. Expression of several 
genes was up-regulated (up looking arrow), unchanged (=), or down-regulated (down looking arrow) in co-cultured 
DPSC and DFSC.
the trailing DFSC. These pioneer DFSC travel until they 
reach the DPSC territory, and immediately after contacting 
DPSC they move back to their point of origin where they 
transmit the acquired information for an oriented DFSC 
migration towards DPSC. Shortly afterwards, the trailing 
DFSC migrate fast as cohorts, occupy most of the empty 
territory, and finally embrace and restrain the DPSC. This 
DFSC motion closely resembles that of dental follicle 
cells during odontogenesis, where they encircle the enamel 
organ and the dental papilla of the developing tooth germ 
(Fig. 7). Thus, a step of embryonic tooth development 
was reiterated in the in vitro co-culture model. The fact 
that DFSC are isolated from a developing and not yet 
differentiated tissue that surrounds the not erupted tooth 
germ might explain the greater migration activity of 
DFSC compared with DPSC, which are isolated from the 
mature pulp tissue. Although collectively migrating cells 
often lose their motility as they reach their target (Aman 
and Piotrowski, 2010), DFSC at the end of the migratory 
pathway were still motile.
 Tooth damage is the result of different mechanisms of 
injury combined with the incapacity for intrinsic dental 
tissue repair. In autologous stem cell-based approaches, 
patient-related factors, such as the healthy or pathological 
condition of the dental pulp and periodontal ligament, 
may influence the quality of the therapeutic preparation 
Potential signalling pathway molecules: BMP/TGFβ, Wnt
in vivo in vitro culture in vitro co-culture
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(Catón et al., 2011). Regeneration of dental pulp does not 
yet constitute a treatment modality in the clinical field of 
endodontics. The use of DPSC holds a strong promise in 
this respect. These cells can differentiate into odontoblasts 
that will form new dentin, endothelial cells that would 
support the re-vascularisation and neurons that will re-
innervate the regenerated pulp tissue (Catón et al., 2011; 
Nakashima and Iohara, 2011). If DPSC are injected into the 
injured area they do not have to migrate fast or over long 
distances since the pulp space is delimited by the dental 
mineral structures, thus making DPSC the most appropriate 
choice for pulp regeneration. Another major challenge 
in dentistry is the regeneration of the disease-affected 
periodontal tissues (i.e. tooth root cementum, alveolar bone 
and periodontal ligament), in a manner that recapitulates 
embryonic tooth development. Periodontium acts as a 
suspension for the tooth, adapting to the mechanical and 
masticatory loads. DFSC are capable of differentiating 
into all cell types composing the periodontal tissues, they 
can travel fast and far away from the site of injection, thus 
ensuring a quick and appropriate tissue recovery.
 To improve the use of DPSC for dentin repair and DFSC 
for periodontal regeneration, it is important to replicate 
the permissive signals that initiate the differentiation 
of pulp cells into odontoblasts and of follicle cells into 
periodontal ligament fibroblasts, respectively (Fig. 7). 
Such a strategy is likely to restore better the damaged 
soft and hard dental tissues. WNT proteins are regulators 
of cell proliferation, migration and differentiation during 
tooth development and regeneration (Dassule and 
McMahon, 1998; Sarkar and Sharpe, 2000), and have a 
great therapeutic potential for hard tissue remodelling and 
regeneration after injury (Long, 2011; Reya and Clevers, 
2005). Recent clinical therapeutic strategies focus on the 
inhibition of the WNT antagonists such as the Secreted-
Frizzled Related Protein-1 (SFRP1), which is expressed in 
dental follicle cells during odontogenesis (Liu and Wise, 
2007; Liu et al., 2012; Morsczeck and Schmalz, 2010). 
SFRP1 expression is regulated by TGFβ/BMP signalling 
molecules (Li et al., 2011a) that are involved in dental 
cell specification and differentiation (Huang et al., 2010; 
Ko et al., 2007; Mitsiadis and Graf, 2009; Thesleff et 
al., 1995). For example, aberrant BMP signalling affects 
odontoblast differentiation and induces ectopic bone 
formation that replaces normal dentin (Li et al., 2011b). 
In dental mesenchyme, BMP4 regulates the expression 
of MSX1 (Vainio et al., 1993), which is a crucial gene for 
tooth formation since its point mutation in humans causes 
partial anodontia (Vastardis et al., 1996). The interplay 
between TGFβ/BMP and WNT signalling pathways is 
needed to ensure dental stem cell specification during 
tooth repair (Du et al., 2012; Silvério et al., 2012). In our 
co-culture model, expression of MSX1 was significantly 
up-regulated in both DFSC and DPSC, indicating that these 
two stem cell populations have a great capacity to form 
dental structures. TWIST1 could promote the odontogenic 
potential of DPSC by antagonising the function of RUNX2 
that favours osteoblast differentiation (Li et al., 2011b; 
Pan et al., 2010; Zhao et al., 2005). However, the co-
culture of DPSC and DFSC resulted in down-regulation 
of TWIST1 and significant up-regulation of RUNX2 
expression, suggesting that DPSC lose their capacity to 
differentiate into odontoblasts in the presence of DFSC. 
SFRP1 expression in DFSC was not altered when DFSC 
were co-cultured with various ratios of DPSC, indicating 
that DFSC retain their potential to form periodontal tissues 
in the presence of DPSC. Recent studies have shown that 
ADAM28 overexpression has opposite effects on DPSC and 
DFSC: ADAM28 promotes proliferation of DFSC (Zhao 
et al., 2010), while it inhibits proliferation and induces 
differentiation of DPSC (Zhao et al., 2011b). In co-cultures, 
ADAM28 expression was increased dramatically in both 
DFSC and DPSC, indicating that the proliferative potential 
resides within DFSC.
Conclusions
In conclusion, our observations have highlighted that 
DFSC and DPSC behave differently in co-culture from 
when cultured alone and compete with each other in 
order to replenish the free territory. The fact that DFSC 
migrate faster than DPSC and dominate them establishes 
new criteria for the selection and use of specific stem cell 
populations for the repair and regeneration of particular 
dental tissues in the clinic. These results, based on dental 
stem cell lines, could be extrapolated for the controlled 
regeneration of organs that have important vital functions.
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Discussion with Reviewers
Reviewer I: As the authors are experts in the dental 
field, could they discuss the possibility of using mixed 
populations of DPSC and DFSC in transplantations 
targeting tooth repair?
Authors: Dental follicle cells and dental papilla cells are in 
close contact during odontogenesis. Signalling molecules 
from the dental papilla could promote proliferation and 
differentiation of dental follicle cells during development. 
Indeed, in our co-culture model we have shown that DPSC 
stimulated the migration abilities of DFSC. In addition, 
previous results have shown that, in co-culture, DPSC can 
promote differentiation of DFSC and formation of hard 
tissues (Bai et al., 2010). We hypothesise that the use of 
mixed DFSC and DPSC populations for tooth repair may 
accelerate cytodifferentiation and hard matrix deposition 
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events. However, it is of importance to carefully define the 
appropriate percentage and dosage of DFSC and DPSC 
according to the targeted dental tissue (dental pulp or 
periodontal tissues). Taking these parameters into account, 
repair of the dentin-pulp complex and/or periodontal 
tissues could occur in a faster than normal way.
 In the co-culture, DFSC motion closely resembles that 
of dental follicle cells during odontogenesis. Dental follicle 
cells encircle the enamel organ and the dental papilla of 
the developing tooth germ. DFSC could also be used for 
the regeneration of a follicle around a tooth germ formed 
in vitro (recombination of dental epithelium with dental 
papilla mesenchyme: formation of a brand new tooth). 
Once the follicle will form around the tooth germ, the 
explant could be implanted into the alveolar bone in vivo. 
This technique will probably allow the development and 
eruption of a new tooth with all appropriate tissues and 
possible functions.
Reviewer II: DPSC and DFSC seem to be both originated 
from mesenchymal stem cells because they share similar 
surface markers and give rise to similar cell types. 
However, they do have different migration activity in 
vitro. What mechanisms underly the different migration 
capacity? How this can be used in regenerative medicine?
Authors: Briefly, the difference in the migration activity in 
the in vitro co-culture system can be explained by the fact 
that DFSC are isolated from a developing tissue (neural 
crest-derived mesenchymal tissue that forms the dental 
sac, which surrounds the epithelial enamel organ and the 
mesenchymal dental papilla of the developing tooth germ 
before eruption) and might thus exhibit a greater migration 
activity than DPSC, which belong to a tissue that is already 
developed and mature.
 In the recent literature there are not many articles 
concerning this topic. In particular, there is a description of 
receptors and soluble factors involved in the migration but 
there is not a substantial difference between the two stem 
cell populations (DPSC and DFSC). To our knowledge, 
this is the first study on the co-culture of human DPSC and 
DFSC, thus allowing the investigation of specific/mediated 
interactions between these two stem cell populations. 
In fact, we highlighted that their behaviour differs in 
single population cultures compared with the co-culture 
assay, which allows an insight on cell kinetics and gene 
expression modulation. Several recent papers have reported 
on the migration of DPSC in the presence of different 
chemoattractants (EMPs) and/or induced migration of 
DPSC by selective cytokines (e.g. Howard et al., 2010; 
Suzuki et al., 2011). However, the migration of DFSC, as 
well as the migration in a co-culture model, have not been 
explored in these or other papers. It has been demonstrated 
that TGFβ1, an important signalling molecule for tissue 
regeneration and a marker for functional odontoblasts 
(Melin et al., 2000), and SPARC, a non-collagenous protein 
localised in dentin and bone, are able to stimulate DPSC 
migration (Pavasant et al., 2008). However, these studies 
report on DPSC migration, but not in DFSC. The role of 
the various signalling molecules (IGF, EGF, FGF etc) 
involved in DPSC and DFSC migration is still unknown.
 It is well known that in vivo, DPSC and DFSC are 
localised in specific compartments of the tooth organ and 
their roles are distinct. The in vitro interaction between 
DPSC and DFSC could be useful for better understanding 
the complex in vivo mechanisms involved in repair of 
specific dental tissues. Few reports hypothesise such 
interactions between different cell populations of the 
craniofacial complex. For example, Tancharoen et al. 
(2005) have studied the influence of neuropeptides 
released from dental pulp cells in the periodontal tissue 
and suggested a link between periodontitis and pulp 
inflammation. The results of the study show that DFSC 
and DPSC in our in vitro co-culture system recapitulate 
the in vivo kinetics during odontogenesis, where dental 
follicle cells surround the dental pulp before the eruption 
of the tooth. This property of DFSC may be used for the 
reconstitution of tooth germs in vitro or ex vivo, thus 
allowing their implantation into the alveolar bone for the 
replacement of missing teeth (Mitsiadis and Papagerakis, 
2011).
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Nanodentistry: combining nanostructured materials and stem cells for dental tissue 
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The presented review about the application of nanotechnology for therapeutical purposes in 
dentistry describes benefits and future possibilities of the combinatorial use of stem cells and 
nanomaterials. It covers the pathology and regenerative potential of dental tissues, describes 
stem cell populations within the dental pulp and periodontal tissues, presents promising stem 
cell-based dental tissue regeneration studies performed in animal models, and discusses safety 
and efficacy issues of stem cell-based therapies in dentistry. Furthermore, it informs about 
potential applications of nanomedicine including the monitoring of stem cells after 
transplantation, gene, protein, and drug delivery, as well as nanobiomimetics. 
My contribution includes the literature research with a focus on the different dental stem cell 
populations, as well as the co-writing and co-editing of the manuscript.  
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Pathology & natural regenerative 
potential of dental tissues
Two of the hardest tissues of the body, the 
enamel and dentin, form as a result of sequen-
tial and reciprocal interactions between cells of 
the oral epithelium and the cranial neural crest-
derived mesenchyme [1]. Mesenchymal cells give 
rise to the dental follicle and dental pulp, while 
the oral epithelium forms the ameloblasts. A 
part of the dental pulp cells differentiates into 
odontoblasts that produce dentin matrix, whilst 
ameloblasts form the enamel. When the min-
eralization of the tooth crown is complete, the 
tooth root starts to develop and subsequently 
the tooth erupts in the oral cavity. Once root 
development and cementum deposition have 
been accomplished, the tooth anchors to the sur-
rounding alveolar bone through the periodontal 
ligament (PDL), which contains extracellular 
matrix (ECM) and a great variety of cells such 
as fibroblasts, epithelial rests of Malassez (ERM) 
and endothelial cells.
The mineralized dental tissues are vulnerable 
to various external harmful agents, such as bac-
teria and acids, but also to traumatic injuries 
that jeopardize tooth integrity. Although the 
mitotic and secretory activities of dental pulp 
and periodontal cells are reduced in adult teeth, 
these biological processes can be reactivated 
in pathological conditions (e.g., periodontal 
and carious diseases) or following traumatic 
injury [2]. After a mild lesion, such as early caries, 
surviving postmitotic odontoblasts can produce 
new dentin through a process known as reac-
tionary dentinogenesis. However, a severe den-
tal injury leads to odontoblast apoptosis, which 
activates dental pulp stem cells to differenti-
ate into new odontoblasts, which produce the 
reparative dentin [2]. Periodontal regeneration is 
a complex process that involves the interaction 
of several populations of cells that control the 
specific ECM components. Cell-occlusive bar-
riers ranging from cellulose to synthetic absorb-
able materials, which restrict the repopulation of 
the periodontium from epithelial cells and favor 
growth of PDL cells and cementoblasts, are com-
monly used for periodontium regeneration in 
dental clinics. These materials are often used in 
conjunction with biological factors to enhance 
the regeneration of the alveolar bone. Damaged 
enamel cannot be repaired naturally since ame-
loblasts are not present in humans after tooth 
eruption. Thus, a common practice in dental 
clinics is to substitute the damaged enamel with 
biomaterials, ceramics and precious metals.
It is evident that the natural regenerative 
capacity of dental tissues is often insufficient to 
entirely restore damaged teeth. In such cases, 
stem cell biology combined with tissue engineer-
ing technology could be useful for the devel-
opment of innovative strategies for cell-based 
dental tissue regeneration [3,4]. 
Regenerative dentistry represents an attractive multidisciplinary therapeutic approach that complements 
traditional restorative/surgery techniques and benefits from recent advances in stem cell biology, molecular 
biology, genomics and proteomics. Materials science is important in such advances to move regenerative 
dentistry from the laboratory to the clinic. The design of novel nanostructured materials, such as biomimetic 
matrices and scaffolds for controlling cell fate and differentiation, and nanoparticles for diagnostics, 
imaging and targeted treatment, is needed. The combination of nanotechnology, which allows the creation 
of sophisticated materials with exquisite fine structural detail, and stem cell biology turns out to be 
increasingly useful in regenerative medicine. The administration to patients of dynamic biological agents 
comprising stem cells, bioactive scaffolds and/or nanoparticles will certainly increase the regenerative 
impact of dental pathological tissues. This overview briefly describes some of the actual benefits and 
future possibilities of nanomaterials in the emerging field of stem cell-based regenerative dentistry.
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Stem cell populations within dental 
& periodontal tissues
Stem cells are undifferentiated cells character-
ized by their ability to self-replicate through-
out life and their capacity to differentiate into 
diverse specialized cell types [5]. Adult stem 
cells are found in various tissues of the human 
body of both epithelial and mesenchymal ori-
gin, including skin [6], adipose tissue [7], perios-
teum [8] and cartilage [9]. Owing to their ability 
to give rise to every cell type in a given tissue, 
adult stem cells are responsible for tissue/organ 
homeostasis and regeneration. 
Mesenchymal stem cells have been isolated 
from different locations within adult or post-
natal dental tissues. Dental mesenchymal stem 
cells have been isolated from the pulp of adult 
teeth (dental pulp stem cells [DPSCs]) and 
deciduous teeth [10], the apical part of dental 
papilla [11,12], the dental follicle [13] and the PDL 
(FIGURE 1) [14,15]. All these dental stem cell popu-
lations express typical mesenchymal stem cell 
markers such as STRO-1, MUC-18 or Cd146, 
and Cd44 [16], but some of them also express 
other markers including Cd90, Cd73, Cd29 and 
Cd24 [11,17]. However, the marker or combina-
tion of markers that reliably identifies dental 
stem cells has not been established yet. Thus, 
dental mesenchymal stem cells are often recog-
nized by their ability to give rise to odontogenic 
[10,16,18–21], adipogenic [16,22], chondrogenic [22], 
osteogenic [23], myogenic [24] and neurogenic 
[16,25] lineages in vitro or to regenerate dental 
tissues in vivo [11,17].
Since most dental epithelial cells disappear 
shortly after tooth eruption, identifying epithe-
lial stem cells within adult dental tissues consti-
tutes a major challenge. Putative epithelial stem 
cell populations have been isolated from third 
molars [26] and, most surprisingly, dental pulp 
[27]. However, to date, ERM located in the PDL 
(FIGURE 1), appear as the more promising source of 
epithelial stem cells [28,29].
Recently, pluripotent stem cells, named den-
tal pulp pluripotent stem cells, have been iso-
lated from the dental pulp of third molars [30]. 
These cells show the ability to differentiate into 
tissues that derive from embryonic mesodermal, 
endodermal and ectodermal layers, suggesting 
their potential utility for the regeneration of 
both epithelial and mesenchymal dental tissues.
Stem cell-based dental tissue 
regeneration 
Harmful agents (e.g., caries) damage the 
hard tissues of the tooth first and then reach 
the dental pulp. The affected dental pulp is 
usually amputated (pulpotomy) or extracted 
(pulp ectomy) and substituted with an artificial 
material after disinfection of the pulp cavity [3]. 
Although the tooth is preserved in its normal 
position, it is not vital anymore and it cannot 
completely fulfill its role [3]. Thus, the regenera-
tion of the dentin–pulp complex represents the 
ideal solution and this process requires the revas-
cularization and reinnervation of the pulp, as 
well as the deposition of newly generated dentin. 
As previously mentioned, DPSCs have the abil-
ity to differentiate into odontoblasts, endothelial 
cells and neurons, among other cell types. In 
mice, transplantation of DPSCs can regenerate 
both pulp and dentin tissues in vivo after pulp-
otomy [31]. DPSCs and the apical part of den-
tal papillas isolated from human third molars, 
seeded on a poly-d,l-lactide/glycole scaffold and 
transplanted into the empty root canal space of 
mouse teeth, were able to refill the empty space 
with a newly formed vascularized pulp [17,32]. A 
continuous layer of mineralized tissue resem-
bling dentin was deposited in the existing dental 
walls of the canals [17,32]. Although these results 
prove that DPSCs can regenerate the dental 
pulp, further studies are clearly required to 
investigate their potential clinical applications.
Periodontitis is one of the most common 
infectious diseases in humans. Periodontitis is 
triggered by micro-organisms that attach to the 
teeth, cause chronic inflammation and eventu-
ally destroy the periodontal tissues [3]. Studies 
in immunocompromised mice have shown that 
transplanted PDL stem cells were able to regen-
erate the periodontium, thus indicating their 
huge potential for future cell-based therapies in 
the dental clinic [3]. However, severe damage 
of the periodontal tissues often results in tooth 
loss, so it is still necessary to develop new strat-
egies in order to potentially use entirely regen-
erated teeth in clinics. This could be achieved 
either by generating a tooth germ in vitro before 
implanting it in vivo, or by grafting dental stem 
cells in the oral cavity. In this last case, dental 
stem cells could be carried on tooth-shaped bio-
mimetic scaffolds [3]. Using different scaffolds 
it has been possible to induce differentiation 
of PDL stem cells and DPSCs into the various 
cell types composing the root and/or the peri-
odontal tissues both in vitro and in vivo [33,34]. 
DPSCs were implanted subcutaneously onto 
the back of severe combined immuno deficient 
mice (CB-17/Icr-SCID/SCID mice) [33]. 
Regarding regeneration of dental epithelium, it 
has been shown that ERM derived from porcine 
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mandible can differentiate into ameloblasts after 
co-culture with dental pulp cells in vitro. These 
ameloblast-like cells were positive for keratin 14 
and amelogenin. Moreover, after transplanta-
tion of ERM cells combined with primary 
dental pulp cells an enamel-like tissue was 
produced in the implant. Histological analysis 
revealed that appropriate stages of amelogenesis, 
from initiation to maturation, were present in 
all implants. Thick enamel–dentin structures 
were clearly recognized, and ameloblast-like 
cells expressing keratin 14 and amelogenin were 
found 8 weeks post-transplantation [29].
Equally important for the development of 
stem cell-based therapies in dentistry is the 
use of signaling molecules. Several molecules 
involved in periodontal development are already 
in use in the clinical practice. A long time ago, 
it was shown that PDGF molecules were able to 
stimulate periodontal healing and regeneration 
[35,36]. Since then, other molecules, such as BMPs 
[37–39] and amelogenins [40], have been used 
for the stimulation of periodontal tissue 
regeneration.
Current studies focus on the identification of 
the correct population of cells, suitable signaling 
molecules and desirable scaffold materials that 
will be used as carriers for specific cell types.
Safety & efficacy issues of stem 
cell-based therapies in dentistry
Stem cell-based therapies are both promising 
and challenging. The engraftment of exogenous 
therapeutic cells in patients must obey strict 
safety rules, exclude tumor formation and avoid 
or minimize rejection [41,42]. The purity, bio-
logical activity and quantity of the injected cells 
should be optimized to ensure cell function-
ality. Cell functionality should be tested both 
in vitro and in vivo in various animal models. 
Defined strategies should also be developed to 
monitor the behavior and fate of the engrafted 
cells before any clinical trial. There is a consen-
sus that differentiated cells that originate from 
stem cells rather than undifferentiated stem 
cells should be used directly for transplanta-
tion in the clinics [42]. Even if stem cell injec-
tion or transplantation is successful in animal 
models, it is important to optimize and secure 
stem cell-based therapeutic strategies before 
clinical trials.
An optimal engraftment strategy must avoid 
(or minimize) immune response in the host. 
Grafted or injected stem cells are recognized 
as foreign material by the immune system of 
the host, thus generating a cascade of events 
resulting in the destruction and rejection of 
the transplanted cells. This process can com-
promise the immune status of the recipient. 
Immunosuppressive treatments that increase 
graft survival are undesirable, since it has 
been shown that a correlation exists between 
the length of exposure to immunosuppressive 
drugs and the risk of malignancy after stem cell 
transplantation. Recent results have shown that 
mesenchymal stem cells from umbilical cord 
blood, dental pulp, PDL and bone marrow have 
immunosuppressive properties in vitro [43–45]. 
Moreover, the clonogenic nature of adult stem 
cells represents an advantage over heterogeneous 
stem cell populations resulting in a more repro-
ducible, potent immunosuppressive effect in 
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Figure 1. The various dental stem populations within an adult human 
tooth. 
DPPSC: Dental pulp pluripotent stem cell; DPSC: Dental pulp stem cell; 
ERM: Epithelial cell rest of Malassez; PDL: Periodontal ligament; PDLSC: Periodontal 
ligament stem cell; SCAP: Stem cell from the apical papilla; SHED: Stem cell from 
human exfoliated deciduous teeth.
Nanomedicine (2012) 7(11)1746 future science group
Review Mitsiadis, Woloszyk & Jiménez-Rojo
advantageous because there is minimal risk of 
immunological rejection and disease transmis-
sion. However, the outcome of all tissue engi-
neering approaches using autologous stem cell 
transplantation is subjective to the patient since 
the patient is both (at the same time) the source 
and the recipient of the cells that will be used for 
his/her own treatment. Factors related to the age 
and general health status of the patient, health 
condition of the dental pulp and periodontium 
at the moment of surgery, as well as the size and 
site of the injury, may influence the efficacy of 
stem cell-based dental treatments. The influence 
of these factors on the efficacy of cell prepara-
tions for cell-based dental treatments has not 
been investigated exhaustively.
The generation of induced pluripotent stem 
cells (iPSCs) by reprogramming somatic cells 
via a cocktail of transcription factors could be 
advantageous towards cell-based regenerative 
therapies [47,48]. Somatic cells have been repro-
grammed and turned into pluripotent cells by 
the overexpression of a cocktail of four tran-
scription factors (Oct4, Sox2, c-Myc and Klf4) 
[47]. It has recently been shown that mouse 
iPSCs can give rise to neural crest-like cells that 
can be further differentiated into odontogenic 
mesenchymal cells [49]. iPSCs could be gener-
ated from somatic cells of the patient, who will 
be the donor and recipient simultaneously, thus 
overcoming the problems associated with allo-
geneic immune rejection [50]. Although tempt-
ing, this potential has not yet been proven, 
since there is not clear understanding of the 
effects that the reprogrammed cells could have 
on the immune system [51]. For example, studies 
in animal models have shown immunoreactiv-
ity towards grafted iPSCs of the same genetic 
background [52]. Both adult dental stem cells 
and iPSCs represent an attractive source of 
cells for regenerative dentistry. Nevertheless, 
there are still safety and immunogenicity issues 
that should be overcome before their use in 
the clinic.
Although promising advances have been 
made in dental stem cell isolation and expan-
sion, it is still necessary to refine these proce-
dures. It is noteworthy that stem cells from 
every individual patient should be considered as 
specific pools and be quality controlled accord-
ingly. It is obvious that there is not yet an ideal 
and unique approach for cell-based repair of 
dental tissues. However, rapid progress in stem 
cell biology and biomaterial sciences might 
allow the development of new methods and 
protocols for personalized dental treatments.
Nanomedicine: a giant leap forward 
in disease diagnosis & treatment
Nanomedicine represents a subfield of nano-
technology that uses particles in the size range 
of 1–1000 nm for the treatment, diagnosis, 
monitoring and control of various diseases 
[53,54]. Nanoparticles, which are similar in scale 
to biological macromolecules such as DNA and 
proteins [53], can be used for targeted therapy 
through DNA, protein and drug delivery, 
in vivo imaging, and diagnostics, as well as for 
the creation of active scaffolds and implants 
[55–57]. Nanoparticles can be composed of 
organic materials (e.g., lipids), inorganic materi-
als (e.g., iron oxide or gold), or a combination of 
both types. Novel and improved nano structured 
materials can be tailored by engineering their 
characteristics such as structure, stability, size, 
shape and surface properties in order for them 
to be selectively delivered to precise sites (target 
regions) of the body [58]. This can be achieved 
through passive or active targeting mechanisms: 
passive targeting is enabled by enhanced vas-
cular permeability during neo-angiogenesis of 
injured or pathological body sites, while active 
targeting benefits from overexpression in the 
infectious or damaged areas of several cell 
surface molecules that can bind specifically to 
precoated nanoparticle ligands [58,59]. Recently, 
a dual modular system that mimics the commu-
nication-dependent recruitment of inflamma-
tory cells to regions of disease has been devel-
oped to improve the tissue target efficiency of 
nanoparticles [60]. Another more recent study 
has demonstrated the programming and assem-
bly of DNA-based nanorobots that are able 
to carry molecular loads, transport chemical 
ingredients to target cells and stimulate their 
intracellular alterations [61].
These sophisticated biomaterials are increas-
ingly being incorporated into the stem cell 
biology field. The combination of stem cells 
with innovative nanotechnology holds great 
promise for applications in the biomedical 
arena. Fundamental challenges include stem 
cell expansion in vitro without using feeder 
layers, enhancement of stem cells survival after 
transplantation and reproducible regulation of 
their fate in the body [55]. The development of 
nanomaterials could be helpful in detecting 
and manipulating stem cells that will be used 
for tissue repair in the clinic. Nanomaterials 
are being used to precisely define the stem cell 
microenvironment through the provision of 
morphogenetic gradients and cell adhesion mol-
ecules, to direct stem cell fates and to provide 
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a template for stem cells for the formation of 
new tissues and organs. Furthermore, inter-
nalization of nanoparticles, previously labeled 
with chelated ions, small molecules, metals and 
nanocrystals, by stem cells enables their detec-
tion by imaging. The physical, chemical and 
biological properties of nanomaterials can be 
exploited to influence proliferation, attachment, 
fate and differentiation of stem cells [62]. This 
multidisciplinary approach allowed scientists to 
create a fully synthetic organ for transplanta-
tion after soaking a porous polymer nanocom-
posite tracheobronchial replica in a solution of 
bone marrow stem cells [63]. Although these 
new developments are encouraging, long-term 
studies are necessary before we can exploit 
such synthetic nanosystems in the clinic. For 
example, it is important to verify nontoxicity, 
exclude tumorigenic potential [64] and adverse 
side effects on a systemic level of nanoparti-
cles, and study their interference with the self-
renewal ability of stem cells. In addition, the 
pharmaceutical industry, has been reticent to 
engage with the cell-based regenerative medi-
cine industry probably because of the complex 
regulatory and ethical issues [65]. This leads to 
uncertainty regarding the cost and time that 
will be required to successfully gain market 
approval for nanomedicine.
n Monitoring of stem cells after 
transplantation: magnetic 
nanoparticles & quantum dots
Stem cell-based regenerative therapies necessi-
tate thorough testing in animals and, then in 
humans. For the evaluation of the therapeu-
tic efficacy of the transplanted stem cells, it is 
important to track their survival, migration, fate 
and regenerative impact in vivo. Transplanted 
stem cells can be assessed for long-term peri-
ods using noninvasive imaging techniques 
[66,67]. Stem cells can be tracked in vivo after 
their transplantation using different strate-
gies: initial labeling of stem cells with fluores-
cent dyes or magnetic nanoparticles, such as 
superparamagnetic iron oxide, and stem cell 
transfection with several reporter genes such as 
the LacZ and green fluorescent protein (GFP) 
[68,69]. The visualization of the labeled stem cells 
requires either simple, or complex and sophis-
ticated imaging systems such as MRI [66,70,71], 
computed tomography imaging [72], PET and 
single-photon emission computed tomography 
imaging [73]. Superparamagnetic iron oxide 
nanoparticles (60–150 nm in diameter) are 
composed of biodegradable and recyclable iron 
and are coated with dextran or carboxydextran 
to prevent aggregation and ensure aqueous solu-
bility [74,75]. Magnetic nanoparticles can attach 
to the stem cell surface, but are also capable 
of being internalized by phagocytosis or, more 
often, by endocytosis [76], a process that is often 
facilitated by the use of coating and membrane 
receptor-binding agents [69,77]. Endocytosis of 
magnetic nanoparticles does not affect stem cell 
viability, growth, fate or differentiation [78].
Quantum dots (QDs) are cadmium sel-
enide semiconductor f luorescence-emitting 
nanostructures (less than 10 nm in diameter) 
that are used for long-term labeling of stem 
cells [79–81]. QDs present a number of advan-
tages over conventional organic dyes (e.g., 
1,1’-dioctadecyl-3,3,3’3’-tetramethylindocarbo-
cyanine perchlorate) and fluorescent proteins 
(e.g., green fluorescent protein): high bright-
ness, superb photostability and a single excita-
tion wavelength for multiple colors [82]. Due to 
their excellent optical properties, the detection 
of QD-labeled stem cells relies on imaging sys-
tems that are less sophisticated and complex 
than MRI. QDs have been used to monitor in 
real time the dynamics of various cell compo-
nents [83]. Information concerning participation 
and clustering of multiple cell surface molecules 
involved in stem cell migration and differentia-
tion may be useful for the design of innovative 
scaffolds for homing stem cells before trans-
plantation. QDs are also internalized by endo-
cytosis, which is improved by the use of specific 
peptides such as RGD, phospholipids and chol-
era toxin [84–86]. A number of internalized QDs 
are transported via endosomes to the perinu-
clear region [87], while QDs that will not be used 
by the cells display an oxidative degradation [68] 
that could lead to mitochondria dysfunction 
and, ultimately, cell death [88]. It is possible that 
the composition and physical properties of QDs 
and magnetic nanoparticles lead to unique toxic 
responses [53,85,87]. To date there is no conclu-
sive evidence of known human toxic responses 
that are exclusively caused by nanomaterials [53]. 
Furthermore, most of the studies demonstrated 
no interference of these nanoparticles with stem 
cell differentiation [84,85]. However, variations 
in the composition, structure, size and surface 
coating of nanoparticles may influence stem cell 
behavior and fate [88,89].
Magnetic nanoparticles and QDs may pro-
vide valuable information about stem cell migra-
tion, anchorage, fate and differentiation in the 
context of dental pathology (e.g., periodontitis, 
pulpitis and traumatic injury) and repair [3,5,90]. 
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For example, internalized nanoparticles would 
allow monitoring of the kinetics and fate of the 
labeled stem cells that were injected into the peri-
odontal space or pulp chamber following dental 
injury (FIGURE 2). These approaches are necessary 
to evaluate the therapeutic effects of stem cells 
when exposed to a specific microenvironment 
before their application in dental clinics.
n Targeting therapy: gene, protein 
& drug intracellular delivery
One of the most attractive concepts in manipu-
lating the fate of stem cells and directing their 
differentiation into specific cell populations is 
the use of nanomaterials for intracellular gene 
delivery (e.g., RNAi and DNA) [91,92]. Generally, 
viral (e.g., adenoviruses, lentiviruses and retro-
viruses) and nonviral vectors (e.g., lipids and 
polymers) can be used for cellular transfection 
and/or nucleofection, thus offering durable gene 
expression within stem cells [93–96]. Nonviral car-
riers have a number of advantages over viral vec-
tors, since they exhibit low-risk immuno genicity 
and insertional mutagenesis, controllable toxic-
ity, and excellent gene-carrying capacity [95]. 
Many efforts for the improvement of nonviral 
vectors are focused on cationic polymers that 
interact with negatively charged DNA or RNAi. 
Polymers, including poly(l-lysine)-palmitic acid, 
poly(l-lysine) and polyethylenimine, condense 
the genetic material into particles of 200–300 nm 
in diameter, protect them from enzymes and 
facilitate cellular entrance [94,97]. These com-
plexes of polymers and genetic material (called 
‘polyplexes’) have a transfection efficiency that is 
equivalent to adenoviral vectors [97].
Nanoparticles, carbon nanotubes and silicon 
nanowire arrays have also been used for gene 
delivery [98,99]. The apatite particles coated with 
E-cadherin and fibronectin, ensure high gene 
delivery capacity in stem cells [100].
Polymeric, biodegradable nanoparticles of 
100–300 nm in diameter could also serve as 
platforms to incorporate and deliver proteins and 
chemicals within stem cells. It has been shown 
that, after internalization, these nanoparticles 
accumulate in the perinuclear region and have 
minimal effect on the viability and prolifera-
tion of stem cells, but a high impact on their 
differentiation [68].
The cytotoxicity of ‘polyplexes’, nanopar-
ticles and nanotubes has been evaluated in 
stem cells and the results showed that, in gen-
eral, the toxicity correlates with the chemistry, 
concentration, size, shape and coating of the 
nanomaterials [97,98].
n Nanobiomimetics: design of 
bioactive scaffolds & artificial stem cell 
niches
The behavior of stem cells is tightly controlled 
by a specialized microenvironment called 
the ‘stem cell niche’ [5]. This microenviron-
ment regulates the survival, proliferation and 
differentiation of stem cells.
Injection of stem cells into the injured or 
pathological tissue limits their spread and does 
not ensure their good engraftment [101]. Injected 
cells could die due to the absence of trophic 
factors or oxygen, or lack of a suitable ECM for 
their adhesion. This can be avoided by placing 
stem cells in biocompatible and biodegradable 
nanofiber scaffolds that temporarily recreate the 
fibrous 3D network of the ECM and mimic the 
structural aspects of the stem cell niche. Hence, 
stem cells are anchored to the nanofibers of the 
scaffolds, which behave as artificial stem cell 
niches, and then transplanted to the lesion site. 
This will improve stem cell survival, migration 
and differentiation potentials, and finally their 
3D organization [101]. Stem cells cultured on 
nanofiber scaffolds exhibit high viability and 
lower mobility, and differ in morphology when 
compared with cells cultured on conventional 
substrates (e.g., polystyrene) [102,103]. Nanofibers 
with a controlled diameter (e.g., 300–1000 nm) 
are composed of either natural polymers, such 
as collagen and silk, or synthetic polymers 
including poly(lactic acid) and poly(amide) 
[102,104,105]. The 3D organization, surface and 
chemistry of these scaffolds result in stem cell 
self-renewal, migration and differentiation. 
Nanofiber scaffolds have high porosity and spe-
cific surfaces that offer an ideal environment for 
stem cell homing.
Identifying the appropriate stem cell popula-
tions and providing the suitable microenviron-
ment that allows them to repair or regenerate 
an injured tissue is the key for a successful cell-
based therapy. Nanotechnology may be used 
to create artificial microenvironments that will 
direct stem cells or progenitor cells towards a 
precise fate and function. A big challenge is to 
engineer materials that resemble the structural 
complexity of stem cell niches, which represent 
specific anatomic locations homing stem cells 
and preventing them from exiting the mitotic 
cycle [106]. ECM molecules, such as collagen, 
fibronectin, laminin and proteoglycans, repre-
sent the noncellular components of the niches 
and are important for the creation of a partic-
ular microenvironment (e.g., tooth or bone). 
ECM provides nanoscale structures, such as 
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the 15–300 nm in diameter collagen fibrils that 
allow cell adhesion (via integrins) and immobi-
lization of signaling molecules, thus influencing 
the fate and behavior (i.e., proliferation, migra-
tion and differentiation) of stem cells [107]. The 
concentration, size, spacing, surface chemistry 
and shape (e.g., ridges, grooves, pores and pits) 
of the artificial nanostructures (e.g., nanotubes 
and nanolines) are important parameters for the 
development of cell adhesion sites that moni-
tor stem cell behavior [108–110]. For example, it 
has been shown that surface irregularity (e.g., 
nanoline grating) and diverse surface chemis-
tries (e.g., silica and poly[methyl methacrylate]) 
are capable of enhancing adhesion, alignment, 
growth and differentiation of stem cells [108,109].
In vivo transplantation of stem cells anchored 
to nanofiber-based scaffolds is a technique suc-
cessfully used in regenerative medicine [111,112]. 
Transplanted biodegradable scaffolds act as tem-
porary niches that guide, by controlling stem 
cell behavior, the formation of a new specific 
ECM for tissue repair. The design of tissue-spe-
cific artificial niches offers new perspectives to 
stem cell-based applications in dentistry for the 
treatment of peculiar anatomic sites (e.g., alve-
olar bone, dentin–pulp complex, enamel and 
periodontium). Furthermore, nano materials 
could be successfully used for the generation of 
new nanotextured ‘osteogenic coating’ dental 
implants that may lead to direct bone material 
contact and also bone healing in those cases 
in which bone is compromised. The variety of 
adult stem cell populations within dental tissues 
indicates that their differentiation potential and 
response to nanoscale materials may be differ-
ent. However, there are not yet methodical com-
parative studies that will allow the assessment 
of nanomaterials on the various dental stem cell 
lines. The lack of this crucial information delays 
the application of stem cell-based therapies in 
dental clinics.
Conclusion 
There is no doubt that nanotechnology offers 
enormous benefits and a plethora of exciting 
perspectives to cell-based regenerative medi-
cine. Recent advances in nanoscale materials 
increase the potential to control stem cell fate, 
improve DNA and drug delivery, modulate 
the immune response to implanted cells, and 
create advanced scaffolds for the treatment of 
various diseases. Nanomaterials and cell-based 
products must be regulated and manufactured 
at a low-cost scale to ensure their successful 
application in clinics. Dentists could benefit 
from the use of nanoparticles to label stem cells, 
which, after being placed on scaffolds, could be 
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Figure 2. Nanotechnology in regenerative dentistry. (A) DSCs can be labeled 
with nanoparticles before placing them into biomimetic scaffolds. (B) Afterwards, 
those scaffolds that contain labeled DSCs could be transplanted to repair damaged 
dental tissues. Tooth crown, pulp and periodontium are the most commonly 
affected dental tissues. 
DSC: Dental stem cell; PDL: Periodontal ligament.
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in order to regenerate them (FIGURE 2). The appli-
cation of nanotechnology for dental purposes 
(nanodentistry) holds great promise as a type of 
personalized medicine for the management of 
target-specific treatment and imaging of dental 
tissues.
Future perspective
Dental clinics could benefit in the near future 
from the combinatorial use of stem cells and 
nanostructures (e.g., creation of specific scaf-
folds). These devices, which will contain cells, 
could be implanted into damaged dental sites 
in order to regenerate them. However, there 
are serious issues concerning standardization 
of techniques, nanoparticles and stem cells that 
have to be solved before their clinical application 
in humans.
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Executive summary
Pathology & natural regenerative potential of dental tissues
  The mineralized dental tissues are vulnerable to various external harmful agents such as bacteria and acids, but also to traumatic 
injuries that jeopardize tooth integrity. The natural regenerative capacity of dental tissues is often insufficient to entirely restore 
damaged teeth.
Stem cell populations within dental & periodontal tissues
  Dental mesenchymal stem cells have been isolated from the pulp of adult and deciduous teeth, the apical part of dental papilla, the 
dental follicle and the periodontal ligament.
  Putative epithelial stem cell populations have been isolated from dental pulp. However, epithelial cell rests of Malassez, located in the 
periodontal ligament, appear as the more promising source of epithelial stem cells.
Stem cell-based dental tissue regeneration
  Studies in animals have shown that transplanted dental mesenchymal stem cells were able to regenerate the periodontium and dental 
pulp in vivo, thus indicating their huge potential for future cell-based therapies in dental clinics.
Safety & efficacy issues of stem cell-based therapies in dentistry
  There are still safety and efficacy issues that need to be solved before the application of stem cell-based therapies in clinics. 
Immunogenicity of the transplanted cells is one example. The potential use of induced pluripotent stem cells in regenerative dentistry is 
discussed.
Nanomedicine: a giant leap forward in disease diagnosis & treatment
  Nanomedicine represents a subfield of nanotechnology that uses particles in the size range 1–1000 nm for the treatment, diagnosis, 
monitoring and control of various diseases. Different sophisticated biomaterials are increasingly being incorporated into the stem cell 
biology field.
Monitoring of stem cells after transplantation: magnetic nanoparticles & quantum dots
  For the evaluation of the therapeutic efficacy of the transplanted stem cells it is important to track their survival, migration, fate and 
regenerative impact in vivo. Stem cells can be tracked in vivo after their transplantation using different types of nanoparticles, such as 
superparamagnetic iron oxide or quantum dots.
Targeting therapy: gene, protein & drug intracellular delivery
  Polyplexes, nanoparticles, carbon nanotubes and silicon nanowire arrays can be used for gene delivery to stem cells before 
transplanting them in vivo.
Nanobiomimetics: design of bioactive scaffolds & artificial stem cell niches
  Biocompatible and biodegradable nanofiber scaffolds constitute artificial stem cell niches that influence the survival, self-renewal and 
differentiation of stem cells.
Conclusion
  The use of nanotechnology for dental purposes (nanodentistry) holds great promise as a type of personalized medicine for the 
management of target-specific treatment and imaging of dental tissues. However, there are still certain safety issues to be solved 
before any clinical application.
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dental pulp stem cells and silk fibroin scaffolds (PAPER) 
 
This paper describes the findings of a collaborative project between the Institute of Oral Biology 
(University of Zurich) and the Institute for Biomechanics (ETH Zurich), which was mostly 
performed by Sabrina Holsten Dircksen within the framework of her Master Thesis. To finalize the 
project, I used frozen samples from the study for RNA extraction in order to study the gene 
expression within the different groups, which are typically expressed in mineralized tissues like 
bone, dentin, and cementum. Based on the manuscript of Sabrina Holsten Dircksen and my gene 
expression analysis, I compiled all the results and figures, and rewrote the manuscript in order to 
adapt it for publication in PLoS ONE. 
This study investigated the influence of the mechanobiological environment of human dental pulp 
stem cells in vitro on their mineralization potential when seeded on a 3D silk fibroin scaffold. 
Mechanical stimulation was provided by a spinner flask bioreactor, while osteogenic 
differentiation medium was used as a biological stimulus. Histological analyses and micro-
computed tomography (microCT) of the samples showed low levels of mineralisation when 
samples were cultured in static conditions, while their culture in a dynamic environment with 
osteogenic medium and weekly microCT scans significantly increased the formation of 
homogeneously mineralised structures, which was also confirmed by the elevated calcium levels. 
The gene expression analysis suggested that hDPSCs are able to adapt a non-dental identity by 
changing the culture conditions only. Taken together, the presented findings showed that the 
mechanically dynamic environment can direct hDPSCs towards the osteogenic lineage significantly 
stronger than osteogenic medium alone. However, the combination of mechanical and biological 
stimuli yields the highest amount of mineralization, suggesting a synergistic effect.   
Influence of the Mechanical Environment on the
Engineering of Mineralised Tissues Using Human Dental
Pulp Stem Cells and Silk Fibroin Scaffolds
Anna Woloszyk1, Sabrina Holsten Dircksen2, Nagihan Bostanci3, Ralph Müller2, Sandra Hofmann2,4,5,
Thimios A. Mitsiadis1*
1Orofacial Development and Regeneration, Institute of Oral Biology, Centre of Dental Medicine, University of Zurich, Zurich, Switzerland, 2 Institute for Biomechanics, ETH
Zurich, Zurich, Switzerland, 3Oral Translational Research, Institute of Oral Biology, Centre of Dental Medicine, University of Zurich, Zurich, Switzerland, 4Department of
Biomedical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands, 5 Institute for Complex Molecular Sciences, Eindhoven University of
Technology, Eindhoven, the Netherlands
Abstract
Teeth constitute a promising source of stem cells that can be used for tissue engineering and regenerative medicine
purposes. Bone loss in the craniofacial complex due to pathological conditions and severe injuries could be treated with
new materials combined with human dental pulp stem cells (hDPSCs) that have the same embryonic origin as craniofacial
bones. Optimising combinations of scaffolds, cells, growth factors and culture conditions still remains a great challenge. In
the present study, we evaluate the mineralisation potential of hDPSCs seeded on porous silk fibroin scaffolds in a
mechanically dynamic environment provided by spinner flask bioreactors. Cell-seeded scaffolds were cultured in either
standard or osteogenic media in both static and dynamic conditions for 47 days. Histological analysis and micro-computed
tomography of the samples showed low levels of mineralisation when samples were cultured in static conditions (0.1660.1
BV/TV%), while their culture in a dynamic environment with osteogenic medium and weekly mCT scans (4.961.6 BV/TV%)
significantly increased the formation of homogeneously mineralised structures, which was also confirmed by the elevated
calcium levels (4.561.0 vs. 8.861.7 mg/mL). Molecular analysis of the samples showed that the expression of tooth
correlated genes such as Dentin Sialophosphoprotein and Nestin were downregulated by a factor of 6.7 and 7.4, respectively,
in hDPSCs when cultured in presence of osteogenic medium. This finding indicates that hDPSCs are able to adopt a non-
dental identity by changing the culture conditions only. Also an increased expression of Osteocalcin (1.4x) and Collagen type
I (1.7x) was found after culture under mechanically dynamic conditions in control medium. In conclusion, the combination
of hDPSCs and silk scaffolds cultured under mechanical loading in spinner flask bioreactors could offer a novel and
promising approach for bone tissue engineering where appropriate and rapid bone regeneration in mechanically loaded
tissues is required.
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Introduction
Hard tissues of the craniofacial complex are subjected to
physical, chemical and biological health risk factors of the
surrounding environment. Examples are high mechanical impact
resulting in fractures, smoking as a risk factor for osteoporosis and
bone fracture [1], as well as microbiological infections of the
periodontal tissues resulting in alveolar bone and subsequent tooth
loss [2]. Repair of these bones requires the reconstruction of their
anatomical, physiological, and functional properties, which cannot
yet be fully accomplished by current treatment strategies [3]. For
this reason, a considerable effort has been made during the last
two decades to generate innovative engineering products that
could be used together with specific populations of stem/
progenitor cells and growth factors in order to form the most
adequate and physiological substitutes for bone repair.
Mesenchymal cells forming craniofacial bones and dental tissues
(e.g. dentin) have the same embryonic origin and share many
biochemical and molecular properties [4–6]. These tissues are
composed mostly of collagen type I and, to a lesser degree, of other
tissue-specific extracellular matrix components that with the
progressive deposition of hydroxyapatite crystals become highly
mineralised [7,8]. As for all other tissues, their homeostasis is based
on the presence of sufficient vasculature [9], innervation [10], and
specific stem cell populations. These cells are characterised by
their ability to self-renew without losing their potency to
differentiate into various cell types [11].
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Bones undergo constant remodelling by a well-orchestrated
interplay of stem cell-derived osteoblasts and osteoclasts [12]. In
contrast to that, dentin is not remodelled but continuously
deposited by odontoblasts throughout the life of a tooth [13,14].
Following serious dental injuries or carious lesions, disintegrated
odontoblasts can be replaced by newly-formed odontoblasts that
originate from stem cells residing in the dental pulp [5,14–16].
Bone marrow stem cells (BMSCs) were the first to be used in
clinics with success for the treatment of leukemias since the 1950 s
[17] and thus constitute the golden standard in stem cell research.
Since the discovery of dental pulp stem cells (DPSCs) comparative
studies have shown that both BMSCs and DPSCs have almost
identical properties in terms of gene expression and differentiation
potential (e.g. osteogenic, chondrogenic, adipogenic, myogenic,
neurogenic) [15,18,19]. However, DPSCs exhibit higher clono-
genic and proliferative potential when compared to BMSCs [20].
In contrast to BMSCs that originate from the mesoderm, DPSCs
are derived from cranial neural crest (CNC) cells, as demonstrated
by the expression of markers characteristic for CNC-derived stem
cells like GFAP, HNK-1, nestin, P75, and S-100 [11,21].
Common embryonic origin together with the Hox gene expression
profile was shown to play a key role in determining progenitor cell
fate during adult bone regeneration [22]. It was demonstrated that
Hox-negative neural crest-derived skeletal stem cells adopted a
Hox-positive profile and differentiated into osteoblasts after
transplantation into a defect in the mesoderm-derived tibia. On
the contrary, Hox-positive mesoderm-derived skeletal stem cells
did not adopt a Hox-negative profile and differentiated into
chondroblasts after transplantation into a defect in the neural
crest-derived mandible [22]. This proves that stem cells differ in
plasticity and that they have a ‘positional memory’ that depends
on their Hox gene expression profile [23]. The use of DPSCs is
thus important for reconstitution of craniofacial tissues and
presumably much more appropriate than the use of BMSCs.
Furthermore, DPSCs are easily accessible after routine tooth
extraction procedures resulting in little morbidity and therefore a
realistic autologous cell source, while BMSC isolation requires
invasive and painful surgery. Optimising the combination of
DPSCs, scaffolds, growth factors, and the use of mechanical
loading for the generation of particular hard tissues is currently a
great challenge.
Numerous types of silk fibroin scaffolds have been used for tissue
engineering purposes in the last two decades [24,25]. Important
advantages of silk compared to other biomaterials are the excellent
biocompatible and mechanical properties, load-bearing capacity,
and lack of releasing toxic by-products during silk degradation
[26]. Silk scaffolds have been used in combination with a variety of
cell types to obtain the most desirable effects for specific tissue
repair. The behaviour and fate of stem cells closely depend on the
geometry and composition of the scaffolds, as well as the applied
forces [27]. For example, BMSCs were incorporated in hexa-
fluoro-2-propanol based porous silk scaffolds for optimal bone
regeneration [28–31]. Mechanical cues, including shear stress,
substrate stiffness and nano-topography, have been shown to also
stimulate osteogenesis [32]. Mechanotransduction is carried out
through several mechanoreceptors, like integrins, cadherins, gap
junctions, and Ca2+ channels, which are able to alter gene
expression in response to loading or stretching [33–35]. A tool for
imposing shear stress on cells during in vitro culture conditions is
the spinner flask bioreactor through increased turbulent fluid flow,
generated by stirring of the medium. Compared to static cultures,
the bioreactor improves the culture conditions since it allows
better control in terms of temperature, pH, pressure, nutrient and
oxygen supply as well as waste removal [36,37].
After investigating the osteogenic potential of human DPSCs
seeded in silk scaffolds cultured in both static and dynamic
conditions, in the present study we were able to show that these
cells are reactive to mechanical loading, which is an important
component of both the bone and the tooth environment and is
able to increase the mineralisation of silk scaffolds by human
DPSCs in vitro.
Materials and Methods
Preparation of silk fibroin scaffolds
Silk fibroin scaffolds were prepared as previously described [29].
Briefly, silkworm cocoons (Trudel Inc., Zurich, Switzerland) were
boiled 2 times for 1 h in an aqueous solution of 0.02 M Na2CO3
(Fluka, Buchs SG, Switzerland) and rinsed with ultrapure water
(UPW) to extract sericin. Lyophilized silk was dissolved in
hexafluoro-2-propanol (HFIP) (abcr GmbH & Co., Karlsruhe,
Germany) to obtain a 17% (w/v) silk fibroin solution. NaCl
crystals (224–315 mm in diameter) (Sigma-Aldrich, Buchs SG,
Switzerland) were weighed in Teflon containers and silk fibroin/
HFIP solution was added at a ratio of 20: 1 (NaCl/silk fibroin).
After complete evaporation of the solvent NaCl/silk fibroin blocks
were immersed in 90% (v/v) methanol (Sigma-Aldrich, Buchs SG,
Switzerland) in UPW for 30 min, dried and NaCl was leached by
incubation in UPW for 2 days resulting in scaffolds with more
than 90% porosity [38]. 25 disk shaped scaffolds were punched (10
mm diameter, 1–2 mm thick) and autoclaved at 121uC and 1 bar
for 20 min.
Isolation, culture and characterisation of dental pulp
stem cells (DPSCs)
DPSCs were obtained from dental pulps of clinically healthy
teeth from 14–16 year old patients who had their teeth extracted
due to orthodontic treatment. The procedure was reviewed and
approved by the Institutional Review Board of the Centre of
Dental Medicine, University of Zurich and was performed with
guardians’ and underage patients’ written informed consent
abiding by the guidelines for studies with human cells of
irreversibly anonymous origin. Written consents are stored in the
dental faculty for all anonymized studies. After removal of the
dental pulp from the tooth, DPSCs were isolated, expanded and
characterized as described earlier [39]. All experiments were
performed with DPSCs at passage 3 (P3) or P4.
Scaffold seeding
25 silk fibroin scaffolds were pre-wetted in Dulbecco’s Modified
Eagle Medium (DMEM) for 36 hours at room temperature before
seeding them with DPSCs (5 scaffolds per group) at a density of
56106 cells per scaffold in 50 mL of control medium (DMEM,
10% FBS, 1% Pen-Strep and 50 ng/mL fungizone). To allow
attachment of DPSCs to the scaffolds, they were incubated for
90 min in a humidified incubator at 37uC. Thereafter, 1 mL
culture medium per well (12-well-plate) was added and scaffolds
were incubated for additional 24 h. Subsequently, scaffolds were
placed in spinner flask bioreactors with a stirring speed of 120 rpm
(referred to as dynamic) or in spinner flask bioreactors without
stirring (referred to as static) and were cultured in either control or
osteogenic medium (control medium plus 50 mg/mL ascorbic acid-
2-phosphate, 100 nM dexamethasone, 7 mM b-glycerolpho-
sphate) at 37uC with 5% CO2. All cell culture ingredients were
obtained from Gibco Invitrogen, Basel, Switzerland.
Behaviour of Dental Stem Cells in Silk Scaffolds
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Sample analysis
Micro-computed tomography (mCT). mCT measurements
were performed on a mCT80 imaging system (Scanco Medical,
Brüttisellen, Switzerland). Samples were scanned either weekly
starting from day 19 (groups Sp.O.W, Sp.C.W) or on the last day
of the experiment only to determine potential x-ray effects on cell
development (groups Sp.O.E, St.O.E, St.C.E) (n=5–6 per group).
Scanning was performed at an isotropic nominal resolution of 18
mm, energy level was set to 45 kVp, intensity to 177 mA, 200 ms
integration time and two-fold frame averaging. A constrained
Gaussian filter was applied to reduce part of the noise. Filter
support was set to 1.0 and filter width sigma to 0.8. Segmentation
was performed to distinguish mineralised tissue from non-
mineralised tissue. A threshold that corresponded to a hydroxy-
apatite density of 145 mg HA/ccm was set after visual judgement
of the grey images to identify mineralised structures. Components
smaller than 50 voxels were filtered away by applying component
labelling. Quantitative morphometry was performed to assess
relative mineralised extracellular matrix volume of the entire
construct using direct microstructural bone analysis as previously
described for human bone biopsies [40].
After 47 days of culture, scaffolds were blotted on clean paper
towels to determine the total wet weight. Scaffolds were weighed,
cut into six pieces, weighed again and processed for various
analyses (n=5–6 per group). Where necessary, samples were
disintegrated using steel balls and a Mini-Beadbeater (Biospec,
Bartlesville, OK, USA) three times at 25,000 rpm for 10 s with
cooling of the samples in between the cycles.
Cell proliferation and viability. Cell proliferation was
determined by DNA analysis from disintegrated samples. DNA
content was measured using the Quant-iT PicoGreen dsDNA
Assay Kit (Life Technologies Europe B.V., Zug, Switzerland) and
cell viability was evaluated using the AlamarBlue assay (Life
Technologies Europe B.V., Zug, Switzerland) according to the
manufacturer’s instructions. Fluorescence was measured using a
plate reader (Infinite 200 PRO, Tecan Group Ltd, Männedorf,
Switzerland).
Osteogenic potential of DPSCs. To study the osteogenic
capacity of DPSCs seeded into silk fibroin scaffolds we performed
alkaline phosphatase (ALP) and calcium deposition assays
additionally to the mCT evaluation. For this purpose, disintegrated
scaffold pieces were used. ALP activity (Sigma-Aldrich, Buchs SG,
Switzerland) was measured spectrophotometrically based on
conversion of p-nitrophenyl phosphate to p-nitrophenol as
previously described [29]. Quantification of calcium was per-
formed with the Calcium (CPC) LiquiColor Test according to the
manufacturer’s instructions (DiaSys Greiner, Flacht, Germany).
Collagen type I was assessed by staining the intact samples with
Sirius Red (Sigma-Aldrich, Buchs SG, Switzerland) as described
previously [41]. After washing the samples with UPW, the
remaining colour in saturated picric acid was bleached in a 1: 1
mix of Methanol and 0.2 M NaOH (Sigma-Aldrich, Buchs SG,
Switzerland).
Histology. After fixation of the constructs in 10% neutral
buffered formalin at room temperature for 20 min and 5 times
washing with UPW, samples were dehydrated and impregnated
with paraffin over night by use of a tissue processor (TPC 15 Duo,
Medite AG, Winter Garden FL, United States) before being
embedded in paraffin using a paraffin embedding station (TES 99,
Medite AG, Winter Garden, FL, USA). Paraffin sections of 6–7
mm (HM355S, Microm International, Walldorf, Germany) were
stained with Haematoxylin and Eosin (H&E) (Sigma-Aldrich,
Buchs SG, Switzerland) for a general overview. Collagen
distribution was visualised by Sirius Red staining while mineral-
isation was shown with von Kossa staining (Sigma-Aldrich, Buchs
SG, Switzerland).
Gene expression analysis. RNA was extracted using a
RNA extraction kit (RNeasy Mini Kit, Qiagen, Basel, Switzerland)
and then transcribed into cDNA (High Capacity cDNA Reverse
Transcription Kit, Applied Biosciences, Foster City, CA, USA).
Quantitative Real Time (qRT) PCR was performed using SYBR-
Green-based protocols in a StepOne Real Time PCR System
(Applied Biosystems, Life Technologies, Basel, Switzerland).
Expression analysis of ALP, Collagen type I, Dentin Sialopho-
sphoprotein (DSPP), Nestin, Osteocalcin and GAPDH (house-
keeping gene) were carried out using the qPCR SYBR Master Mix
(Applied Biosystems, Carlsbad, USA) in combination with
oligonucleotide primers (Tab. 1), specifically designed for the
indicated genes. Expression levels were calculated by the
comparative DCt method (22DCt formula) after being normalised
to the Ct-value of the GAPDH housekeeping gene.
Statistical analysis
Comparisons of the groups were performed using one-way
analysis of variance (ANOVA). When there were significant
differences (p,0.05), comparisons betweeen the groups were
further assessed with Bonferroni multiple-comparison test. Data
were considered statistically significant at p,0.05 and highly
significant at p,0.01.
Results
Mineralised tissue formation by hDPSCs
Mineralisation was monitored by time-lapse mCT starting from
day 19 of in vitro culture in two of the five experimental groups,
which were both cultured in a mechanically dynamic system in
either osteogenic (Sp.O.W) or control medium (Sp.C.W) (Fig. 1b).
Cells grown in control medium formed mineralised matrix with a
delay of 2 weeks (Fig. 1d). A comparison of all the groups (Fig. 1a)
showed significantly higher mineralisation in samples cultured at
120 rpm (dynamic) than samples cultured at 0 rpm (static) (p,
0.01) (Fig. 1c, 1e), being even more abundant in samples that were
cultured additionally in osteogenic medium (Fig. 1b, 1d). Miner-
alisation followed a linear pattern (Fig. 1d) with correlation
coefficients of 0.99 and 0.98 for samples cultured in osteogenic
and control medium, respectively. Both qualitative and quantita-
tive analyses of the bone-like tissue volume fraction for all groups
demonstrated that mineralisation was significantly higher in
DPSC-seeded scaffolds cultured in spinner flasks at 120 rpm in
osteogenic medium with weekly mCT scans (Fig. 1c1, 1e) when
compared to the static control samples (Fig. 1c4, 1c5, 1e) (p,
0.01). Samples cultured at 120 rpm (Fig. 1c1–3) exhibited a more
homogenous mineralisation than samples cultured at 0 rpm
(Fig. 1c4, 1c5).
Histological analysis of the tissue formed by DPSCs
Haematoxylin and Eosin staining showed that in samples
cultured in spinner flasks the cells were distributed all over the
scaffolds (Fig. 2a1–2a3). In their centre these scaffolds presented
larger hollow areas free of cells and extracellular matrix (ECM).
The amount of cells and ECM appeared to be lower in samples
cultured in control medium (Fig. 2a2, 2a5) when compared to cells
grown in osteogenic medium (Fig. 2a1, 2a4). The von Kossa
staining confirmed the presence of phosphate in all groups
(Fig. 2b1–2b5) and the Sirius Red staining allowed the visualisa-
tion of collagen type I fibres in all groups (Fig. 2c1–2c5).
Qualitatively, the most homogenous distribution of collagen fibres
was found in samples cultured in osteogenic medium in spinner
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flasks with weekly mCT scans (Fig. 2c1). Both controls showed a
very weak signal due to the low amount of collagen produced by
the cells (Fig. 2c2, 2c5), which was confirmed by the Sirius Red
assay (results not shown) where average collagen concentrations
Table 1. Primers used in the study.
Primers Sequence Function
Alkaline Phosphatase (ALP) fw ATGAAGGAAAAGCCAAGCAG marker for matrix mineralisation
rv ATGGAGACATTCTCTCGTTC
Collagen type I (Col1) fw AAGATGGACTCAACGGTCTC marker for bone formation
rv CAGGAAGCTGAAGTCGAAAC
Dentin sialophosphoprotein fw GAATTCTGCTGGTATTCCAG marker for dentinogenesis
(DSPP) rv GCCATTAGATTCATCACTGC
Glyceraldehyde 3-phosphate fw ATCACTGCCACCCAGAAGAC housekeeping gene
dehydrogenase (GAPDH) rv ATGAGGTCCACCACCCTGTT
Nestin fw CCTGCAAAAGGAGAATCAAG marker for cell proliferation/migration,
rv GTTCTCAATGTCTCTTGGTC marker for odontoblasts
Osteocalcin (OC) fw TCTCTGCTCACTCTGCTGG marker for osteoblasts
rv GCGTTTGTAGGCGGTCTTC
doi:10.1371/journal.pone.0111010.t001
Figure 1. Mineralisation analysis using mCT. (a) Experimental groups. (b) Time-lapse mCT images of samples cultured in spinner flasks in either
osteogenic (upper row) or control (lower row) medium. (c) mCT images of one representative sample per experimental group after 47 days of culture.
(d) Time-dependent increase in bone-like tissue volume fraction as observed with weekly mCT scans. (e) Bone-like tissue volume fraction for all
groups after 47 days of culture. Scale bars: 1 mm.
doi:10.1371/journal.pone.0111010.g001
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were highest in groups that had been cultured in osteogenic
medium. Collagen concentrations in both static and dynamic
samples with mCT at the end of the culture (Sp.O.E, St.O.E) were
shown to be significantly higher than the dynamic sample cultured
in control medium with weekly mCT scans (Sp.C.W) with p,0.05
and p,0.01, respectively.
Biochemical analysis
The AlamarBlue assay showed that cell viability was not
significantly different between the groups. However, cells cultured
in the control medium were slightly more active than cells cultured
in osteogenic medium (e.g. Sp.C.W=107.2689.8 vs.
Sp.O.W=54.3632.5) (Fig. 3a). Furthermore, the number of cells
was not significantly different between the groups except between
samples cultured at 120 rpm in control medium with weekly mCT
scans (Sp.C.W) and samples cultured at 0 rpm in osteogenic
medium with one mCT scan in the end of the study (St.O.E) (p,
0.05) (Fig. 3b). Calcium deposition was significantly increased 1.5–
2 fold (p,0.05) when cells were cultured in osteogenic medium
and/or in spinner flasks at 120 rpm (Fig. 3c). ALP activity, which
is a marker for odontoblastic and osteoblastic differentiation, was
negatively influenced by weekly mCT scans (p,0.01) as well as by
static culture conditions (p,0.05). The highest level of ALP
activity (13.562.7 mg p-nitrophenol/total DNA) was measured in
samples cultured at 120 rpm with osteogenic medium and without
weekly mCT scans (Fig. 3d).
Gene expression analysis
ALP, DSPP and Nestin expressions were downregulated in the
experimental groups after 47 days of culture when compared to
the control groups (Fig. 4a–c). ALP downregulation by a factor of
1.4–2.2 was not significant, whereas in the case of DSPP and
Nestin the gene expression was significantly downregulated (p,
0.05) in all groups except in the samples cultured at 120 rpm with
control medium and weekly mCT scans (Sp.C.W). Similar
expression patterns were observed between Collagen type I and
Osteocalcin (Fig. 4d, e). In samples cultured dynamically (at 120
rpm) with control medium and weekly mCT scans (Sp.C.W) gene
expression was higher by 1.6 fold and 1.4 fold (p,0.01),
respectively, when compared to the control, with a highly
significant increase in the case of Collagen type I. All remaining
experimental groups were downregulated by a factor of 1.4–4.2,
with only the samples cultured at 120 rpm in osteogenic medium
with a mCT scan at the end of the experiment (Sp.O.E) being
significantly different (p,0.01) for both Collagen type I and
Osteocalcin.
Discussion
The dental pulp is an easily accessible source of multipotent cell
populations. Therefore, the goal of this study was to investigate the
potential of dental pulp stem cells (DPSCs) to be used for the
regeneration of bone tissue and if mechanical loading could
improve the behaviour of this cell population. For this purpose,
human DPSCs (hDPSCs) were seeded on silk fibroin scaffolds that
Figure 2. Histological analysis of hDPSCs seeded on silk fibroin scaffolds after 47 days of culture. (a) Haematoxylin and Eosin staining of
histological sections from all groups. Extracellular matrix and silk scaffolds are stained red/pink. Cell nuclei are stained purple/violet. (b) Von Kossa
staining. Silk scaffolds and mineralised nodules are stained in brown. Arrows indicate areas where phosphate is present. (c) Sirius Red staining
showing the distribution of Collagen (red colour). Abbreviations: Sp.O.W: spinner flask culture in osteogenic medium with weekly x-ray; Sp.C.W:
spinner flask culture in control medium with weekly x-ray; Sp.O.E: spinner flask culture in osteogenic medium with x-ray at the end; St.O.E: static
culture in osteogenic medium with x-ray at the end; St.C.E: static culture in control medium with x-ray at the end. Scale bars: 500 mm.
doi:10.1371/journal.pone.0111010.g002
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offer a three-dimensional (3D) environment, which has been
shown to allow proper cell adhesion and proliferation [42] and
were cultured in static (0 rpm) and dynamic (120 rpm) conditions.
Mechanical loading has previously been shown to positively
affect proliferation, differentiation, and ECM production when
tension was applied on hDPSCs in two-dimensional (2D) and 3D
cultures [43]. In line with the previous findings, the present study
demonstrates that the application of mechanical loading in the
form of turbulent flow accelerates the process of mineral
deposition. Additionally, biochemical analyses have confirmed
that the spinner flask culture conditions promote the differentia-
tion capability of hDPSCs into mineral producing cells while they
reduce their proliferation activity. This is not surprising since
recent studies have shown that proliferation and differentiation
cannot progress at the same time [44]. Indeed, hDPSCs that were
exposed to uniaxial mechanical stretch increased their prolifera-
tion rate, while their differentiation into osteoblasts was dramat-
ically decreased [45]. In contrast, hDPSCs stimulated by
hydrostatic pressure increased their differentiation rate despite
their reduced number and adhesion capacity [46]. In the present
study we showed that the application of mechanical loading in the
form of flow accelerated the process of mineral deposition.
Biochemical analyses indicated higher cell proliferation activity in
the statically cultured samples, while under dynamic culture
conditions the differentiation capability of hDPSCs into mineral
producing cells was promoted. This result was also confirmed by
the amount of mineralised ECM deposition as evaluated by mCT.
Statically (0 rpm) cultured scaffolds were mineralised only on their
top and edges, whereas a stirring speed of 120 rpm resulted in a
more homogeneous mineralisation in the scaffolds. These low
levels of mineralisation in statically cultured samples could be
explained by the limited nutrient supply in 3D scaffolds that
exceed the size of 1 mm, as pointed out by previous in vitro
studies where the formation of tissues was problematic in the
centre of the scaffold [47,48]. By applying mechanical loading the
nutrient supply could be improved.
Although there have been some attempts to regenerate lost
alveolar bone (specialised bone structure that supports tooth) in
patients using autologous hDPSCs seeded onto collagen sponge
scaffolds [49], the results are still unsatisfactory. In these studies,
hDPSCs have been isolated from third molars and seeded onto
collagen sponge scaffolds before their implantation at the defective
jaw sites. X-rays and histological analyses have shown that new
bone was formed at the implantation sites three months post-
surgery. Follow-up studies (three years post-surgery) have revealed
that the regenerated bone was more compact than the physiolog-
ical one [49]. These in vivo results clearly show that hDPSCs are
able to differentiate into osteoblasts and repair bone defects in the
orofacial area in a mechanically loaded environment. However,
the density of the bone produced by hDPSCs when seeded onto
collagen scaffolds was more compact than alveolar bone, which
could compromise its metabolic functions due to the decrease in
Figure 3. Biochemical analysis after 47 days of culture. (a) Cell metabolic activity [activity/total DNA]. (b) DNA content per scaffold [ng/mL]. (c)
Calcium content per scaffold [mg/mL]. (d) ALP activity normalised to cell number [mg/p-nitrophenol/total DNA]. Data is shown as average6 standard
deviation (n= 5). Asterisks indicate significant (p,0.05) or highly significant (p,0.01) difference between the groups. Abbreviations: Sp.O.W: spinner
flask culture in osteogenic medium with weekly x-ray; Sp.C.W: spinner flask culture in control medium with weekly x-ray; Sp.O.E: spinner flask culture
in osteogenic medium with x-ray at the end; St.O.E: static culture in osteogenic medium with x-ray at the end; St.C.E: static culture in control medium
with x-ray at the end.
doi:10.1371/journal.pone.0111010.g003
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porosity. High bone density could be the result of the fast
degradation time (4–5 weeks) of the collagen sponge [50], thus
resulting in the lack of mechanical support before bone formation
is completed.
Silk fibroin scaffolds could be an alternative to collagen
materials since they perform better than collagen scaffolds sharing
similar microstructures [51–53]. Silk fibroin is a biocompatible
(after the removal of sericin) and biodegradable material whose
physical and mechanical properties can be easily manipulated
through structural readjustments [25,26,54]. Compared to colla-
gen, silk fibroin offers a higher mechanical stability and a much
slower degradation rate [25]. It has been demonstrated that bone-
like tissue deposits occur appositionally to the silk fibroin scaffold,
suggesting that the internal geometry of the scaffold might be used
to determine the structure of the engineered bone [29,51]. At the
same time this effect could not be accomplished with collagen
scaffolds due to their faster degradation and the resulting loss of
mechanical stability and geometrical guidance for the incorporat-
ed cells. Histological analyses confirmed high cell compatibility of
silk fibroin scaffolds under dynamic conditions with a good
amount of ECM being produced by hDPSCs over most of the
scaffold volume.
Real Time PCR studies showed that hDPSCs cultured in
osteogenic medium lost their dental genotypic profile, as indicated
by the decreased levels of DSPP and Nestin expression when
compared to the control. Even though DSPP has been also found
to be expressed in bone, cementum, and certain non-mineralised
tissues, the expression levels in these tissues were shown to be
much lower than in dentin [55]. In contrast, expression of
Osteocalcin that is mainly a bone-specific gene [56] and Collagen
type I, which is expressed in both bone and dentin tissues, was
upregulated in mechanically loaded samples. This has been
already demonstrated in several previous studies and has been
connected to the improved transport of nutrients [57–59].
Interestingly, a significantly positive effect of radiation on the
mineralisation of the scaffold was observed during the mCT scans
that contradicts previously reported results, where both hard tissue
formation and cell survival were significantly reduced [60–62]. In
a previous study where BMSCs were cultured on silk fibroin
scaffolds mCT imaging had no impact on the osteogenic
performance of the cells when compared to non-exposed samples
[63].
Conclusion
In summary, by biochemical, histological, and mCT evaluations
together with molecular analyses we have shown that hDPSCs
have the potential to form mineralised matrix when grown on
porous 3D silk fibroin scaffolds. This potential can be enhanced by
mechanical loading and the addition of osteogenic factors in the
culture medium. The clinical relevance lies in the availability of
hDPSCs, their common embryonic origin with craniofacial tissues,
Figure 4. Gene expression analysis. Images showing normalised fold expression against GAPDH for the genes ALP (a), DSPP (b), Nestin (c),
Collagen type I (d) and Osteocalcin (e). Data is shown as average 6 standard deviation of three samples. Asterisks indicate significant (p,0.05) or
highly significant (p,0.01) difference between the groups. Abbreviations: Sp.O.W: spinner flask culture in osteogenic medium with weekly x-ray;
Sp.C.W: spinner flask culture in control medium with weekly x-ray; Sp.O.E: spinner flask culture in osteogenic medium with x-ray at the end; St.O.E:
static culture in osteogenic medium with x-ray at the end; St.C.E: static culture in control medium with x-ray at the end.
doi:10.1371/journal.pone.0111010.g004
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and the advantageous characteristics of the silk fibroin scaffold for
applications in bone regeneration.
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A new in vivo MRI method to non-invasively monitor and quantify the perfusion capacity of 3D-
biomaterials grown on the chorioallantoic membrane of chick embryos (PAPER) 
 
The goal of this paper was to present a new in vivo MRI method for the non-invasive monitoring 
and quantification of the perfusion capacity of 3D biomaterials when cultured on the 
chorioallantoic membrane (CAM) of chicken embryos. To validate the method, which has been 
established based on the synthetic polymer DegraPol®, it was necessary to include measurements 
performed on a different type of scaffold. 
We had started to use the CAM assay in the laboratory of Dr. Johanna Buschmann for our own 
studies, where we wanted to investigate the influence of human dental pulp stem cells (hDPSCs) 
on the vascularization efficiency of silk fibroin scaffolds. In order to complete the manuscript, the 
perfusion capacity of samples containing either empty silk scaffolds or hDPSC-seeded silk scaffolds 
were monitored and quantified using the in vivo MRI method after an incubation time of 7 days. I 
had extracted the hDPSCs from wisdom teeth, followed by cell expansion and cell seeding on the 
silk scaffolds, which were pre-incubated in vitro. Furthermore, I performed the CAM assay as well 
as the histological and immunohistological (anti-CD31 antibody) analysis and documentation of 
the samples after the in vivo MRI scan. While preparing the manuscript I provided the descriptions 
about ‘Silk fibroin scaffolds’ and ‘Cells’ in the ‘Materials and Methods’ section. 
Interestingly, three to four times larger perfusion capacities were obtained in silk fibroin scaffolds 
when compared to DegraPol®, with a slightly higher perfusion capacity in hDPSC-seeded silk 
scaffolds. Similar to the DegraPol® scaffolds, the perfusion capacity measured within the silk 
fibroin scaffolds declined from the interface towards the surface region. The CD31-staining 
confirmed that functional vessels containing red blood cells of the chicken were present within 
the silk fibroin scaffold. The proof-of-principle in silk fibroin scaffolds showed that the in vivo MRI 
method developed by Kivrak Pfiffner et al. can be applied for the determination of the perfusion 
capacity in a large variety of bioengineered materials. 
  
A New In Vivo Magnetic Resonance Imaging Method
to Noninvasively Monitor and Quantify the Perfusion Capacity
of Three-Dimensional Biomaterials Grown on the
Chorioallantoic Membrane of Chick Embryos
Fatma Kivrak Pfiffner, MSc,1,* Conny Waschkies, PhD,2,3,* Yinghua Tian, PhD,3 Anna Woloszyk, MSc,4,5
Maurizio Calcagni, MD,1 Pietro Giovanoli, MD,1 Markus Rudin, PhD,2 and Johanna Buschmann, PhD1
Adequate vascularization in biomaterials is essential for tissue regeneration and repair. Current models do not
allow easy analysis of vascularization of implants in vivo, leaving it a highly desirable goal. A tool that allows
monitoring of perfusion capacity of such biomaterials noninvasively in a cheap, efficient, and reliable in vivo
model would hence add great benefit to research in this field. We established, for the first time, an in vivomagnetic
resonance imaging (MRI) method to quantify the perfusion capacity of a model biomaterial, DegraPol foam
scaffold, placed on the embryonic avian chorioallantoic membrane (CAM) in ovo. Perfusion capacity was as-
sessed through changes in the longitudinal relaxation rate before and after injection of a paramagnetic MRI
contrast agent, Gd-DOTA (Dotarem; Guerbet S.A.). Relaxation rate changes were compared in three different
regions of the scaffold, that is, at the interface to the CAM, in the middle and on the surface of the scaffold
( p< 0.05). The highest relaxation rate changes, and hence perfusion capacities, were measured in the interface
region where the scaffold was attached to the CAM, whereas the surface of the scaffold showed the lowest
relaxation rate changes. A strong positive correlation was obtained between relaxation rate changes and histo-
logically determined vessel density (R2= 0.983), which corroborates our MRI findings. As a proof-of-principle, we
measured the perfusion capacity in different scaffold materials, silk fibroin either with or without human dental
pulp stem cells. For these, three to four times larger perfusion capacities were obtained compared to DegraPol;
demonstrating that our method is sensitive to reveal such differences. In summary, we present a novel in vivo
method for analyzing the perfusion capacity in three-dimensional-biomaterials grown on the CAM, enabling the
determination of the perfusion capacity of a large variety of bioengineered materials.
Introduction
T issue-engineered constructs for regenerative medi-cine are based on scaffolds that are used as a matrix for
cells to attach and proliferate, so that these artificial grafts
can be implanted at defect sites. For this purpose they
should provide a high level of biocompatibility. Moreover,
vascularization is often required, that is, the grafts should be
easily vascularized after implantation and guarantee long-
term functionality and survival of the implanted material
and cells. To sustain the artificial graft in an environment as
a functional tissue, it is necessary that the blood vessels
penetrate the porous grafts from the surrounding tissue since
the transport of oxygen and nutrients is dependent on a
homogenously distributed vascular network in the implanted
scaffold.1–5
Artificial engineered grafts can have different effects on
vascularization. Not only the pore size, but also the size of
the scaffold and the interconnectivity of the pores are im-
portant criteria for blood vessel ingrowth after implanta-
tion.3,4 Numerous ex vivo and in vivo approaches have been
established to monitor vascularization of tissue grafts in-
cluding rodents, chicken, and fish.6,7 Ex vivo assays are
rapid but more limited because of the lack of inflammation
and metabolic processes that may affect vascularization.
Most of the currently available in vivo assays involve time,
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money, and repetitive animal sacrifice, and they are
complex and sometimes not easy to compare.3,8 The cho-
rioallantoic membrane (CAM) of the chick embryo is a
well-established model for studying vascularization in vitro
and in vivo and is typically referred to as CAM assay.9,10 It
is a very useful model because of the easy accessibility of
the vascular network. Moreover, its lack of immune com-
petence enables studies dealing with tumor growth, wound
healing, angiogenesis, antiangiogenesis, or biocompatibility
of xenografts.3,11,12 In addition, the CAM provides an ex-
cellent environment where the cells can attach and prolif-
erate in three-dimensional (3D) scaffolds. Finally, the CAM
assay is a rapid, simple, and low-cost screening method for
tissue reactions toward biomaterials.9
An increasing amount of literature highlights the as yet
unmet need to noninvasively monitor the vascularization
extent of the implanted scaffolds to analyze the success of
tissue regeneration in vivo.13,14 To date, there are only few
studies that use magnetic resonance imaging (MRI) as a
nondestructive, noninvasive method to study biomaterials
on the CAM.9,10 Our current work presents for the first time
the application of MRI to measure the perfusion capacity of
CAM-implanted scaffolds in situ on the CAM in the living
chicken embryo. This method allows a continuous, longi-
tudinal monitoring of developing vessels and hence perfu-
sion capacity in biomaterials in vivo.
The particular objectives of our study were (1) to quantify
the perfusion capacity within a model scaffold biomaterial,
DegraPol foam, implanted for 7 days on the CAM by MRI
in ovo and in vivo as a function of local distance from the
CAM and as a function of time after contrast agent injec-
tion,(2) to correlate our MRI findings with histological an-
alyses of vessel density, and (3) to apply the established
method as a proof-of-principle to different biomaterials
discovering the impact of human dental pulp stem cells
(hDPSCs) on the perfusion capacity of a silk fibroin scaf-
fold. In sum, we present a new and low cost screening




DegraPol. The synthetic polyester-urethane DegraPol is a
biocompatible and biodegradable material based on poly-
hydroxy-butyrate as a crystalline segment and e-caprolactone
as a soft segment.15 Originally, its synthesis aimed at gen-
erating a suitable scaffold material for bone tissue engineer-
ing,16 but has recently also been shown to be a beneficial
scaffold material for cartilage,17 nerves,18 and tendons.19
DegraPol foams were kindly provided by ab medica,
Italy. They were soaked in cyclohexane (Fluka, puriss) and
frozen at - 20C overnight. They were cut into equal pieces
of 8 · 4· 3mm3 immediately after removal from the freezer
and were dried at room temperature (evaporation of cyclo-
hexane). All foams were sterilized with ethylenoxide before
placing them carefully on the CAM.
Silk fibroin. Silk fibroin is a biocompatible (after the re-
moval of sericin) and biodegradable material whose physical
and mechanical properties can be easily manipulated through
structural readjustments.20,21 It is derived from silkworm co-
coons of Bombyx mori, which contains at least two major fi-
broin proteins, light and heavy chains, 25 and 325 kDa,
respectively.22 Due to its versatility it has become a popular
biomaterial for various applications, for example, inbone tissue
engineering.20 Silk fibroin scaffolds (Trudel Silk, Inc.) with a
diameter of 5mm, a height of 3mm, and a pore size of 200–
300mmwere used. Theywere prewetted for 36 h in phosphate-
buffered solution to rehydrate them before use. After
autoclaving (121C, 1 bar, 20min) scaffolds were immersed
either in a cell suspension (0.5· 106 cells/scaffold) or in cell-
free culture medium, respectively. As culture medium,
DMEM/F12 (D8437; Sigma) with 10% FBS (2602-P291705;
PAN Biotech GmbH), 1% Pen/Strep (P0781; Sigma), 1% L-
Glutamine (G7513; Sigma), and 0.02% fungizone (15290-018;
Invitrogen) was used. Cell-seeded and cell-free scaffolds were
placed in the incubator (37C, 5%CO2) to allow attachment of
the cells. After 1 h scaffolds were washed in fresh culture me-
dium and placed into a 24-well-plate with 0.8mL of culture
medium in the incubator overnight. After that the scaffolds
were placed on the CAM of the fertilized chicken eggs.
Cells
hDPSCs were obtained from dental pulps of healthy teeth
of adult patients after the extraction of impacted wisdom
teeth. The procedure was approved by the Kantonale Ethik-
kommission of Zurich (reference number 2012-0588) and
performed with written patients’ consent. After the removal
of the dental pulp from the tooth, hDPSCs were isolated,
expanded, and characterized as described previously.23
CAM assay
Fertilized Lowman white LSL chick eggs (Animalco AG
Geflügelzucht) were incubated at 37C and 65% relative
humidity. On incubation day (ID) 3.5 a circular window
with a diameter of 40–45mm was drilled into the eggshell
after removing 2mL albumen so that the developing CAM
detached from the eggshell. The window in the eggshell was
closed with a sterile Petri dish of 50mm to prevent dehy-
dration. On ID 7, DegraPol foam scaffolds, cell-seeded silk
fibroin scaffolds and cell-free silk fibroin scaffolds were
carefully placed on top of the CAM, one scaffold into each
egg. The scaffolds were put in the middle of 1 cm-diameter
plastic rings to flatten the surface of CAM (Fig. 1). After-
ward the eggs were incubated for another 7 days until ID 14.
In vivo assessment of perfusion capacity using MRI
On ID14, vascularization of the scaffold by capillaries of the
chick embryo’s CAM was studied in situ on the CAM (‘‘in
ovo’’) of the living chicken embryo (‘‘in vivo’’) using MRI in
eight samples. For the MRI examination, the eggs were placed
onto a custom-built sliding bed and enveloped by warm water
tubing to maintain the temperature of the chick embryo in a
physiological range. To prevent motion of the chick embryos,
they were sedated with five drops of 1:100M ketamine
(Ketasol-100; Graeub) dripped onto the CAM surface.
MRI was performed with a 4.7 T/16 cm Bruker Phar-
maScan small animal scanner (Bruker BioSpin) equipped
with an actively decoupled two-coil system consisting of a
72mm bird cage resonator for excitation and a 20mm single
loop surface coil for reception. The surface coil was fixed on
2 KIVRAK PFIFFNER ET AL.
the Petri dish that covered the eggshell window directly
above the scaffold for optimal sensitivity.
Anatomical reference images were obtained in coronal,
transversal, and sagittal slice orientations (FLASH se-
quence, TR/TE 200/3ms, image matrix size 128 · 128, field
of view 60 · 60mm2, five slices, images reconstructed to a
nominal resolution of 0.23 · 0.23 · 1mm3, total scan time
25 s). T1-weighted MR images were acquired with a RARE
sequence of variable TR and TE for quantitative T1 and T2
mapping (TR 200/400/800/1500/3000/4500ms, TE 10/30/
50/70/90ms, RARE-factor 2, image matrix size 220· 150,
field of view 45· 30mm2, spatial resolution 0.2 · 0.2mm2,
slice thickness 1mm, total scan time 9min 40 s).
T1 maps were acquired in eight DegraPol, four silk fibroin
and four silk fibroin samples seeded with hDPSCs before
and after i.v. injection 100mL 0.05M Gd-DOTA MRI
contrast agent (Dotarem; Guerbet S.A.). The time between
Gd-DOTA injection and T1 mapping was held constant at
25min. An additional time series was acquired in three
DegraPol samples with T1 map acquired at 15, 25, 35, 45,
and 60min postinjection.
T1 relaxation times were determined in three regions of
interest at (1) the surface of the scaffold, (2) in the middle,
and (3) at the interface of the scaffold with the CAM. Per-
fusion capacity in these three regions of interest was as-
sessed through changes in the longitudinal relaxation rate,
DR1 =R1–R10, before and after injection of Gd-DOTA, as
the relaxation rate changes with the amount of gadolinium
present in the CAM:
R1 ¼R10 þ r1  [Gd]
where
R1 ¼ 1=T1
are the longitudinal relaxation rate after and R10 before
contrast agent administration and r1 the molar relaxivity of
the contrast agent in s - 1 mol - 1 L and [Gd] the concentra-
tion of Gd in mol L- 1.
Intravenous injection of Gd-DOTA
For intravenous injection of the MRI contrast agent, eggs
were placed on a 37C heating bed and i.v. injection was
performed under a surgical microscope with 12–20· mag-
nification. A big and straight vein on the surface was se-
lected and grasped by a microsurgical forceps and 100 mL
Gd-DOTA slowly injected with a 1.0mL syringe and 30G
needle. A cotton sticker was placed on the injection site of
the vessel with slight pressure before the syringe was
withdrawn to prevent bleeding.
Histological analyses
After completion of the MRI measurements the scaffold-
CAM complex was fixed overnight using 4% formalin
solution in phosphate-buffered saline, then excised, em-
bedded in paraffin, cross sectioned in 5 mm slices, and
stained with hematoxylin and eosin (H&E), CD31
(PECAM-1 [M-20]: sc-1506, Santa Cruz Biotechnology;
staining procedure for paraffin sections of the VECTA-
STAIN Elite ABC Kit-Rabbit IgG [PK-6101; Vector La-
boratories, Inc.]) and Von Willebrand Faktor (Factor VIII;
Dako) according to established procedures.24 Slices were
obtained from three regions of the scaffold: (1) surface, (2)
middle, and (3) interface to the CAM, and three to four
slices for each region were analyzed. The vessel density
was scored semi-quantitatively by counting the number of
vessels manually under a light microscope (Leica DM 6000
B) equipped with a digital camera; with 0 = no vessels,
1 £ 10, 1.5 = 10–30, 2 = 30–50, 2.5 = 50–70, 3 = 70–90,
3.5 = 90–110, 4 = 110–130, 4.5 = 130–150, and 5 ‡ 150
vessels in a cross section of 32mm2.
Statistics
The correlation of capillarity densities and the change in
relaxation rates, DR1, was determined by linear regression
using StatView 5.0.1. Moreover, one-way analysis of vari-
ance was conducted. Pairwise comparison probabilities ( p)




The ability to quantify the perfusion capacity is crucial
for assessing the biocompatibility of tissue-engineered
grafts and biomaterials. Here, we used MRI to assess per-
fusion capacity through changes in the R1 relaxation rates,
DR1, before and after injection of a paramagnetic MRI
contrast agent, Gd-DOTA. In Figure 2, T1-weighed images
before and after injection are depicted. In the precontrast
image, the scaffold and supportive plastic ring and head of
the chick embryo can be distinguished, but are much better
delineated in the postcontrast image, as the scaffold and
embryonic structures show high contrast enhancement,
while the adjacent tissue shows little uptake. As for the
scaffold material implanted on the CAM, it is shown that
contrast enhancement varies locally within the scaffold and
FIG. 1. DegraPol foam scaffold (arrow) placed in the
middle of a supportive plastic ring on top of the CAM on ID
7. CAM, chorioallantoic membrane; ID, incubation day.
Color images available online at www.liebertpub.com/tec
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that the largest signal change appears at the interface to the
CAM (see enlarged section that zooms into the scaffold).
Noteworthy to mention is the clear border of the contrast
agent uptake at the interface to the CAM. While little Gd-
DOTA uptake is found next to the scaffold implying little
vascularization, there is a high contrast agent uptake at the
interface. A quantitative analysis is summarized in Figure 3,
which shows that the relaxation rate change, DR1, and hence
perfusion capacity, declines from interface to the CAM to-
ward the surface region of the scaffold (n= 8).
Finally, the relaxation rate change, DR1, was monitored as
a function of time after injection of Gd-DOTA (n = 3). As
shown in Figure 4, the signal intensity reached a plateau at
35min in all regions of interest studied.
Histology
Quantification of vessel density was accomplished by
counting the number of blood vessels within cross sections of
8· 4mm stained by H&E (Fig. 5a). Vessels were identified as
roundish blue structures lining endothelial cells.Representative
images for each score level are available as Supplementary
Data to this article (Supplementary Fig. S1; Supplementary
Data are available online at www.liebertpub.com/tec). Vessel
counts fromH&Estainingwere also confirmedbyan additional
scoring in von Willebrand Factor immunostained correspond-
ing sections (Fig. 5b). In addition, CD31 staining revealed the
same vessel counts as determined byH&E and vonWillebrand
Factor stainings (Fig. 5c). These histological analyses revealed
that the interface region of the implanted DegraPol scaffold
with the CAM showed the highest number of small blood
vessels compared with middle and surface, with an average
vessel density score of 3.05– 1.34; 2.42– 1.15; and 1.47– 0.65,
respectively. The surface regionwith the longest distance to the
CAM had the lowest number of small blood vessels (Fig. 6).
Therefore, the same regional pattern of vascularization was
observed as in our MRI data. Furthermore, a strong correlation
was obtained between relaxation rate changes, DR1, and the
histological scores for vessel density (R2= 0.983). Thus, the
histology data corroborate the MRI findings.
Perfusion capacity in different biomaterials
(proof-of-principle)
To apply the method to other biomaterials than DegraPol,
relaxation rate changes, DR1, of silk fibroin scaffolds
( – hDPSCs) were measured for the same corresponding
FIG. 2. In ovo T1-weighted magnetic resonance images
acquired 7 days postimplantation in an axial slice through
the scaffold. (a) before (b) 25min after i.v. injection of Gd-
DOTA. Enlarged section: scaffold with regions of interest
(circles) at the interface with the CAM, in the middle and on
the surface of the scaffold.
FIG. 3. Relaxation rate change DR1 in three regions of
interest at the interface, middle, and surface of the DegraPol
and silk fibroin scaffolds either with or without human
dental pulp stem cells (hDPSCs) grown for 1 week on the
CAM. Values are given as mean – standard deviation. p-
Values are denoted as * is p < 0.05; **p< 0.01; and
***p< 0.001. Asterisks without line refer to comparisons to
DegraPol.
FIG. 4. Relaxation rate change DR1 as a function of time
after contrast agent injection in three regions of interest at
the interface, middle, and surface of the DegraPol scaffold.
Values are given as mean – standard deviation.
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scaffold regions (interface, middle, and surface, Fig. 3). For
all three regions, the perfusion capacity of silk fibroin
scaffolds was significantly higher compared with the De-
graPol scaffolds (three to four times higher, p < 0.0001).
However, the hDPSCs did not evoke a statistically signifi-
cant higher perfusion of the silk fibroin scaffolds compared
to the cell-free silk fibroin scaffolds ( p> 0.1). Only a trend
was noticed for all three regions, where the perfusion was
higher in the presence of the hDPSCs compared to the cell-
free scaffolds. CD31 staining clearly showed the vessels
inside the silk fibroin scaffold seeded by hDPSCs (Fig. 5d).
Finally, in both biomaterials, DegraPol and silk fibroin
( – hDPSCs), perfusion capacity declines from the interface
toward the surface, in line with the scaffolds being vascu-
larized from the CAM toward the surface.
Discussion
In this study, we present for the first time a cheap
screening method for noninvasive quantification of the
perfusion capacity of biomaterials with MRI in vivo. We
found a strong positive correlation between local changes in
T1-based relaxation rates in biomaterials grown 1 week on
the CAM and the vessel density determined by histology.
Vascularization in 3D biomaterials is a limiting factor for
successful implantation and functionalization of these en-
gineered tissues. The highly vascularized CAM of the chick
embryo is a useful model to evaluate the tissue response and
perfusion capacity of scaffolds placed on top of the CAM.
Furthermore, this avian model provides a good nutritional en-
vironment to tissue-engineered materials. Compared to the
traditional mammalian models, the CAM assay is cheap, more
time efficient, and does not have any immune-system based
reaction toward foreign bodies.6Thus, it allows—amongmany
other applications—to work with human tumor cells to study
tumor-induced angiogenesis25 or chemoprevention.26 Even in
environmental pollution and health debates, it may serve as a
valuable model.27 Finally, the CAM assay has been well es-
tablished,6 is low priced, and predominantly used to study an-
giogenesis and anti-angiogenesis in response to different drugs,
growth factors, and cell types.3,28
As a model biomaterial, we chose a biodegradable De-
graPol foam because this polyester-urethane has been shown
FIG. 5. Histological cross sec-
tions showing the capillaries in the
scaffold material: (a) Hematoxylin
and eosin staining of DegraPol at
100 ·magnification; (b) immuno-
staining with von Willebrand
Factor of DegraPol at 200 · mag-
nification; (c) immunostaining with
CD31 of DegraPol at 630· mag-
nification (counterstaining Tolui-
dine Blue) and (d) immunostaining
with CD31 of silk fibroin seeded
with hDPSCs (counterstaining he-
matoxylin) at 400· magnification.
A few vessels are exemplarily
highlighted by arrows. Color ima-
ges available online at www
.liebertpub.com/tec
FIG. 6. Relaxation rate change DR1 as a measure of per-
fusion capacity versus vessel density obtained by semi-
quantitative scoring of histological slices in three regions of
interest at the interface, middle, and surface of the scaffold-
CAM complex. Relaxation rate change and vessel density in
the scaffold are highest at the interface to the CAM and
decrease with distance from the CAM. Score 1 £ 10,
score 1.5 = 10–30, score 2 = 30–50, score 2.5 = 50–70, score
3 = 70–90, score 3.5 = 90–110, score 4 = 110–130, score
4.5 = 130–150, and score 5 ‡ 150 vessels counted in a cross
section of 32mm2. Values are given as mean – standard
deviation. p-Values are denoted as (*) is p < 0.1; *p< 0.05;
and **p < 0.01.
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to be biocompatible with respect to osteoblasts,16 chon-
drocytes,17 and tenocytes29 among others. To date, many
studies examined the tissue response toward biomaterials
using the CAM model,3,8 or tested different biomaterials
such as PVC or modified polyurethanes with respect to
angiogenesis and inflammatory response.30 However, they
often use ‘‘end-point’’ information such as histological
analysis which necessitates the destruction of the tissue-
engineered construct. In a previous study we therefore
presented MRI as a nondestructive, analytical tool for
studying vascularization ex vivo in the same biomaterial
grown on the CAM.10 While MRI has been employed
in vivo to determine the mineralization of bone constructs
placed on the CAM,9 it has not been used so far for the
assessment of the perfusion capacity. Our present study
therefore shows for the first time MRI as a suitable method
to examine the perfusion capacity in biomaterials placed on
the CAM in situ in the living chicken embryo. The combi-
nation of the CAM model with an in ovo and in vivo MRI
readout offers the potential to longitudinally monitor the
perfusion capacity of biomaterials. In other words, the
vascularization process can be followed in vivo by nonin-
vasive MRI, thereby offering a novel screening method to
quantify the perfusion capacity of a series of different bio-
materials at different time points in the same sample.
In particular, our data show that the perfusion capacity of
scaffolds grown for 1 week on the CAM can be quantified by
analyzing relaxation rate changes, as these are dependent on
the amount of contrast agent present in the vascular network.
Inspection of contrast-enhancement within the scaffold re-
vealed regional variations and a region of interest analysis of
relaxation rate changes was performed to assess such het-
erogeneity more quantitatively. As such, perfusion capacity
was found to be highest at the interface where the scaffold
was attached to the CAM while it gradually decreased with
distance from the interface with lowest perfusion capacity
found at the surface of the scaffold. Presumably, DegraPol
scaffolds were too large to be fully vascularized as has been
found for smaller DegraPol foams (30mm3 as compared to
96mm3 used here) in our previous study.10 Semi-quantitative
histological analyses of vessel density in locally staggered
histological sections taken from the interface, middle, and
surface of the scaffold corroborates the MRI findings as the
highest vessel density was found at the interface and lowest at
the surface of the scaffold. Furthermore, histological scores
were found to strongly correlate with the relaxation rate
changes, providing further support for our notion that relax-
ation rate changes may be used as a simplified measure for
perfusion capacity.
In order to apply this newly established method to a
typical question in the field of tissue engineering (as a proof-
of-principle), silk fibroin scaffolds either with or without
hDPSCs were also analyzed with respect to their perfusion
capacity by MRI. First of all, the differences in the relaxa-
tion rates between the two materials DegraPol and silk fi-
broin were significant; silk fibroin showed three to four
times higher relaxation rates compared with DegraPol,
which renders silk fibroin a much better scaffold material in
terms of a fast vascularization. Second, silk fibroin seeded
with hDPSCs had higher relaxation rates compared to cell-
free constructs (trend), implying that an in vitro preseeding
of only 1 day (!) has already a beneficial impact on the
perfusion extent in ovo. The hDPSCs are involved in the
building of new vessels inside the silk fibroin as confirmed
by histological analysis of typical endothelial cell markers
(von Willebrand Factor and CD31). Therefore, our method
leads to remarkable changes in DR1 for different scaffold
materials and it is sensitive already for minor changes in
preparation such as a 1-day preseeding by stem cells.
Some limitations of the in ovo CAM model as used in our
study should bementioned, however. First, only 30–40%of the
windowed eggs survived the opening of the eggshell. Thismay
mostly be attributed to eggshell dust contaminating the other-
wise sterile egg cavity and its environment during windowing.
Smaller windows might reduce the risk of contamination,
however, larger windows allow minimizing the distance be-
tween the scaffold and the surface coil during MRI measure-
ments and facilitate access to the vasculature during contrast
agent injection, which is necessary for higher resolutions.
Second, the injection of the contrast agent was a highly delicate
process due to the small vessel size and flexibility within the
egg yolk. An experienced microsurgeon (Y.T.) provided the
required skills, but these can be also acquired by others through
dedicated trainingThird, there is a limitation in size of the
biomaterial under investigation; a size of 8· 4· 3mm3 as used
in case of the DegraPol scaffolds could have a bigger area
placed on the CAM, however, the height (3mm) cannot be
increased much because during a time frame of 7 days, vessel
growth starting from the CAM surface might not reach the top
of the scaffold. Moreover, the timing between contrast agent
injection and relaxation time measurement was set at 25min.
This time windowwas considered ample for the contrast agent
to distribute in the microvasculature and extravascular com-
partment and the relaxation rate change, and hence perfusion
signal, being not dominated by wash-in effects of bigger ves-
sels. To assess possible effects of this specific time windowwe
acquired a time series of relaxation rate changes between 15–
60min postinjection in three samples. These data reveal that
contrast agent uptake is highest 35minpostinjection, indicating
that other processes, such as diffusion, also contribute to the
rather slow contrast agent uptake.31 Thus, for highest contrast
our preset time window of 25min postinjection, which was
preset such as to maximize uptake of contrast agent but also
aimed at reducing necessary scantime, will be increased in
future studies.
Finally it should be mentioned that in our study we did
not take full advantage of our method’s potential to perform
longitudinal measurements that our in ovo CAM model
combined with noninvasive in vivo MRI readout offers. To
do so, a couple of legal, physiological, and technical issues
will need to be tackled: Experimental procedures with fer-
tilized eggs fall under the legislation of the Swiss federal
ordinance on animal protection and welfare starting on ID
14 and hence the prerequisite legal framework needs to be
set into place for experiments lasting longer than ID 14. On
the physiological side it remains to be established how much
the development of the vascular network and ultimately
perfusion capacity is affected by stress induced by the
handling of the egg, anesthesia, MRI measurement and
contrast agent injection. Previous studies indicate that such
effects exist and warrant further investigation.32 And finally,
contrast agent doses might need to be titrated down such as
to enable repeated measurements, in particular as renal
clearing rates in the avian embryo are not known and the
6 KIVRAK PFIFFNER ET AL.
contrast agent supposedly remains in the closed environ-
ment of the egg.
Nevertheless, the method established here is really ben-
eficial for tissue engineering and regeneration purposes be-
cause it allows performing a cheap and fast in vivo screening
of the perfusion extent of any biomaterials or bioartificial
constructs. It hence allows gathering valuable preclinical
information about a material’s potential long-term func-
tionality and survival in the host tissue and therefore may
steer early candidate selection for further development.
Furthermore, for the benefit of the three Rs, it has become
mandatory to evaluate cell-scaffold constructs prior to
in vivo experiments.33 With a cost of only 2 dollars per egg
it is much cheaper compared with animal models such as
mice ( > 25 dollars), rats (> 35 dollars), or rabbits ( > 200
dollars). Moreover, vascularization of the biomaterials can
be monitored as a function of time with noninvasive MRI
and valuable information can be gathered within a time
frame of only 2 weeks including 1 week of incubation and 1
week of monitoring angiogenesis in the material under view.
In sum, the CAM model’s cost effectiveness and the
absence of immune-defense reactions combined with the
noninvasiveness of MRI to access the perfusion capacity of
biomaterials and tissue-engineered constructs in vivo and
in ovo will increase the attractiveness of this distinguished
combination in the future. We conclude that the CAM assay
together with noninvasive MRI presents a reliable in vivo
model for monitoring the perfusion capacity of biomaterials.
Further studies are planned with arrays of different bioma-
terials and differently pre-engineered biomaterials in our
laboratory.
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Odyssey of human dental pulp stem cells and their remarkable ability to survive in extremely 
adverse conditions (OPINION) 
 
The goal of this communication was to inform the scientific community about an interesting 
observation we have made when shipping cells from Naples, Italy to Zurich, Switzerland. Instead 
of arriving within 24 hours the shipping of the cells took eight full days. Contrary to our 
expectations, the cells were not dead, but were still alive and continued proliferating after 
changing the medium, which suggests that human dental pulp stem cells are able to survive for 
prolonged periods of time in conditions of extreme stress. 
I contributed by documenting the cell status after their arrival, performing literature research, as 
well as co-writing and co-editing the manuscript.  
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Adult tissues contain stem cells, which proliferate to compensate for tissue loss throughout the life
of the organism (Li and Clevers, 2010; Jiménez-Rojo et al., 2012). Therefore, adult stem cells are
important for tissue repair and regeneration after injury. In seriously injured or carious teeth, stem
cells residing in the dental pulp are responsible for the repair and regeneration of the damaged
dental tissues (Catón et al., 2011; Mitsiadis et al., 2011). Dental pulp stem cells (DPSCs) can be iso-
lated after labeling of the pulp cells with fluorescent mesenchymal stem cell (MSC) markers such
as STRO-1, CD146, and CD44, followed by fluorescence-activated cell sorting (FACS) (Mitsiadis
et al., 2012). Additional identification procedures include morphological criteria, adherence prop-
erties, proliferation, and differentiation potential, as well as tissue repair abilities of the sorted stem
cell populations. The potential of DPSCs for the regeneration of bone tissue in patients has been
demonstrated with a successful trial assay that has been realized in Napoli (Italy) several years ago
(Catón et al., 2011; Mitsiadis et al., 2012).
We have established a close scientific collaboration with the Napoli stem cell team headed by
Prof. Gianpaolo Papaccio for the exchange of knowledge and materials. Several months ago, we
have requested for a bunch of freshly isolated DPSCs in order to complete a number of experiments
that we are currently realizing in our laboratories in Zurich (Switzerland). DPSCs were shipped
with an express delivery company on the 26/11/2014 from Napoli with destination to Zurich. The
shipped DPSCs were grown as a monolayer in a 25 cm2 culture flask containing the standard MSC
culture medium. The flask that was sealed with Parafilm and left in ambient temperature should
normally arrive to the destination the next day, but for unknown reasons the journey of DPSCs
was longer and more exciting than expected. The DPSCs have followed an astonishing itinerary
from Italy, to France (Paris), Great Britain, South Africa (Johannesburg), back to France, thereafter
to Spain, France again. From France the cells finally arrived to Zurich Switzerland through Basel
on the 4/12/2014. This itinerary can be considered as an Odyssey of DPSCs, which had to develop
sophisticated mechanisms for their survival under these extremely adverse conditions.
Sometimes discoveries are arising by chance, following a mistake or having an unexpected
behavior. It was expected that the flask, upon its late arrival, would contain only dead cells. How-
ever, surprisingly, DPSCs (or a big part of them) were still alive after their journey (Figure 1A).
DPSCs were extremely proliferative and became confluent within 3 days, after changing the
medium (Figures 1B,C). How this could be explained? Recent findings indicate that quiescent
(reserve) and proliferating (active) stem cell pools may coexist in separate but adjacent com-
partments of many tissues (Li and Clevers, 2010). It has been proposed that stem cells can
adopt a reversible quiescence state characterized by reduced metabolic activity in conditions such
as lack of oxygen and/or nutrients (Cheung and Rando, 2013). However, the mechanisms that
Mitsiadis and Woloszyk Travelling dental pulp stem cells
FIGURE 1 | Visualization of human dental pulp stem cells (hDPSCs): (A) upon arrival to Zurich (first passage), (B) after 6 h of culture (second passage),
and (C) after 3 days of culture (second passage). Scale bars indicate the magnifications.
allow quiescent stem cells to survive metabolic or environmen-
tal stress, to preserve their cellular and genomic integrity and to
assure long-term survival are not yet elucidated. It has been sug-
gested that quiescence is an actively maintained state regulated by
intrinsic mechanisms to sustain metabolic function during per-
sistent environmental stress, and thus ensuring stem cell survival
(Cheung and Rando, 2013). Viable stem cells were found in post-
mortem tissues (Latil et al., 2012). These cells were able to main-
tain their functional properties after prolonged storage in anoxia
in vitro and after transplantation (Latil et al., 2012). Similarly,
it has been shown that several stem cell populations reside in
poorly oxygenated niches (Simsek et al., 2010). Quiescent stem
cells have the ability to sense environmental changes and respond
by re-entering the cell cycle for proliferation (Cheung and Rando,
2013). Severe hypoxia could be critical for maintaining the viabil-
ity of DPSCs. It is possible that mechanisms compatible with the
low metabolic state of quiescence have allowed rapid responses
for DMSCs re-activation.
This Odyssey revealed that DPSCs are able to survive for
prolonged periods of time in conditions of extreme stress.
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Human dental pulp stem cells and gingival fibroblasts seeded into silk fibroin scaffolds have the 
same ability in attracting vessels (PAPER, shared first authorship) 
 
In our previous studies we had observed that human dental pulp stem cell (hDPSC)-seeded silk 
fibroin scaffolds were able to attract more vessels than empty scaffolds. In order to test if this 
ability to attract vessels is unique to hDPSCs we wanted to compare the results to silk fibroin 
scaffolds seeded with another population of cells isolated from an oral-derived tissue, namely 
human gingival fibroblasts (hGFs). Similar to previous studies, the experimental part that I 
performed included the extraction of cells from the tissue of interest, i.e. human dental pulp and 
human gingiva, respectively, cell expansion, cell seeding of the scaffolds and culture of the 
cell-seeded samples on the CAM. The analyses of the samples were performed in close 
collaboration with Dr. Johanna Buschmann and her team at the University Hospital, who used an 
in vivo MRI technique to measure the perfusion capacity of the vascularized samples on the CAM 
of the living anesthetized chicken embryo after the injection of a contrast agent. After the MRI 
measurements, I continued with the sample analysis, which included histology and a manual 
blood vessel analysis. While preparing the manuscript I compiled the figures and contributed to 
the writing and literature research. 
The results of both in vivo MRI and manual blood vessel analyses clearly demonstrated that 
hDPSCs and hGFs possess equal abilities in attracting blood vessels into silk fibroin scaffolds.  
A possible explanation for a similar blood vessel attraction potential of both hDPSCs and hGFs is 
the fact that similar to hDPSCs also hGFs are derived from the cranial neural crest, and have been 
shown to possess stem cell properties before. Moreover, also hGFs are known to secrete 
angiogenic factors. Further studies are necessary in order to establish, which properties of a cell 
population are essential for the successful attraction of the host’s vasculature into a 3D 
biomaterial and how this potential could be incorporated into future clinical strategies for the use 
of autologous tissue engineered implants for regenerative purposes.  
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Neovascularization is one of the most important processes during tissue repair
and regeneration. Current healing approaches based on the use of biomaterials
combined with stem cells in critical-size bone defects fail due to the insufficient
implant vascularization and integration into the host tissues. Therefore, here we studied
the attraction, ingrowth, and distribution of blood vessels from the chicken embryo
chorioallantoic membrane into implanted silk fibroin scaffolds seeded with either human
dental pulp stem cells or human gingival fibroblasts. Perfusion capacity was evaluated
by non-invasive in vivo Magnetic Resonance Imaging while the number and density
of blood vessels were measured by histomorphometry. Our results demonstrate that
human dental pulp stem cells and gingival fibroblasts possess equal abilities in attracting
vessels within silk fibroin scaffolds. Additionally, the prolonged in vitro pre-incubation
period of these two cell populations favors the homogeneous distribution of vessels within
silk fibroin scaffolds, which further improves implant survival and guarantees successful
healing and regeneration.
Keywords: regenerative medicine, vascularization, mesenchymal stem cells, human gingival fibroblasts (hGFs),
human dental pulp stem cells (hDPSCs), silk fibroin scaffolds, chorioallantoic membrane (CAM)
INTRODUCTION
Classical bone defect treatments require the use of anatomically adapted devices that can establish
tissue functionality and provide relief of symptoms to patients. However, the effectiveness and
durability of treatments involving orthopedic or maxillofacial implants and transplantations of
autologous bone grafts are still debatable. Indeed, the outcome of these regenerative solutions
may be compromised by a variety of iatrogenic complications such as tissue morbidity and/or
inflammation following implant or graft transplantation. Stem cell-based therapeutic approaches
offer attractive alternatives in clinics since they can promise physiologically improved structural
and functional outcomes. These therapies require a significant number of stem cell populations for
implantation into specifically designed and composed scaffolds with various biological activities
and compositions that can ensure their fast integration into the defect site. To avoid post-operative
Woloszyk et al. Vessel Attraction Impact of hDPSCs
complications it is essential to promote rapid, constant,
and complete vascularization of these implantable constructs
(Giannicola et al., 2010). Different strategies have been developed
in order to enhance the vascularization capabilities of the various
implanted materials. Cell seeding is one of the most popular and
beneficial strategies to achieve this important goal. For example,
it has been demonstrated that bone marrow stem cells (BMSCs)
and endothelial cells seeded together in decalcified bone scaffolds
can accelerate the vascularization process during calvaria bone
repair (Koob et al., 2011). Similarly, it has been shown that
human amniotic fluid-derived stem cells are able to enhance
and stabilize vessel attraction and formation within collagen-
chondroitin sulfate scaffolds (Lloyd-Griffith et al., 2015). Cell-
seeded grafts may also have immunosuppressive functions that
allow an improved healing procedure, as it has been already
shown for adipose-derived stem cell-seeded scaffolds (Plock et al.,
2015).
The use of human dental pulp stem cells (hDPSCs; Gronthos
et al., 2000; Shi et al., 2001; Huang et al., 2009) and human
gingival fibroblasts (hGFs; Xu et al., 2013; Chiquet et al., 2015)
for regenerative purposes has been proposed as an alternative
to BMSCs, since these cell populations exhibit similar properties
and have the ability to adopt a variety of alternative fates in
response to extrinsic factors. Indeed, it has been shown that hGFs
have distinct functional activities in the regeneration and repair
of periodontal tissues (Lee et al., 2013; Chiquet et al., 2015).
Similarly, numerous studies have demonstrated that hDPSCs
have the potential to differentiate into different cell types such
as myocytes, chondrocytes, adipocytes, neurons, and osteoblasts
both in vitro and in vivo (Gronthos et al., 2000; Zhang et al.,
2006; d’Aquino et al., 2007; Bluteau et al., 2008; Mitsiadis et al.,
2015). In addition, in vitro and in vivo studies have shown that
hDPSCs may affect endothelial cell behavior by enhancing their
migration and attraction toward them (Hilkens et al., 2014).
The first clinical trial using autologous hDPSCs combined with
commercially available collagen scaffolds (i.e., Gingistat R©) for
alveolar bone reconstruction has been successfully performed
several years ago (d’Aquino et al., 2009). A 3 years follow-up
study has shown that the structure of the regenerated bone at
the grafted site was more compact than normal spongy alveolar
bone (Giuliani et al., 2013), thus indicating that the choice of
the appropriate scaffold and/or stem cell population is crucial for
targeted, tissue-specific, regenerative procedures.
Silk fibroin scaffolds are commonly used in the medical field
for a diverse set of applications such as vascular, neuronal,
skin, cartilage, and bone regeneration (Altman et al., 2003;
Kundu et al., 2013). Using bioreactor devices, we have previously
shown that hDPSC-seeded silk fibroin scaffolds are able to form
mineralized structures in vitro in a very short period of time
(Woloszyk et al., 2014). In another recent study using the chicken
embryo chorioallantoic membrane (CAM) assay combined with
magnetic resonance imaging (MRI), we have demonstrated that
hDPSCs can attract vessels within silk fibroin scaffolds (Kivrak
Pfiffner et al., 2015).
Here we extended our previous studies and compared the
capacity of hDPSCs and human gingival fibroblasts (hGFs)
to attract vessels within silk fibroin scaffolds. Vascularization
of the silk fibroin scaffolds was assessed using MRI and
histomorphometric measurements. The results clearly
demonstrated that hDPSCs and hGFs have similar abilities
in attracting vessels and thus could be equally used in clinics for
generating richly vascularized tissues.
MATERIALS AND METHODS
Production of Silk Fibroin Scaffolds
Silk fibroin scaffolds were produced using the salt leaching
technique as previously described (Sofia et al., 2001; Nazarov
et al., 2004; Hofmann et al., 2007). Briefly, silkworm cocoons
(Trudel Inc., Zurich, Switzerland) were boiled in 0.02M sodium
carbonate (Fluka AG, Buchs SG, Switzerland) and rinsed with
ultrapure water (UPW) to extract sericin. After drying, the silk
was dissolved in 9M lithium bromide and dialyzed against UPW
for 36 h followed by lyophilization (Alpha 1-2, Martin Christ
GMBH, Osterode am Harz, Germany). A 17% (w/v) silk fibroin
solution was prepared by dissolving lyophilized silk in 1,1,1,3,3,3-
hexafluoro-2-propanol (HFIP) (abcr GmbH & Co., Karlsruhe,
Germany). This solution was added to Teflon containers filled
with sodium chloride (Sigma-Aldrich Chemie GmbH, Buchs
SG, Switzerland) at a ratio of 1:20 (silk fibroin:NaCl). After the
evaporation of HFIP, the blocks were immersed in 90%methanol
for 30min (Sofia et al., 2001). The scaffolds were dried for at least
48 h before sodium chloride was leached out in five changes of
UPW in 48 h resulting in scaffolds with more than 90% porosity
(Nazarov et al., 2004). Wet silk fibroin scaffolds were cut into
cylinders of 5mm diameter and 3mm height (59mm3) and were
sterilized by autoclaving at 121◦C and 1 bar for 20min.
Cell Culture
The procedure for anonymized cell collection was approved by
the Kantonale Ethikkommission of Zurich (reference number
2012-0588) and performed with written patients’ consent.
Human dental pulp stem cells (hDPSCs) were isolated from
the dental pulp of extracted impacted wisdom teeth of healthy
patients as previously described (Tirino et al., 2012). The
dental pulps were enzymatically digested for 1 h at 37◦C in a
solution of collagenase (3 mg/mL; Life Technologies Europe
B.V., Zug ZG, Switzerland) and dispase (4 mg/mL; Sigma-
Aldrich Chemie GmbH, Buchs SG, Switzerland). A filtered
single-cell suspension was plated in a 40mm Petri dish with
hDPSC growth medium containing DMEM/F12 (Sigma-Aldrich
Chemie GmbH, Buchs SG, Switzerland) with 10% fetal bovine
serum (FBS) (PAN Biotech GmbH, Aidenbach, Germany), 1%
penicillin/streptomycin (P/S) (Sigma-Aldrich Chemie GmbH,
Buchs SG, Switzerland), 1% L-glutamine (Sigma-Aldrich Chemie
GmbH, Buchs SG, Switzerland), and 0.5µg/ml fungizone
(Life Technologies Europe B.V., Zug ZG, Switzerland) after
washing away the enzyme solution. Healthy parts of gingiva
were collected from biopsies. Gingival tissues were washed
in phosphate buffered saline (PBS) (Life Technologies Europe
B.V., Zug ZG, Switzerland), sectioned into small pieces and
placed in 35mm Petri dishes (TPP Techno Plastic Products
AG, Trasadingen SH, Switzerland) for the outgrowth of human
gingival fibroblasts (hGFs). The fibroblast growth medium is
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composed by high glucose DMEM (Life Technologies Europe
B.V., Zug ZG, Switzerland), 10% FBS, 1% P/S, and 1%
HEPES (Sigma-Aldrich Chemie GmbH, Buchs SG, Switzerland).
hDPSCs were cultured in DMEM/F12 (Sigma-Aldrich Chemie
GmbH, Buchs SG, Switzerland) supplemented with 10% fetal
bovine serum (FBS) (Biochrom AG, Berlin, Germany), 1%
Penicillin/Streptamycin (P/S) (Sigma-Aldrich Chemie GmbH,
Buchs SG, Switzerland), and 0.5µg/mL fungizone (Thermo
Fisher Scientific AG, Reinach BL, Switzerland). hGFs were
expanded in DMEM high glucose (Thermo Fisher Scientific
AG, Reinach BL, Switzerland) supplemented with 10% FBS, 1%
P/S, and 1% HEPES (Thermo Fisher Scientific AG, Reinach
BL, Switzerland). Cells were passaged at 80–90% confluence.
All experiments were performed with cells from passages 4
and 5.
Scaffold Seeding
Sterile silk fibroin scaffolds were seeded with cells at a density of
0.5× 106 per scaffold and then placed in a humidified incubator
for 1 h at 37◦C and 5% CO2. The cells that were not attached
to the scaffolds were washed away and then the seeded scaffolds
were incubated for 1 week at 37◦C before being placed on the
CAM of fertilized chicken eggs. Empty scaffolds were used as
controls (data not shown).
CAM Assay
No IACUC approval is necessary when performing experiments
in chicken embryos until embryonic day 14 according to Swiss
animal care guidelines (TSchV, Art. 112). Fertilized Lohman
white LSL chicken eggs (Animalco AG, Staufen AG, Switzerland)
were pre-incubated for 3 days at 38◦C at a rotation speed
of 360◦/4 h (Bruja 3000, Brutmaschinen-Janeschitz GmbH,
Hammelburg, Germany). On embryonic day 3 (ED 3) the eggs
were processed for in ovo cultivation, which requires the opening
of the shell with a drill (Dremel§, Conrad Electronic AG,
Wollerau SZ, Switzerland). 2mL of albumen was always removed
with a syringe to increase the empty space under the top of the
egg shell. The eggs were stabilized in 60mm Petri dishes (Greiner
Bio-One GmbH, Frickenhausen, Germany) and the created holes
of the shells were covered with another 60mm Petri dish that
was fixed with a tape before the incubation of eggs at 37◦C.
On ED 7, empty and cell-seeded scaffolds were placed on the
CAM (1-2/egg) in the middle of silicone rings that ensure a
flat surface (Figures 1A,B) during their incubation period of 7
days.
In vivo Assessment of Perfusion Capacity
Using MRI
Vascularization of the scaffolds by capillaries of the chicken
embryo’s CAM was studied on ED 14 using Magnetic Resonance
Imaging (MRI) as previously described (Kivrak Pfiffner et al.,
2015). The eggs were placed onto a custom-built sliding
bed and enveloped by warm water tubing to maintain the
temperature of the chicken embryo in a physiological range.
To prevent motion, the chicken embryo was sedated with
5 drops of 1:100M ketamine (Ketasol-100, Dr. E. Graeub
AG, Bern BE, Switzerland) dripped onto the CAM surface.
MRI was performed with a 4.7 T/16 cm Bruker PharmaScan
small animal scanner (Bruker BioSpin MRI GmbH, Ettlingen,
Germany) equipped with an actively decoupled two-coil system
consisting of a 72mm bird cage resonator for excitation and
a 20mm single loop surface coil for reception. Anatomical
reference images were obtained in coronal, transversal, and
sagittal slice orientations. T1-weighted MR images were acquired
with a RARE sequence of variable TR and TE for quantitative
T1 and T2 mapping. T1 maps were acquired in the samples
before and after intravenous injection of 100µL of 0.05M Gd-
DOTA MRI contrast agent (Dotarem R©, Guerbet AG, Zuerich
ZH, Switzerland). The time between Gd-DOTA injection and
T1 mapping was kept constant at 25min. T1 relaxation times
were determined in three regions of interest: at the interface
of the scaffold with the CAM (i.e., lower part), in the middle
part of the scaffold, and finally at the surface of the scaffold
(i.e., upper part). Perfusion capacity in these three regions
was assessed through changes in the longitudinal relaxation
rate 1R1 before and after injection of Gd-DOTA, as the
relaxation rate changes with the amount of gadolinium present in
the CAM.
Histological Analysis
The scaffold-CAM complex was fixed in 4% paraformaldehyde
(PFA) at 4◦C overnight. The cell-seeded constructs were
excised from the CAM, embedded in paraffin (Haslab
GmbH, Ostermundigen BE, Switzerland) and sectioned
vertically in 5µm thick sections. For histological evaluation,
sections from the center of the scaffolds were stained with
Hematoxylin and Eosin (H&E) (Mayer’s hemalum solution,
Merck KGaA, Darmstadt, Germany; Eosin Y, Sigma-Aldrich
Chemie GmbH, Buchs SG, Switzerland). Pictures were
taken using the Axio Scan.Z1 slidescanner (Carl Zeiss AG,
Oberkochen, Germany), a Hitachi HV-F202FCL camera
(Hitachi, Ltd., Tokyo, Japan), and the ZEN 2012 SP2 software
(Carl Zeiss AG, Oberkochen, Deutschland) provided by the
Center for Microscopy and Image analysis, University of
Zurich.
Manual Vessel Analysis
The number of vessels and the percentage of vessels per scaffold
area were determined by counting the number of vessels in
longitudinal sections taken from the center of the scaffold (i.e.,
middle part). Each vessel was marked in black and ImageJ v1.48s
(National Institutes of Health, USA) was used to analyze the
number of marked vessels and their total area. Three sections of
each sample (3× hDPSCs, 3× hGFs) were analyzed.
Statistics
For a comparison of the groups a one-way analysis of
variance (ANOVA) was performed using GraphPad Prism
v6.05 (GraphPad Software, Inc., La Jolla, CA, USA). A
Bonferroni’s multiple comparisons test was conducted to
determine significant differences between the groups. Data were
considered significant at p < 0.05 (∗) and highly significant at
p < 0.01 (∗∗).
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FIGURE 1 | Experimental setup and MRI analysis. (A,B) The scaffold is placed in the middle of a silicone ring on top of the CAM of a fertilized egg, which is
stabilized in a Petri dish and incubated for 1 week. (C) Top and (D) bottom views of the scaffold after 1 week of incubation in ovo. (E) Scheme showing the analyzed
parts of the samples. (F) Magnetic resonance image of the vascularized scaffold before and after the injection of the contrast agent Gd-DOTA. (G) Relaxation rate
change 1R1 in the interface, middle, and surface region of the scaffolds. Values are given as mean ± standard deviation. No statistically significant differences were
found. (H) Percent change of the mean 1R1 and slope of regression line between the interface and the surface layers within each group. CAM, chorioallantoic
membrane; sc, scaffold; sr, silicone ring; vs, vessel; hDPSCs, human dental pulp stem cells; hGFs, human gingival fibroblasts.
RESULTS
Macroscopic Analysis
In growing vessels were visible on the surfaces of the hDPSC- and
hGF-seeded silk fibroin scaffolds, both on the top (Figure 1C)
and on the bottom (Figure 1D) of the samples after their CAM
incubation for 1 week.
MRI Analysis
For a more precise analysis of the perfusion capacity of the
samples, the scaffolds were divided into three equally sized
regions, specified as “interface” (i.e., bottom of the scaffold
touching the CAM), “middle,” and “surface” (Figure 1E).
Thereafter, their perfusion capacity was determined by
calculating the change of R1 relaxation rates (1R1) measured
by MRI before and after contrast enhancement by injected
Gd-DOTA, a paramagnetic contrast agent (Figure 1F). The 1R1
values within the three regions of the scaffolds showed a gradual
decrease of their perfusion capacity toward the surface region
(Figure 1G). A comparison of the perfusion capacity between
the hDPSC- and hGF-seeded silk fibroin scaffolds showed no
significant differences of 1R1within any of the three scaffold
regions (Figure 1G). Both cell-seeded scaffolds showed only a
percent change from interface to surface of approximately−37%
(Figure 1H) resulting in much flatter slopes of −0.57 (hDPSCs)
and −0.50 (hGFs) when compared to a slope of −1.33 observed
in empty silk scaffolds (data not shown; Kivrak Pfiffner et al.,
2015).
Histological and Manual Vessel Analysis
Qualitative and quantitative analyses of the vascularized scaffolds
were performed using sections stained with Hematoxylin and
Eosin (H&E). These histological sections showed large areas of
tissue expansion (depicted by the blue dashed line) into the
scaffold (depicted by the red dotted line) (Figure 2A). While
in the samples seeded with hDPSCs the growing tissue filled
approximately half of the scaffold areas (Figure 2A1), the tissue
occupied roughly two-thirds of the scaffolds seeded with hGFs
(Figure 2A2). CAM-derived blood vessels have penetrated both
hDPSC- and hGF-seeded scaffolds (Figures 2A3–6). A manual
analysis was performed in order to determine the number and
Frontiers in Physiology | www.frontiersin.org 4 April 2016 | Volume 7 | Article 140
Woloszyk et al. Vessel Attraction Impact of hDPSCs
FIGURE 2 | Hematoxylin and Eosin stainings of longitudinal sections and histomorphometric analysis. (A1,3,5,7) hDPSCs-seeded scaffolds. (A2,4,6,8)
hGFs-seeded scaffolds. (A1,2) Scaffold section overview. Blue dashed line indicates the front line of the growing tissue. Red dotted line indicates the outline of the
scaffold. Scale bar = 1mm. (A3,4) Magnifications showing vascularization in the area marked with a red box in the corresponding overview picture. Arrows indicate
capillaries. Scale bar = 25µm. (A5,6) Magnifications showing single capillaries. Scale bar = 10µm. (A7,8) Schematic representation of the capillaries shown in 5 and
6. (B1) Number of vessels per scaffold area. (B2) Percent vessel area per scaffold area. Values are given as mean ± standard deviation. No statistically significant
differences were found. EC, endothelial cells; hDPSCs, human dental pulp stem cells; hGFs, human gingival fibroblasts.
the percent area occupied by the vessels within the three defined
scaffold areas (Figure 2B). The corresponding graphs showed
proportional values for scaffolds seeded with hDPSCs and hGFs.
Although the average size of the counted vessels in both scaffolds
was the same, a higher number of vessels was counted in hGFs-
seeded scaffolds. This is due to the larger area occupied by the
tissue in hGFs-seeded scaffolds when compared to the occupied
tissue area in hDPSC-seeded scaffolds. The distribution of the
vasculature along the horizontal axis of the scaffold was nearly
homogeneous, whereas the vessel density decreased along the
vertical axis following an interface-middle-surface gradient.
DISCUSSION
The use of biomaterials combined with stem cells aims at the
successful healing and regeneration of injured or pathological
tissues and organs (Stock and Vacanti, 2001; Griffith and
Naughton, 2002). An essential prerequisite for effective tissue
repair is the integration of the grafted material into the
host tissue and its fast and effective vascularization, which
ensures the constant supply of nutrients and oxygen, thus
preventing necrosis of the newly formed tissue (Novosel et al.,
2011). Therefore, it is essential and vital in stem cell-based
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regenerative treatments to immediately attract blood vessels into
the implanted cell-seeded scaffolds. Enhanced vascularization
of the silk fibroin scaffolds has been achieved by integrating
a mixture of endothelial cells with osteoblasts (Unger et al.,
2010), but also by adding only one of these two cell populations
(Unger et al., 2010; Ghanaati et al., 2011). Here we analyzed
the capacity of human dental pulp stem cells (hDPSCs) and
gingival fibroblasts (hGFs) seeded into silk fibroin scaffolds
to attract vessels from the chicken embryo chorioallantoic
membrane (CAM). Vascularization of the scaffolds was assessed
with magnetic resonance imaging (MRI) and histomorphometric
analyses demonstrating that both hDPSCs and hGFs have an
equal capacity in attracting vessels within silk fibroin scaffolds.
Small discrepancies between MRI and histomorphometric
analysis data can be explained by the sample size that was
evaluated: histomorphometry assesses only a part of the scaffold,
whereas MRI measures the entire scaffold. The high perfusion
capacity and the homogenous vessel distribution within hDPSC-
or hGF-seeded silk fibroin scaffolds suggest an improved and
faster regenerative outcome. The present results also indicate
that a relatively long pre-incubation period (i.e., 1 week) of
these cells is necessary for obtaining the homogeneous and
abundant vascularization of the entire scaffold that favors its
integration into the host tissue. Indeed, our previous studies
based exclusively on MRI measurements have shown that a
shorter pre-incubation period (i.e., 1 day) of hDPSCs is not
leading to such a uniform distribution of vessels within silk
scaffolds (Kivrak Pfiffner et al., 2015). Comparison between
hDPSCs and hGFs seeded scaffolds did not result in obvious
differences concerning the attraction of vessels. Similarly to the
hDPSCs, hGFs are derived from cranial neural crest cells that
possess stem cell properties (Xu et al., 2013; Chiquet et al.,
2015; Mitsiadis et al., 2015) and exhibit a higher regenerative
potential when compared to fibroblasts of non-oral origin
(Eslami et al., 2009) that may explain the similarities observed in
vessel attraction into the scaffolds by hDPSCs and hGFs. Previous
studies based on gene expression analysis have compared the
angiogenic properties of hDPSCs and hGFs and suggested that
hDPSCs possess a stronger angiogenic potential (Hilkens et al.,
2014). However, studies realized on the CAM have shown
that the number of vessels growing into hDPSC- and hGF-
containing MatrigelTM droplets was not variable (Hilkens et al.,
2014). Vascular ingrowths have been observed into cell-free silk
scaffolds after subcutaneous transplantation in mice, but these
structures were mainly localized on the scaffold surface (Unger
et al., 2010; Ghanaati et al., 2011).
Taken together the present findings clearly demonstrate that
hDPSCs and hGFs possess equal capabilities in attracting
vessels within silk fibroin scaffolds. Furthermore, these
results show that the prolonged pre-incubation period
of these two cell populations before their implantation,
favors the homogeneous distribution of vessels within silk
fibroin scaffolds, a process that guarantees successful tissue
regeneration.
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Three-dimensional imaging of the developing vasculature within stem cell-seeded scaffolds 
cultured in ovo (METHODS ARTICLE) 
 
In this paper we present our protocol, which we had established for the perfusion of vascularized 
3D biomaterials when cultured on the chorioallantoic membrane (CAM) of developing chicken 
embryos followed by microcomputed tomography (microCT) imaging of the vasculature. 
Previous publications had described a similar procedure for 3D biomaterials implanted in 
mammals (e.g. mice and rats). However, no protocol was available for 3D biomaterials incubated 
on the CAM of fertilized chicken eggs, which can be used to study the ingrowth and distribution of 
vessels into 3D scaffolds. In order to visualize the vascular network with microCT, a perfusion of 
the vascular system with a radiopaque compound was required. My literature research for an 
injectable radiopaque material suggested the use of MicroFil®, which cures once the samples are 
placed at 4°C overnight.  
While preparing the manuscript I was responsible for the compilation of the figures and 
contributed to the writing and literature research. I provided a step-by-step protocol describing 
the seeding of 3D silk scaffolds with human dental pulp stem cells and their pre-culture in vitro, 
the in ovo culture conditions for the CAM assay, as well as the procedure for the MicroFil® 
perfusion, and microCT scanning. The optimization of this procedure included the fixation of the 
needle in the vessels of the CAM for successful perfusion, the adaptation of the proportions of the 
MicroFil® color and diluent for optimal filling of the vasculature, and the preparation of the 
samples for microCT scanning. The presented visualization method shows that a technique, which 
is commonly used in in vivo experiments performed in rodents, can also be applied in the cost-
effective and easy to perform CAM assay. Therefore, it offers an additional analytical technique 
for the well-established in ovo angiogenesis assay, providing an easy but important tool for 
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Successful tissue engineering requires functional vascularization of the three-dimensional
constructs with the aim to serve as implants for tissue replacement and regeneration.
The survival of the implant is only possible if the supply of oxygen and nutrients by
developing capillaries from the host is established. The chorioallantoic membrane (CAM)
assay is a valuable tool to study the ingrowth and distribution of vessels into scaffolds
composed by appropriate biomaterials and stem cell populations that are used in
cell-based regenerative approaches. The developing vasculature of chicken embryos
within cell-seeded scaffolds can be visualized with microcomputed tomography after
intravenous injection of MicroFil®, which is a radiopaque contrast agent. Here, we provide
a step-by-step protocol for the seeding of stem cells into silk fibroin scaffolds, the CAM
culture conditions, the procedure of MicroFil® perfusion, and finally the microcomputed
tomography scanning. Three-dimensional imaging of the vascularized tissue engineered
constructs provides an important analytical tool for studying the potential of cell seeded
scaffolds to attract vessels and form vascular networks, as well as for analyzing the
number, density, length, branching, and diameter of vessels. This in ovo method can
greatly help to screen implants that will be used for tissue regeneration purposes before
their in vivo testing, thereby reducing the amount of animals needed for pre-clinical
studies.
Keywords: chorioallantoic membrane (CAM), vascularization, stem cells, biomaterials, 3D imaging, MicroFil®,
microcomputed tomography, regenerative medicine
INTRODUCTION
The formation of new networks of blood vessels (i.e., angiogenesis) is essential in embryonic
development, tissue homeostasis, pathology, and regeneration. Hematopoietic cells circulating
within the vasculature supply the surrounding tissues with oxygen and nutrients, transport
hormones, remove waste products, and CO2, and protect the body from infections (Carmeliet
and Jain, 2011). Successful engineering of tissue substitutes and transplantable organs depends
on their rapid and adequate angiogenesis, since the appropriate supply of oxygen and nutrients
is crucial for their long-term survival (Mitsiadis and Harada, 2015; Mitsiadis et al., 2015). A dense
network of capillaries is formed in most tissues of the body that regulates the diffusion limit of
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oxygen (Carmeliet and Jain, 2000; Novosel et al., 2011).
Spontaneous vascular ingrowth from the host tissue to the
transplanted devices (e.g., empty biodegradable implants) is
very slow and limited to several tenths of micrometers per
day (Rouwkema et al., 2008). Therefore, the improvement and
acceleration of implant vascularization remains a key challenge
in regenerative medicine.
Classical in vivo angiogenesis assays rely on small (e.g.,
mice, rats) and large (e.g., sheep, goats) animal models,
where engineered constructs are most commonly implanted
subcutaneously at their dorsal part (Staton et al., 2009;
Jungraithmayr et al., 2013; Wang et al., 2015). However,
these surgical procedures are time-consuming and often
associated with high costs and repetitive animal sacrifice. The
chorioallantoic membrane (CAM) is highly vascularized and
serves as a transient gas exchange surface during the incubation
period, similar to the lung (Romanoff, 1960). Originally, the
CAM assay was used in order to study the developmental
potential of embryonic tissue grafts (Rücker et al., 2006). As
chicken embryos become immunocompetent only by day 18
of their development (Janković et al., 1975), various biological
processes where vascularization plays a role can be studied
without inducing an immune response, including insufficient
vascularization (e.g., ischemic disorders) or excessive vessel
formation (e.g., cancer), with the goal to either enhance or
decrease vessel growth, respectively (Ribatti, 2014).
To visualize the three-dimensional (3D) development of the
vasculature within implants cultured on the CAM, perfusion of
the chicken embryos was performed with the radiopaque contrast
agent MicroFil R© followed by microcomputed tomography
(microCT) of the implants. We demonstrate that this technique,
which is commonly used in in vivo experiments performed
in rodents (Bolland et al., 2008; Schmidt et al., 2009;
Stoppato et al., 2013), can also successfully be applied in the
CAM assay.
MATERIALS AND METHODS
Seeding of Human Dental Pulp Stem Cells
a. Defrost cryopreserved human dental pulp stem cells and
culture in Dulbecco’s Modified Eagle Medium: Nutrient
Mixture F-12 (DMEM/F12) + 10% fetal bovine serum +
1% penicillin/streptamycin + 0.5 µg/mL fungizone in a
humidified incubator at 37◦C and 5% CO2. Change the
medium every 3–4 days.
b. At 80–90% confluency, trypsinize the cells, use a 70
µm strainer to obtain a single-cell suspension, centrifuge
(1500 rpm, 5min, RT), and resuspend the cell pellet at a
concentration of 1× 106 cells/50 µL.
c. Place the sterile cylindrical scaffold (silk fibroin, 5mm
diameter, 3mm height) on a sterile filter paper to absorb
any residual liquid and move the scaffold into the well of a
96-well-plate.
d. Seed the scaffold by pipetting 50 µL of the cell suspension on
top of the scaffold, turn the scaffold, take up the cell suspension
from the bottom of the well, and release it again on top of the
scaffold.
e. For cell attachment, place the cell-seeded scaffolds in a
humidified incubator for 1 h at 37◦C and 5% CO2. Wash the
scaffold before placing it in a clean well of a 24-well-plate and
adding 1 mL of medium. Culture for desired period of time
and change medium every 3–4 days.
The procedure for anonymized cell collection was approved by
the Kantonale Ethikkommission of Zurich and performed with
written patients’ consent.
Preparation of the Chicken Eggs for the
CAM Assay and Placing of the Cell-Seeded
Samples
a. Pre-incubate fertilized Lohman white LSL (Lohman Selected
Leghorn) chicken eggs in an egg incubator for 3 days at 38◦C
at a rotation speed of 360◦/4 h.
b. On embryonic day 3 (ED 3), stop the rotation in the morning
and let the eggs rest in this position for 3 h to ensure that the
embryo is on the top.
c. Mark the top of the egg with a pencil and carefully wipe the
egg-shell with 70% ethanol without turning it.
d. Inside a clean bench, place the egg in a 60 mm Petri dish on
top of a piece of tape to stabilize the egg.
e. Make a small hole in the shell with the tip of sterile pointy
scissors and remove 4 mL of albumen using a syringe and a
needle to lower the developing embryo.
f. Put ScotchTM tape on the area where you want to make the
window.
g. Make another small hole, insert the scissors carefully and start
cutting an oval hole while turning the egg with the other hand.
h. Remove the shell and cover the opening with a second 60 mm
Petri dish, which needs to be fixed to the bottom lid with tape,
and incubate in a humidified incubator at 37◦C and 0% CO2.
i. On ED 7, the cell-seeded scaffolds can be placed on the
vascularized CAM. Remove the Petri dish lid, place a silicone
ring (taken from sterile cryovials) on the CAM to ensure a flat
surface, and position the sample in the middle of this ring.
j. Incubate for 7 days until ED 14 in a humidified incubator at
37◦C and 0% CO2.
Microfil® Perfusion and Microct Imaging
a. On ED 14, the chicken embryos are perfused with a mix of the
MicroFil R© components. Dilute the silicone rubber injection
compound (yellow) 10-fold in MV-Diluent and add 10% (by
weight) MV-Curing Agent right before use. Working time is
at least 20min and starts with the addition of curing agent.
b. Fill the MicroFil R© mix into a 5mL syringe and attach a three-
way valve (Discofix R© C) with a 10 cm tube for more flexibility
between the 30G ½” needle and the syringe.
c. Using a stereoscope, fix a branch of the vitelline vasculature
matching the diameter of the needle with blunt end tweezers
and carefully insert the needle into the vessel. Apply a small
drop of superglue where the needle enters the vasculature
(Figure 1).
d. Inject the MicroFil R© mix carefully into the vasculature until
the pressure increases.
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FIGURE 1 | Setup for the perfusion of the chorioallantoic membrane
vasculature. The scaffold is placed in the middle of a silicone ring and
cultured for 7 days in ovo. For proper perfusion a 30G ½” needle is fixed with a
drop of superglue before MicroFil® (yellow) injection.
e. If filling of the vasculature is not sufficient, inject MicroFil R©
a second time into a non-perfused vessel. Remove the tube
from the needle, which remains in the CAM, and attach a fresh
needle to the tube. Repeat steps c and d.
f. Place the perfused chicken embryo overnight at 4◦C for
complete curing of the MicroFil R©.
g. On the next day, remove the perfused scaffold samples
from the CAM using scissors, wash in PBS, fix in 4%
paraformaldehyde, wash in PBS, and place in 70% ethanol
until microCT imaging.
h. Perform microCT scanning at an isotropic resolution of 20
µm, an energy level of 70 kVp, an intensity of 114 µA, and
300 ms integration time.
According to Swiss animal care guidelines experiments
performed in chicken embryos until ED 14 do not need ethical
approval (TSchV, Art. 112).
RESULTS
We have used the CAM assay to study the vascularization
of a 3D biomaterial when placed in a highly vascularized
environment. The perfusion of the vascular system was
performed without pre-perfusion with phosphate buffered saline,
as the blood was forced out by the injected MicroFil R©. The
initial perfusion efficiency with MicroFil R© diluted according to
the manufacturer’s recommendation was improved by using a
higher dilution of the silicone rubber injection compound, which
required an increased amount of the MV-Curing Agent of 10%
instead of 5% (by weight). If the perfusion was not complete
after one injection, a second injection site was chosen to fill non-
perfused areas (Figures 2A,B). Immunohistological stainings can
still be performed on sections of paraffin-embedded samples after
perfusion and microCT analysis (Figure 2C).
The microCT scan showed the MicroFil R© perfused 3D
vascular structure growing into the scaffold (red area in
FIGURE 2 | Macroscopical and microscopical view of perfused
samples. (A) Perfused (yellow) and non-perfused (red) vessels after one
injection showing incomplete perfusion. (B) Exemplary sample after two
injections of MicroFil®. (C) Histological section of a perfused sample showing
vessels (brown) containing MicroFil®.
Figure 2B) from the bottom and from the sides within 7 days of
in ovo culture.While themacroscopical image of the same sample
in ovo (Figure 3A) provides only the information about the
vascularization visible on the surface of the CAM, the microCT
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FIGURE 3 | Stem cell-seeded scaffolds perfused with MicroFil® after
their in ovo culture. (A) Macroscopic view of a scaffold (green dashed line)
immediately after perfusion with yellow MicroFil®. The silicone ring is seen in
white, vasculature in yellow. (B) Microcomputed tomography image of the
vascular cast within the scaffold (red color). Vasculature outside the scaffold
area is marked in brown. New capillaries are sprouting from one large vessel
that encircles the scaffold (white arrows).
image visualizes the whole vascular network. Interestingly, new
capillaries are sprouting from one large vessel that encircles the
scaffold, (Figure 3B, white arrows). The generated microCT data
can be further used for complete morphometric characterization
of the vascular network, including the number, length, branching,
and diameter of vessels.
DISCUSSION
The generation of vascularized tissues and organs remains one
of the key challenges in regenerative medicine (Novosel et al.,
2011; Mitsiadis et al., 2012; Dew et al., 2015). Visualization
of angiogenesis within implanted engineered devices aiming at
tissue replacement and/or regeneration is pivotal for predicting
and understanding the outcome of new regenerative approaches
before their application in clinics.
Several techniques have been extensively used to study
the vascular architecture of the whole body, as well as the
microvasculature of specific organs and tissues in both health
and disease. The development of new visualization methods
using microcomputed tomography (microCT) improved our
knowledge on specific tissue anatomy, physiology, and pathology
tremendously. Further, developments using perfusion of tissues
and organs before microCT scanning allowed additional analyses
at the histological level and generated a plethora of volumetric
and quantitative data (Garcia-Sanz et al., 1998). Therefore,
the combination of vascular perfusion with microCT imaging
and analysis has been applied in many fields, including
embryonic vascular development (Anderson-Berry et al., 2005),
cancer research (Xuan et al., 2007), cardiac disease models
(Sangaralingham et al., 2012), and tissue engineering (Bolland
et al., 2008; Stoppato et al., 2013). For example, the combination
of MicroFil R© perfusion with microCT imaging has been used
to study angiogenesis in tissue engineered constructs implanted
subcutaneously into immunosuppressed mice. Both natural
allografts and osteosynthetic [poly (D,L)-lactic acid; PDLLA]
grafts seeded with human bone marrow stromal cells (BMSCs)
have been used for this study. The presence of BMSCs was
able to increase the number of vessels within the implants
(Bolland et al., 2008). Similarly, MicroFil R© perfusion and
microCT scanning have been performed in VEGF-treated
porous polyurethane scaffolds implanted subcutaneously into
rats (Schmidt et al., 2009). A more recent study using MicroFil R©
perfusion and microCT scanning has demonstrated that silk
fibroin fibers combined with a PDLLA salt-leached sponge
promoted vascularization when implanted subcutaneously into
rats (Stoppato et al., 2013).
However, all these previous studies are based on rodents
and therefore necessitate extensive animal care-taking, ethical
approvals, as well as surgical skills and equipment. Moreover,
a minimum of 10 days incubation time is needed in order to
analyze implant vasculature. In contrast, the CAM assay is a
simple, cost-effective, and highly reproducible method, which
does not require ethical approval when performing experiments
in chicken embryos until embryonic day 14 (Swiss animal care
guidelines, TSchV, Art. 112). Even though the incubation time
on the CAM is limited to a period of 7 days, it constitutes
an excellent screening method to study the early phase of
angiogenesis within implanted scaffolds. Following the “3Rs”
principles of replacement, refinement, and reduction of animal
use in research, the CAM assay combined with MicroFil R©
perfusion and microCT analysis as described in this protocol
provides a valuable intermediate platform for initial assessments
prior to pre-clinical studies in mammals.
This technique could be applied for the direct comparison of
scaffolds (ceramics, synthetic polymers, and natural polymers)
seeded with stem cell populations of different origins [e.g.,
adipose-derived stem cells (ASCs), bone marrow stem cells
(BMSCs), DPSCs, periodontal ligament stem cells]. For example,
it has been shown that BMSCs possess angiogenic potential
(Oswald et al., 2004), but little is known about their capability
to attract vessels in engineered structures. In contrast, ASCs
have been demonstrated to promote the neovascularization when
seeded in different scaffolds (De Francesco et al., 2009; Chan
et al., 2016; Guo et al., 2016). In conclusion, the present method
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can constitute a valuable tool for studying in detail cell-mediated
vascularization efficiency.
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